Studies of exocytosis at single cells by Thornley, Keith T.
Studies of Exocytosis at Single Cells 
 
 
 
 
Keith T. Thornley 
 
 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Department of Chemistry 
 
 
 
 
Chapel Hill 
2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Approved by: 
 
Dr. R. Mark Wightman 
 
Dr. Linda Spremulli 
 
Dr. Nancy Thompson 
 
Dr. Gary Glish 
 
Dr. Mark Schoenfisch 
Abstract 
 
Keith T. Thornley:  Studies of Exocytosis at Single Cells 
(Under the direction of Dr. R. Mark Wightman) 
 
 
 Intercellular communication via chemical signaling is vital to the healthy functioning 
of multicellular organisms.  In exocytosis, intracellular vesicles undergo Ca2+-triggered fusion 
with the cell plasma membrane, releasing their chemical messengers into the extracellular 
space.  As exocytosis serves as the primary mechanism of communication at neuronal 
synapses, great emphasis has been placed on understanding the complex cellular 
regulation of this process.  This dissertation focused on the use of amperometry and fast 
scan cyclic voltammetry at carbon-fiber microelectrodes to monitor exocytosis in real-time at 
both isolated neurons and chromaffin cells, well-characterized model cells for neuronal 
exocytosis.  These techniques provide the necessary temporal resolution and sensitivity 
required to detect the chemical signals resulting from individual vesicular release events.  
Amperometric recordings at midbrain dopamine neurons showed that somatodendritic 
dopamine release is exocytotic, with a bimodal distribution of vesicular events.  A 
combinatorial approach was used to demonstrate alterations in biogenic amine exocytosis in 
mice lacking the mitochondrial uncoupling protein UCP2 or the hormone leptin.  Conversely, 
a mouse model of fragile X syndrome revealed no deficiencies in vesicular release 
mechanisms.  Electrochemical methodologies were developed to distinguish catecholamine 
transmitters from the L-tyrosine-derived trace amines.  Application of these methods 
revealed poor vesicular accumulation of trace amines precludes their function as false 
transmitters.  Finally, vesicular quantal size in chromaffin cells was shown to be resistant to 
exogenous application of catecholamine precursors.  
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Chapter 1 
 
Techniques for the Study of Exocytosis 
 
 
Introduction 
 Chemical signaling forms the basis of intercellular communication in multicellular 
organisms.  Following triggered secretion, chemical messengers diffuse to their site of action 
where they are specifically detected by target cells.  Exocytosis is a secretory process in 
which intracellular vesicles containing chemical messengers fuse with the cell's plasma 
membrane extruding the vesicular content into the extracellular space.  Exocytosis is the 
primary cellular mechanism for the triggered release of chemical messengers, and has been 
the object of intense study as it represents the principle method of communication at the 
neuronal synapse. 
 In the mammalian nervous system, information is transmitted in pathways via 
specialized cells called neurons (Figure 1.1).  Neurons are excitable cells that communicate 
with each other through a combination of electrical and chemical signals.  Through strict 
regulation of intracellular and extracellular ion concentrations (mainly Na+, K+, and Cl-), 
neurons maintain a negative resting potential across the plasma membrane of 
approximately 70 mV (with the intracellular compartment being more negative) (Squire, 
2008).  Neurons receive inputs at their dendrites, where the action of chemical messengers 
on ionotropic receptors produces changes in ion concentration gradients that manifest as 
fluctuations in membrane potential.  These fluctuations can be excitatory or inhibitory, with 
excitatory responses corresponding to positive deflections in the membrane potential and 
inhibitory responses to negative deflections.  Responses from the entire dendritic field are 
  
 
 
Figure 1.1.  Schematic drawing of a neuron.  Neurons receive inputs at the dendrites.  
Inputs are summed at the cell body, or soma.  If the inputs are significant , the neuron will 
fire an action potential that propagates down the axon to the axon terminals, which form 
specialized specialized connections called synapses (black box) on the dendrites of target 
neurons.  
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summed at the cell body, or soma.  If the membrane potential is deflected above the 
threshold, the neuron will fire an action potential.  During an action potential, the positive 
deflections in membrane potential trigger the opening of voltage-gated Na+ channels and the 
influx of Na+ ions into the cell along their concentration gradient, further depolarizing the 
membrane.  As voltage-gated K+ channels open, prompting efflux of K+ ions out of the cell 
along their concentration gradient, and the Na+ channels begin to inactive, the cell returns to 
its resting membrane potential.  The action potential propagates down the axon as local 
depolarization stimulates the opening of neighboring Na+ and K+ channels, ultimately 
reaching the synapse, a specialized connection between axon terminals and the dendrites 
of their target neurons.  At the synapse, the invading action potential causes voltage-gated 
calcium channels (VGCCs) to open, and the resulting Ca2+ influx triggers the exocytosis of 
chemical neurotransmitters (Llinas et al., 1992; Borst and Sakmann, 1996).  The 
transmitters diffuse across the synaptic cleft, a 20-50 nm gap ensuring the electrical 
depolarization isn't transferred to the next cell, and their actions on postsynaptic receptors 
begin the signal transduction process anew. 
Exocytosis 
 Figure 1.2 shows a drawing that outlines some of the major steps in the exocytotic 
process.  Vesicles are packaged with neurotransmitters via active transport and then are 
localized in clusters/pools near the presynaptic active zone.  Prior to release, vesicles must 
be physically relocated to the plasma membrane.  In a series of ATP-dependent steps, 
vesicles are recruited, tethered, and docked to the plasma membrane (Burgoyne and 
Morgan, 2003).  A final priming step renders vesicles competent for Ca2+-triggered formation 
of the fusion pore and secretion of their contents into the extracellular space.  Following 
release, vesicles are recycled for further rounds of exocytosis through three primary routes 
depending on whether full fusion and incorporation of the vesicular membrane into the 
plasma membrane occurred.  Vesicles that do not undergo full fusion may be recycled  
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Figure 1.2.  The synaptic vesicle cycle.  Red arrows indicate steps in exocytosis and yellow 
arrows indicate steps in endocytosis.  Synaptic vesicles are filled with neurotransmitters via 
active transport (1).  Prior to release, vesicles are mobilized from clusters/pools (2) to dock 
at the plasma membrane (3).  Following a priming step (4), vesicles are capable of 
undergoing Ca2+-triggered fusion (5).  Vesicles are recycled via several pathways including 
local reuse (6), fast recycling without an endosomal intermediate (7), and clathrin-mediated 
endocytosis with or without an endosomal intermediate (8-9).  (Sudhof, 2004) 
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without undocking, leaving them available for immediate release (sometimes termed "kiss 
and stay" exocytosis), or can undock and undergo local repackaging ("kiss and run" 
exocytosis) (Harata et al., 2006).  After full fusion, vesicles undergo a slower endocytosis 
pathway via clathrin-coated pits that may or may not involve an endosomal intermediate 
(Smith et al., 2008). 
Points of Regulation 
 Neurotransmitters are packaged at high concentrations into vesicles via active 
transport.  Biochemical studies have revealed seven transporter proteins for the classical 
neurotransmitters:  three differentially-expressed transporters for glutamate (Bellocchio et 
al., 2000; Fremeau et al., 2001; Fremeau et al., 2002), two differentially expressed 
transporters for all the monoamines (Erickson et al., 1992; Liu et al., 1992), a single 
transporter for gamma-aminobutyric acid (GABA) and glycine (McIntire et al., 1997; Sagne 
et al., 1997), and a single transporter for acetylcholine (Roghani et al., 1994).  Active 
transport is driven by a vacuolar-type proton pump that couples hydrolysis of ATP to the 
movement of H+ from the cytosol to the vesicle interior, generating an electrochemical 
gradient (Maycox et al., 1988).  The vesicular transporters then couple translocation of 
transmitter against its concentration gradient with the exchange of H+ running down its 
electrochemical gradient (Chaudhry et al., 2008).  Transporters play two important roles in 
chemical communication.  First, expression of a particular vesicular transporter is a major 
determinant in the type of neurotransmitter used at a synapse.  As an example, GABAergic 
neurons transfected with a vesicular glutamate transmitter became capable of releasing 
glutamate in addition to GABA (Takamori et al., 2000).  Second, vesicular transporters help 
regulate the amount of neurotransmitter released during exocytosis.  For instance, 
overexpression of the vesicular monoamine transporter (VMAT2) has been shown to 
increase vesicular dopamine content (Pothos et al., 2000), while hemizygous deletion of the 
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VMAT2 gene lead to significantly reduced dopamine levels in the striatum (Wang et al., 
1997). 
 A second concept crucial to understanding the regulated process of exocytosis is 
that of vesicle pools.  Within a presynaptic terminal, the population of vesicles can be 
divided into two separate vesicle pools based on morphological and physiological criteria: 
the readily releasable pool (RRP), consisting of those vesicles docked at the active zone 
and immediately available for exocytosis, and the reserve pool (RP), consisting of those 
vesicles clustered at a distance from the plasma membrane and not immediately available 
for release (Rizzoli and Betz, 2005).  Directly following stimulation of the nerve terminal, 
vesicles in the RRP are released, leading to a depletion of the pool.  In response to 
prolonged or intense stimuli, continued release is dependent on the recycling of vesicles 
back into the RRP and/or the mobilization of vesicles from the RP to the RRP for 
subsequent release.  The cellular mechanisms responsible for sequestering the RP and 
controlling vesicle mobilization are still under investigation, but most work to date has 
focused on synapsins, peripheral membrane proteins associated with synaptic vesicles 
(Schiebler et al., 1986; Benfenati et al., 1989a; Benfenati et al., 1989b).  Mammals express 
three synapsin genes, with most neuronal synapses expressing synapsins 1 and 2 (De 
Camilli et al., 1990; Hosaka and Sudhof, 1998a).  Conserved among all synapsins are a N-
terminal domain containing phosphorylation sites for cAMP-dependent protein kinase and 
Ca2+/calmodulin-dependent kinases and a large, central domain with a high affinity ATP-
binding site (Hosaka and Sudhof, 1998b).  Research showing that synapsins bind to 
cytoskeletal components, particularly actin, as well as synaptic vesicles, and that 
phosphorylation of synapsins eliminates vesicle binding suggests that synapsin could be 
involved in regulating the availability of the RP vesicles via a reversible cross-linking 
between vesicles and/or vesicles and the cytoskeleton (Bahler and Greengard, 1987; 
Benfenati et al., 1992). 
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 The final point of regulation prior to release of neurotransmitters is the actual fusion 
of the vesicular membrane with the cell plasma membrane.  Four classes of proteins have 
been identified as the core machinery controlling this process:  SNARE proteins, SNARE 
regulators, Rab proteins, and Rab effectors (Jahn et al., 2003).  Rab proteins belong to a 
family of small guanosine triphosphate (GTP)-binding proteins, and interact with effectors 
and vesicles in a GTP-dependent manner (Araki et al., 1990; Johnston et al., 1991).  Rab 
proteins are presumed to act as switches, with the active, GTP-bound state rendering 
vesicles competent for docking to the plasma membrane (Rybin et al., 1996).  The 
phospholipid bilayers comprising the vesicular and plasma membrane are both negatively 
charged, resulting in an energy barrier to fusion.  Soluble NSF attachment protein receptor 
(SNARE) proteins are membrane-associated proteins that contain a characteristic residue 
sequence called the SNARE motif.  There are three SNARE proteins linked to exocytosis: 
synaptobrevin located on the vesicular membrane and syntaxin and SNAP-25 on the 
plasma membrane (Sollner et al., 1993).  Synaptobrevin and syntaxin each contain a single 
SNARE motif, while SNAP-25 contains two SNARE motifs.  Association of the four SNARE 
motifs into a "trans complex," a parallel four helical bundle, overcomes the repulsion energy 
barrier and forces the vesicular and plasma membrane together (Hanson et al., 1997; 
Weber et al., 1998).  This results in an unstable intermediate from which the fusion pore can 
form by mixing of the destabilized phospholipid bilayers.  SNARE proteins are additionally 
regulated by the Sec1/Munc18-like proteins.  While necessary for fusion, the exact roles of 
these proteins remain unclear.  To date, evidence suggests that these proteins play a role in 
controlling the availability of syntaxin for SNARE complex formation and the vesicle priming 
step following establishment of the SNARE complex (Hata et al., 1993; Deak et al., 2009). 
Ca2+-Dependence 
 As mentioned earlier, exocytosis of neurotransmitters is a Ca2+-mediated process.  
As the action potential reaches the synapse, depolarization of the cell membrane opens 
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VGCCs, and the resulting influx of Ca2+ ions serves as the ultimate trigger for release.  The 
extent to which Ca2+ elicits vesicular release is then dependent on two factors:  the 
efficiency of the cellular mechanisms for translating increases in intracellular Ca2+ 
concentration ([Ca2+]i) to vesicle fusion and the time course of the Ca2+ signal in the 
synapse.  The putative cellular Ca2+ sensor is synaptotagmin, a synaptic vesicle-associated 
protein with two Ca2+-binding C2 domains (Perin et al., 1990).  Multiple synaptotagmin 
isoforms have been identified in the brain, with synaptotagmin-1,-2, and -9 implicated as the 
Ca2+ sensors in exocytosis (Xu et al., 2007).  The current model suggests that through Ca2+-
dependent interactions with phospholipids and the SNARE proteins, synaptotagmins 
promote fusion pore formation by pulling the SNARE complexes apart (Sudhof, 2004).  
Supporting the role of synaptotagmins in exocytosis, the micromolar Ca2+ affinity of 
synaptotagmins is consistent with the Ca2+ affinity of release measured at the Calyx of Held 
synapse (Meinrenken et al., 2003), and genetic alterations of synaptotagmin Ca2+ affinity 
produce proportional changes in the Ca2+ affinity of release (Fernandez-Chacon et al., 
2001).  In addition to triggering vesicle fusion via synaptotagmin, Ca2+ influx also facilitates 
vesicle mobilization.  Increases in [Ca2+]i have been shown to relocate docked vesicles 
closer to Ca2+ entry sites (Becherer et al., 2003) and to activate the protein scinderin, which 
severs F-actin filaments (Rodriguez Del Castillo et al., 1990).  Disruption of the cortical actin 
cytoskeleton serves as a first step in the recruitment of vesicles to the plasma membrane for 
exocytosis (Burgoyne and Cheek, 1987).  Similarly, the mobilization of RP vesicles is 
thought to depend on Ca2+-mediated phosphorylation of synapsin (Chi et al., 2003). 
 The Ca2+ dynamics in a synapse can be simply represented as a series of fluxes 
between the extracellular medium, the cytosol, and intracellular organelles (chiefly 
mitochondria and the endoplasmic reticulum (ER)) (Figure 1.3).  At rest these fluxes are 
minimal, with the [Ca2+] in the cytosol and mitochondrial matrix in the 100 nM range and the 
[Ca2+] in the extracellular medium and inside the ER above 1 mM.  As the action potential  
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Figure 1.3.  Intracellular Ca2+ regulation in an adrenal chromaffin cell.  Ca2+ entry through 
voltage-gated calcium channels (VOCC) and/or release from the ER generates a local 
microdomain of high [Ca2+].  Cytosolic Ca2+ is cleared by ATP-driven pumps (white circles) 
on the plasma and ER membranes or mitochondrial uptake via the uniporter (U).  Spatial 
organization of the intracellular organelles helps define the boundaries of the microdomain 
and limit global cytosolic Ca2+ increases.  (Garcia et al., 2006)  
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invades the synapse, VGCCs open and Ca2+ rushes from the extracellular medium down its 
concentration gradient into the cytosol.  The spatial distribution of the VGCCs coupled with 
the limited diffusion of Ca2+ due to endogenous cytosolic Ca2+ buffers produces localized 
concentration microdomains in the tens of micromolar (Neher, 1998).  Ca2+ release from the 
ER, triggered via either the Ca2+-gated ryanodine receptors or second messenger inositol 
1,4,5-trisphosphate-gated channels, may also contribute to cytosolic [Ca2+] (Verkhratsky, 
2004).  Clearance of cytosolic Ca2+ occurs at the plasma membrane through the 
combination of a Na+/Ca2+ exchanger and an ATP-driven Ca2+ pump.  Cytosolic Ca2+ may 
also be cleared by uptake into intracellular organelles.  An ATP-driven Ca2+ pump resides on 
the ER membrane, and mitochondria uptake Ca2+ through a low affinity uniporter driven by 
the mitochondrial membrane potential (Gunter and Pfeiffer, 1990).  At basal levels of 
stimulation, the cytosolic Ca2+ transient is shaped primarily by diffusion and the endogenous 
buffers (Neher, 1998).  Global cytosolic [Ca2+] reaches levels around 1 µM, and clearance is 
dominated by the ATP-driven Ca2+ pumps on the plasma and ER membranes (Meinrenken 
et al., 2003; Garcia et al., 2006).  During intense stimulation, cytosolic [Ca2+] may reach 
levels high enough to facilitate uptake through the mitochondrial uniporter.  Mitochondrial 
Ca2+ uptake stimulates cellular respiration (Rizzuto et al., 2000), and Ca2+ clearance via this 
mechanism may provide the necessary energy to restore Ca2+ to resting levels. 
Systems of Interest 
 Regulated secretory vesicle exocytosis has been documented in a vast array of cell 
types including neurons, neuroendocrine cells, exocrine cells, hemopoietic cells, endothelial 
cells, and even sperm.  The primary focus of this work is to better understand the cellular 
mechanisms responsible for neuronal communication, and hence studies have been 
conducted at individual neurons and chromaffin cells, a well-characterized model system for 
neuronal exocytosis. 
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Midbrain Dopamine Neurons 
 Dopamine, along with serotonin and norepinephrine (NE), belongs to the biogenic 
amine class of neurotransmitters.  Dopamine modulates a wide variety of physiological 
functions in the brain from control of locomotion to reward seeking behavior.  The particular 
involvement of dopamine in the brain chemistry of addiction and of motor movement 
disorders such as Parkinson's and Huntington's disease makes the regulated exocytosis of 
dopamine an especially attractive system for study.  The term midbrain refers specifically to 
those dopamine neurons whose cell bodies are located in the substantia nigra (SN) and the 
ventral tegmental area (VTA).  Dopamine neurons in the SN project to the striatum to form 
the nigrostriatal pathway, while dopamine neurons in the VTA project to the nucleus 
accumbens to form the mesolimbic pathway.   
Chromaffin Cells 
 Adrenal medullary chromaffin cells, members of the neuroendocrine system, have 
been widely used in biochemical studies of vesicular exocytosis owing to their common 
origin with sympathetic neurons in the neural crest and their relative ease of isolation as 
homogenous populations in primary culture (Fujita, 1977; Livett, 1984).  Chromaffin cells 
help modulate the body's "fight or flight" response by releasing the catecholamine hormones 
epinephrine (E) and NE into the bloodstream.  A wealth of experimental evidence has 
revealed that the Ca2+ dependence of release and the protein machinery of vesicular 
docking and fusion are conserved in the chromaffin cell and the synapse (Morgan and 
Burgoyne, 1997; Burgoyne and Morgan, 2003).  Chromaffin cells are an especially useful 
model of dopaminergic neurons as they both contain the same catecholamine synthesis 
enzymes and package transmitter into vesicles with VMAT, although via different isoforms 
(Erickson et al., 1996).  The primary distinction between exocytosis at chromaffin cells and 
neurons is the size of the vesicles.  In contrast to the small synaptic vesicles (diameter ≤ 50 
nm) found predominantly at presynaptic active zones, chromaffin cells store catecholamine 
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in large dense core vesicles (LDCVs) with diameters near 300 nm.  The greater capacity of 
LDCVs facilitates measurements of individual vesicular release events.  
Techniques for Study of Exocytosis 
 Real time monitoring of exocytosis is subject to several challenging experimental 
constraints.  First, measurement at spatially resolved regions of isolated cells requires a 
sensor with physical dimensions in the micron range.  Second, observation of individual 
vesicular events requires a technique with extreme sensitivity.  For even though vesicles can 
contain high concentrations of transmitter (up to 0.5 M), their small size necessitates limits of 
detection in the zeptomole to attomole range.  Third, the rapid time course of vesicular 
fusion and release requires a technique with microsecond to millisecond resolution.  And 
finally, a cell that releases multiple transmitters or a transmitter of unknown identity requires 
a technique with chemical selectivity.  When used with carbon-fiber microelectrodes, the 
electrochemical techniques of constant potential amperometry (referred to hereafter as 
amperometry) and fast scan cyclic voltammetry (FSCV) provide the necessary spatial, 
temporal, sensitivity, and selectivity characteristics for accurate recordings of the exocytotic 
process.  These techniques take advantage of the fact that several important secreted 
chemical messengers, including the catecholamines dopamine, NE, and E, are easily 
oxidized.   
 Carbon-fiber microelectrodes provide distinct advantages over conventional-sized 
electrodes for measurements of exocytosis at single cells.  The small size of 
microelectrodes decreases double layer capacitance at the electrode tip, reducing the time 
constant of the electrode and allowing measurements down to the sub-microsecond time 
scale (Amatore and Maisonhaute, 2005).  As the spatial dimensions of the carbon-fiber 
microelectrode approximate that of a single cell, the signal to noise ratio is enhanced over 
sensors with extraneous electroactive surface area (Schroeder et al., 1994).  The use of 
disk geometries is particularly advantageous for single cell recordings.  Disk microelectrodes 
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(Figure 1.4) are fabricated by insulating a carbon fiber (6-10 µm in diameter) in a pulled 
glass capillary and beveling the tip at 45 degrees to create a flat, elliptical sensor surface 
(Kawagoe et al., 1993).  Disk microelectrodes can be positioned flush with the membrane of 
a cell, creating an "artificial synapse" configuration where the restricted extracellular volume 
into which transmitters are released minimizes signal loss due to diffusion and allows the 
release of a small number of molecules in the local vicinity of the sensor/receptor to be 
detected with a high signal to noise ratio (Amatore et al., 2008).  This same approach is 
used by nature at the biological synapse. 
Constant Potential Amperometry 
 In amperometry, the electrode is held at a constant potential sufficient to oxidize or 
reduce an analyte of interest.  Analytes are immediately electrolyzed upon contact with the 
electrode surface, resulting in a measurable current.  Unlike FSCV, in which the electrode 
response is slowed by adsorption and desorption of the analyte to the electrode surface 
(Bath et al., 2000), the temporal response of amperometry is limited only by mass transport 
and electron transfer kinetics.  Thus, amperometry offers superior temporal resolution 
compared to FSCV.  However, amperometry does not allow for positive analyte 
identification.  If multiple electroactive species are present that can undergo oxidation or 
reduction at the electrode holding potential, it is impossible to distinguish their corresponding 
components of the recorded signal.  For this reason, precaution must be taken with 
amperometric measurements in mixed samples to ensure the identity of the released 
species through knowledge of cell type and neurotransmitter content from complementary 
techniques such as FSCV and liquid chromatography.  Amperometry at carbon-fiber 
microelectrodes was first used at bovine chromaffin cells, providing the first direct chemical 
evidence of exocytosis (Leszczyszyn et al., 1990, 1991).  The technique has since been 
applied to directly observe exocytosis at many cell types ranging from pancreatic β-cells to  
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Figure 1.4.  Electron micrograph of a disk carbon-fiber microelectrode.  The carbon fiber is 
sealed in a glass capillary, and the electrode is beveled at 45 degrees to create a flat 
electroactive surface that can be positioned flush with the cell membrane. 
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neurons (Chen et al., 1994; Bruns and Jahn, 1995; Huang et al., 1995; Zhou and Misler, 
1995). 
 Figure 1.5 (top panel) shows a typical experimental setup for amperometry at a 
single cell.  The disk electrode is positioned flush with cell membrane, and exocytosis is 
induced via pressure ejection of chemical secretagogues from a nearby stimulating pipette.  
If the electrode is held at a potential sufficient to oxidize the released transmitter, a series of 
discrete current spikes are recorded (Figure 1.5, bottom panel).  The individual spikes have 
been shown to correspond to the oxidation of molecules released from single vesicles 
(Wightman et al., 1991).  By examining the number and frequency of current spikes along 
with the individual spike characteristics, much information can be revealed about the 
vesicular release mechanisms at target cells.  For example, the total number and frequency 
of events in response to a stimulus can be used to probe the size of the RRP, efficiency of 
vesicle docking and fusion, the recycling of vesicles back into the RRP, and the mobilization 
of vesicles from the RP to the RRP. 
 Figure 1.6 shows an expanded view of an individual amperometric current spike.  
Spikes are generally characterized by a sharp rise in current, corresponding to a rapid flux 
of transmitter intro the extracellular space following vesicular fusion, and a more gradual 
decay to baseline (Schroeder et al., 1996).  Additionally, pre-spike features known as feet 
may sometimes be observed (Chow et al., 1992).  These features have been attributed to 
the leak of transmitter through the fusion pore intermediate that precedes full vesicular 
fusion.  Individual spike characteristics that are commonly measured include the amplitude 
(Imax), halfwidth (t1/2), rise time (tr), decay time (td), and area (or quantal size, Q).  Spike Imax 
values can be related to the maximal flux of transmitter during a fusion event.  The kinetic 
parameters t1/2, tr, and td provide information on the time course of the extrusion of vesicular 
content following fusion.  Spike area is directly related to the number of molecules 
electrolyzed at the electrode surface.  For each spike, the integral of current with respect to  
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Figure 1.5.  Amperometric measurements of exocytosis.  Top panel: transmitted light 
micrograph showing typical experimental setup.  The microelectrode (right) is lowered until it 
contacts the cell membrane.  Exocytosis is triggered by pressure ejection of chemical 
secretagogues from a stim pipette (left) located 20 to 60 µm from the cell.  Scale bar = 20 
µm.  Bottom panel: following stimulation, a series of discrete current spikes are observed at 
the electrode.  Each spike represents the fusion of a single secretory vesicle.  Trace is taken 
from a mouse chromaffin cell stimmed with 60 mM K+.   
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Figure 1.6.  Individual amperometric spike characteristics.  Imax is the peak current or 
amplitude of the spike.  t1/2 is the width at half height.  tr and td are the rise time and decay 
time, respectively.  The area of the spike corresponds to the amount of transmitter released, 
also known as the quantal size (Q).  
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time yields the measured charge (Q, in coulombs), which is proportional to moles of analyte 
(m) by Faraday's law, Q = nFm, where n is the number of electrons involved in the 
electrochemical reaction and F is Faraday's constant. 
 Contrary to the expectations from the quantal hypothesis of neurotransmission, direct 
measurement of exocytosis with amperometry reveals that individual vesicular events are 
surprisingly nonuniform.  Histograms of raw amperometric spike Q and t1/2 data reveal non-
Gaussian distributions heavily skewed towards smaller values with the means being larger 
than the modes (Finnegan et al., 1996; Pothos et al., 1998; Villanueva et al., 2006).  If one 
assumes a uniform concentration of transmitter in the spherical vesicles, then the 
amperometric spike characteristics should depend on vesicular volume (Bekkers et al., 
1990).  Vesicle radii (volume1/3) show a normal Gaussian distribution in most cells, 
suggesting that histograms of the cube roots of Q and t1/2 should also show a Gaussian 
distribution.  These cube root distributions are indeed Gaussian, with relative standard 
deviations approximating those for the vesicle radii (Finnegan et al., 1996). 
Fast Scan Cyclic Voltammetry 
 In FSCV, the electrode potential is periodically scanned in a triangle waveform 
(Figure 1.7).  Voltage limits are chosen such that oxidation and reduction of the analyte of 
interest occur within the potential window.  The fast scan rates result in large background 
currents associated with charging of the double layer capacitance.  Fortunately, these 
background currents are stable over short time periods, allowing the use of digital 
background subtraction to reveal the comparatively small Faradaic current resulting from 
oxidation and reduction of the analyte (Howell et al., 1986).  The current amplitude is directly 
proportional to the local concentration of analyte at the electrode surface, with FSCV at 
carbon-fiber microelectrodes demonstrating nanomolar limits of detection (Cahill et al., 
1996).  The background-subtracted cyclic voltammogram (CV) is characteristic of the 
detected species, and the positions of the peak currents for oxidation and reduction and the  
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Figure 1.7.  Fast scan cyclic voltammetry technique.  In FSCV, a triangular waveform is 
applied to the electrode.  In this example, the electrode is ramped linearly from -0.4 V to 1.3 
V and back at 600 V/s.  The waveform is applied at a frequency of 60 Hz.  The analyte 
(norepinephrine in this case) is oxidized on the positive sweep and reduced on the negative 
sweep.  By scanning at such fast rates, a large charging current is generated (top right).  
The small Faradaic currents generated from analyte oxidation and reduction are hard to 
distinguish in the presence of the charging current (middle right, red ovals).  However, the 
charging background is stable over the time course of our experiments, and can be digitally 
subtracted to give the characteristic CV of the analyte (bottom right).  
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peak shapes can be used to distinguish between analytes (Heien et al., 2004).  This 
chemical selectivity of FSCV has been exploited in studies of exocytosis at single cells 
where multiple chemical messengers are released.  FSCV at carbon-fiber microelectrodes 
has been used to discriminate between vesicular release of E and NE at chromaffin cells 
(Pihel et al., 1994) and to detect release of histamine and serotonin at mast cells (Pihel et 
al., 1995).  The latter providing the first direct evidence for corelease of chemical 
messengers from a single vesicle. 
 Figure 1.8 shows an example of the data obtained by monitoring exocytosis at single 
cells with FSCV.  In this example, the potential at the electrode was scanned from -0.4 V to 
1.3 V and back at 600 V/s to measure the secretion of NE and E from a chromaffin cell.  
With this waveform, the CVs for the two catecholamines are indistinguishable and the peak 
oxidation and reduction currents occur at 0.6 V and -0.2 V, respectively.  In order to view 
multiple CVs simultaneously, FSCV data is generally presented in false color plots (Michael 
et al., 1998).  By extracting the current at the peak oxidation potential from successive CVs, 
a current vs. time trace very similar to those from amperometric measurements can be 
obtained.  As Figure 1.8 clearly shows, FSCV has sufficient temporal resolution to observe 
individual exocytotic events.  However, when compared to an amperometric trace (Figure 
1.5), it is obvious that the resolution is significantly diminished.  This, again, is due to the fact 
that the temporal response in amperometry is limited only by mass transport and electron 
transfer kinetics.  In FSCV, the temporal response is ultimately limited by the frequency at 
which the waveform is applied to the electrode.  In this case, the frequency is 60 Hz, or one 
data point every 16.7 ms.  Despite poorer kinetic information, the advantage to FSCV 
measurements of exocytosis is that the CV can be used to verify the chemical identity of the 
secreted species for each vesicular event.  Thus, amperometry and FSCV can be viewed as 
complementary techniques, each vital to the study of exocytosis at single cells. 
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Figure 1.8.  FSCV measurements of exocytosis.  A 3 s time window of release from a 
mouse chromaffin cell stimulated with 60 mM K+ is shown.  The color plot (bottom) displays 
time on the x axis, voltage on the y axis and current in false color.  Individual events are 
detectable by the color changes at the oxidation and reduction potentials of the analytes (in 
this case the catecholamines epinephrine and norepinephrine).  From the color plot, a 
current versus time trace (top) can be extracted from the peak oxidation potential (dashed 
black line).  CVs for individual events can be used to confirm the identity of the analyte 
(arrow).  
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Fluorescent Ca2+ Imaging 
 The fundamental role of Ca2+ in vesicular release makes real time monitoring of 
changes in [Ca2+]i vital for a complete understanding of exocytosis.  The development of the 
fura family of fluorescent Ca2+ indicators in the lab of Dr. Tsien has provided researchers 
with a simple tool for such measurements (Grynkiewicz et al., 1985).  One of the primary 
advantages of fura dyes is their ability to be prepared as acetoxymethyl ester derivitives, 
rendering the hydrophillic dyes membrane permeable for easy loading into cells.  In the 
cytosol, endogenous cellular esterases cleave the ester linkages effectively trapping the 
indicator inside the cell in its active form.  Figure 1.9A shows the active forms of fura-2 and 
fura-FF.  The addition of two fluorine atoms produces a near 40-fold decrease in Ca2+ affinity 
for fura-FF relative to fura-2.  With Ca2+ dissociation constants (Kd) of 0.14 and 5.5 µM, 
respectively, both fura-2 and fura-FF are suitable for studying the transient changes in 
[Ca2+]i accompanying exocytosis, where resting levels near 100 nM are rapidly increased to 
micromolar levels.  However, fura-2 does exhibit limited sensitivity to [Ca2+]i greater than 1 
µM as these concentrations approach the edge of the dye's linear response window 
(approximately 0.1 to 10 x Kd). 
 Fura dyes bind Ca2+ in a 1:1 manner.  The unbound indicator has a peak 
fluorescence excitation wavelength of 380 nm and a peak fluorescence emission 
wavelength of 510 nm (Figure 1.9B).  Upon Ca2+ binding, the dye undergoes an absorption 
shift to 340 nm, while maintaining peak fluorescence emission at 510 nm (Figure 1.9B).  
Thus, by rapidly switching the excitation wavelength between 340 and 380 nm and 
monitoring emission at 510 nm, it is possible to obtain dynamic information on the ratio of 
bound to unbound dye inside the cell.  The ability to perform ratiometric measurements 
significantly reduces the effects of differing cell thickness, uneven dye loading, dye leakage, 
photobleaching, and intensity of the excitation source; variables the must be accounted for 
in dyes utilizing only changes in fluorescence intensity upon binding (Moore et al., 1990).   
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Figure 1.9.  Structure and excitation spectra of fura Ca2+ dyes.  A.  Molecular structure of 
the active, cell-impermeant forms of fura-2 and fura-FF.  B.  Fluorescence excitation and 
emission spectra for fura-2 (fura-FF spectra are identical).  Peak excitation wavelength for 
the Ca2+-bound dye (trace A) is 340 nm.  Peak excitation wavelength for the free dye (trace 
B) is 380 nm.  Both species exhibit a peak emission wavelength of 510 nm.  Images 
adapted from product manuals available via the manufacturer's website 
(http://www.invitrogen.com/site/us/en/home/brands/Molecular-Probes.html).   
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By calibrating the indicator in solutions of known [Ca2+], experimentally determined ratio 
values can be calibrated to 2+] t ing ation: [Ca i using he follow  equ
ሾܥܽଶାሿ ൌ  ܭௗ  ൈ  
ோିோ೘೔೙
ோ೘ೌೣିோ
 ൈ  ிయఴబ೘ೌೣ
ிయఴబ೘೔೙
                                           (1) 
where Kd is the dissociation constant, R is the experimentally observed ratio, Rmin is the ratio 
measured in a Ca2+-free solution, Rmax is the ratio measured in a solution of dye-saturating 
[Ca2+], F380max is the fluorescence observed with 380 nm excitation in a Ca2+-free solution, 
and F380min is the fluorescence observed with 380 nm excitation in a solution of dye-
saturating [Ca2+].  This equation assumes that the fluorescent properties and the Ca2+ 
affinity of the dye are similar in both the calibration solutions and the cell cytosol. 
 Several important limitations have been addressed in the use of fura dyes for 
measurement of [Ca2+]i (Roe et al., 1990).  These include incomplete hydrolysis of 
acetoxymethyl ester bonds by cytosolic esterases, sequestration of fura dyes in intracellular 
organelles, quenching of fluorescence by heavy metals, active and passive dye loss from 
loaded cells, enhanced cytosolic Ca2+ buffering at high concentrations of the dye (≥100 µM), 
and shifts in the Kd for Ca2+ as a function of the viscosity, ionic strength, and temperature of 
the dye environment.  However, through careful control of experimental conditions and dye 
concentrations, fura dyes can be readily used for accurate determinations of real time 
changes in [Ca2+]i during exocytosis. 
High Performance Liquid Chromatography 
 High performance liquid chromatography (HPLC) with electrochemical detection can 
be used as a valuable supplement to the real time measurement of vesicular release events 
at single cells with amperometry or FSCV.  The high selectivity and sensitivity of this 
separation method allow for the simultaneous determination of multiple neurotransmitters 
and metabolites in biologically complex mixtures such as tissue samples, individual cells, 
and extracellular media.  The initial experiments in this field used open tubular liquid 
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chromatography with electrochemical detection to quantitatively determine the presence of 
dopamine, serotonin, tyrosine, and tryptophan at the femtomolar level in single cells of the 
land snail, Helix aspersa (Kennedy and Jorgenson, 1989).  Further experiments utilized 
reverse phase HPLC with packed microcolumns to quantitate both the E and NE content of 
and secretion from individual bovine chromaffin cells and to measure the histamine and 
serotonin content of single rat peritoneal mast cells (Cooper et al., 1992; Cooper et al., 
1994; Pihel et al., 1995).  The switch from open tubular columns to packed microcolumns 
permitted greater retention and separation, of polar compounds like the catecholamines.  
Combining HPLC determination of cellular neurotransmitter content with amperometric or 
FSCV measurement of vesicular events at single cells provides a more complete 
understanding of the related processes of transmitter synthesis, storage, and release by 
exocytosis.  
Dissertation Overview 
  The following chapters discuss the use of the electrochemical and supporting 
techniques described above to study exocytosis at single cells.  In Chapter 2, amperometry 
and fluorescent Ca2+ imaging at isolated midbrain dopamine neurons were used to examine 
the cellular mechanisms behind somatodendritic dopamine release.  Chapters 3 and 4 both 
describe collaborative efforts to investigate potential changes in regulated exocytosis at 
several transgenic mouse lines.  FSCV, amperometry, and fluorescent Ca2+ imaging were 
used to characterize biogenic amine release in mice lacking the mitochondrial uncoupling 
protein UCP2 and in mouse models of obesity and fragile X syndrome.  Chapter 5 describes 
the electrochemistry of three trace amines at carbon-fiber microelectrodes using FSCV.  The 
FSCV techniques developed in Chapter 5 were then employed in Chapter 6 to explore the 
potential utility of these trace amines as false catecholamine transmitters.  
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Chapter 2 
Origins of Extrasynaptic Dopamine Release 
 
 
 
Introduction 
 In the classical model of neurotransmission, electrochemical signals are propagated 
in a unidirectional manner:  a neuron receives information from incoming synaptic terminals 
at its dendrites, processes the information at the cell body, and then passes the information 
down its axon to terminals that form synapses with the next cell in the pathway.  Over the 
past few decades the classical model has been shown to be incomplete, as a wealth of 
evidence has accumulated demonstrating that the somatodendritic region of neurons is 
capable of synthesizing, storing, and releasing chemical neurotransmitters. 
 As far back as 1975, glyoxylic acid-induced histofluorescence was used to show the 
accumulation and storage of dopamine in the dendrites of substantia nigra (SN) neurons 
(Bjorklund and Lindvall, 1975).  Similar to the storage of dopamine at axon terminals, this 
accumulation was blocked by reserpine, an inhibitor of the vesicular monoamine transporter 
(VMAT2).  Shortly thereafter, experiments with radio-labeled dopamine revealed both 
spontaneous and depolarization-evoked release in the SN from in vivo and in vitro 
preparations (Geffen et al., 1976; Nieoullon et al., 1977).  More recently, electrochemical 
techniques have been used to make direct, real-time measurements of dopamine release in 
somatodendritic regions.  Amperometry has been used to detect quantal release events 
from the cell bodies of SN neurons in slices of rat brain (Jaffe et al., 1998), while  fast scan 
cyclic voltammetry (FSCV) has been used to characterize dopamine release in the ventral 
tegmental area (VTA) of anesthetized rats and in the SN and VTA of rodent brain slices 
(Rice et al., 1994; Rice et al., 1997; John and Jones, 2006; Kita et al., 2009).   
 Much effort has been put into understanding the mechanisms that control 
somatodendritic dopamine release.  At this point, however, debate remains as to whether 
the well-studied, Ca2+-dependent exocytotic release of neurotransmitters from axon 
terminals is also responsible for transmitter release in somatodendritic regions.  Compared 
to axon terminals, the cell bodies and dendrites of dopaminergic neurons contain a sparse 
number of vesicles (Wilson et al., 1977; Wassef et al., 1981; Groves and Linder, 1983; 
Nirenberg et al., 1996b, 1997).  Somatodendritic dopamine may be stored primarily in the 
smooth endoplasmic reticulum (SER) (Mercer et al., 1979).  Supporting this notion, in 
dendrites of dopamine neurons VMAT2 has been shown to localize primarily to 
tubulovesicles resembling saccules of SER and to a lesser extent to synaptic vesicles 
(Nirenberg et al., 1996b). 
 At axon terminals, invading axon potentials trigger exocytosis via the opening of 
voltage-gated calcium channels (VGCCs).  Similarly, somatodendritic release of dopamine 
has been shown to depend on an influx of extracellular Ca2+ (Rice et al., 1997; Bergquist et 
al., 1998; Chen and Rice, 2001; Beckstead et al., 2004).  Interestingly though, 
somatodendritic release persists at low extracellular Ca2+ levels insufficient to support 
release at axon terminals (Hoffman and Gerhardt, 1999; Chen and Rice, 2001).  In addition, 
while dopamine release at axon terminals appears to be mainly dependent on N- and P/Q-
type VGCCs, release at dendrites seems to be supported by either R-type or minimal Ca2+ 
entry through multiple VGCCs (Bergquist et al., 1998; Bergquist and Nissbrandt, 2003; Chen 
et al., 2006).  Backpropagation of action potentials through the dendritic tree has been 
demonstrated for dopaminergic neurons in vitro (Hausser et al., 1995), and may serve as 
the primary trigger for Ca2+ influx.  However, reports have also shown the existence of Ca2+ 
conductances in dopaminergic dendrites that occur independent of Na+ channels opening 
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(Llinas et al., 1984; Hounsgaard et al., 1992); thus clouding the dependence of 
somatodendritic release on dopamine neuron firing. 
 One alternative to a vesicular, Ca2+-mediated mechanism of somatodendritic release 
is reversal of the dopamine transporter (DAT).  DAT has been shown to localize to both the 
plasma membrane and SER in dendrites of dopamine neurons in the SN (Nirenberg et al., 
1996a).  Several findings suggest that at least a portion of somatodendritic dopamine 
release arises from the Ca2+-independent reversal of DAT (Elverfors et al., 1997; Hoffman 
and Gerhardt, 1999; Falkenburger et al., 2001).  However, there are also literature examples 
showing that inhibition of DAT leads to increased dendritic release of dopamine (Cragg et 
al., 1997; Hoffman et al., 1998).  Furthermore, basal and stimulus-induced dendritic 
dopamine release has been shown to depend on SNARE proteins (Bergquist et al., 2002; 
Fortin et al., 2006).  SNAREs mediate fusion of intracellular vesicles with the plasma 
membrane, and their involvement would naturally suggest an exocytotic mechanism as 
opposed to reversal of DAT. 
 This chapter describes an investigation of the biochemical origin of somatodendritic 
dopamine release via amperometric measurements at isolated neurons.  To aid in the 
identification of dopaminergic neurons, cells were harvested from transgenic mice that 
coexpress enhanced green fluorescent protein (GFP) in all cells that express tyrosine 
hydroxlase (TH), the rate-limiting enzyme in dopamine synthesis.  Amperometric recordings 
from the cell bodies of acutely dissociated midbrain dopamine neurons revealed discrete 
current spikes that were dependent on extracellular Ca2+, hallmark indications of exocytosis.   
Two vesicular populations were observed, with a majority of very rapid quantal events 
having single rising and falling phases and a minority of broader events sometimes having 
multiple rising and/or falling phases.  Amperometric recordings at chromaffin cells from both 
wild type (WT) and TH-GFP mice suggest that the exocytotic machinery was not significantly 
affected by expression of the GFP reporter gene. 
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Materials and Methods 
Animals 
 Mice were handled in accordance with the guidelines set forth by the Institutional 
Animal Care and Use Committee (IACUC) at UNC-Chapel Hill.  C57BL/6J mice (WT) were 
obtained from The Jackson Library (Bar Harbor, ME).  A TH-GFP breeding pair was 
generously provided by Dr. Lorraine Iacovitti at Thomas Jefferson University, and a colony 
was maintained locally.  These mice were generated on a C57BL/6J background and 
coexpress GFP in TH-positive cells (Kessler et al., 2003). 
Preparation Acutely Dissociated Midbrain Neurons 
 Acutely dissociated midbrain dopaminergic neurons were prepared as previously 
described (Puopolo et al., 2007), with slight modification.  A P12-P18 mouse pup was 
deeply anesthetized with ether, decapitated, and the brain rapidly removed into ice-cold, 
oxygenated dissociation medium containing (in mM): 82 Na2SO4, 30 K2SO4, 5 MgCl2, 10 
glucose, 10 HEPES, and 0.001 % phenol red, pH adjusted to 7.4 with NaOH.  400 µm thick 
coronal sections containing the midbrain were obtained using a vibrating tissue slicer (World 
Precision Instruments, Sarasota, FL).  Regions containing the SN and VTA were dissected 
out, and the pooled tissue was digested for 40 min at 37 oC in dissociation medium with 3 
mg/mL protease type XXIII.  Digested tissue was washed and triturated with fire-polished 
Pasteur pipette tips of decreasing bore size in dissociation medium with 1 mg/mL each BSA 
and trypsin inhibitor.  Cells were pelleted at 1000 rpm for 5 min, resuspended in 300 µL 
Dulbecco's Modified Eagle's Medium/Nutrient Mixture F-12 Ham (DMEM/F12), and 
distributed evenly to 3 concanavalin A-coated (1 mg/mL) 25 mm round glass coverslips.  
After 15 min attachment plates were fed with 2 mL DMEM/F12 and maintained in a 
humidified, 5 % CO2 atmosphere at 37 oC for at least 1 h prior to experimentation.  For 
neuronal preps seeded on glial monolayers, preparation of cortical astrocyte monolayers 
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was performed as previously described (Pothos et al., 1998).  Glial cells were maintained in 
culture for 2-3 weeks prior to use. 
Preparation Adrenal Medullary Chromaffin Cells 
 Murine chromaffin cells were prepared as previously described (Kolski-Andreaco et 
al., 2007) with some modifications.  A female mouse, 4-8 weeks old, was deeply 
anesthetized with ether, decapitated, and the adrenal glands rapidly removed into ice-cold, 
oxygenated Ca2+ and Mg2+-free Locke's buffer containing (in mM): 154 NaCl, 3.6 KCl, 5.6 
NaHCO3, 5.6 glucose, and 10 HEPES, pH adjusted to 7.2 with NaOH.  The medullae were 
isolated via gentle removal of cortical tissue and digested for 20 min at 37 oC in DMEM/F12 
with 25 U/mL papain.  The digestion media was replaced with a fresh aliquot, followed by a 
second 20 min digestion period.  Digested tissue was washed and triturated with pipette tips 
of decreasing bore size in 500 µL DMEM/F12 with 10 % fetal bovine serum and 2 % horse 
serum.  The resulting cell suspension was distributed evenly to 3 poly-L-lysine-coated (0.1 
mg/mL) 25 mm round glass coverslips.  After 15 min attachment plates were fed with 2 mL 
DMEM/F12 containing 100 U/mL penicillin, 0.1 mg/mL streptomycin, 50 U/mL nystatin, and 
40 µg/mL gentamicin.  Plates were maintained in a humidified, 5 % CO2 atmosphere at 37 
oC for at least 24 h prior to experimentation. 
Electrodes and Electrochemistry 
 Disk carbon-fiber microelectrodes were prepared using T650 carbon fibers (6 µm 
diameter, Amoco, Greenville, SC) as previously described (Kawagoe et al., 1993).  Fibers 
were aspirated into glass capillaries (A-M Systems, Sequim, WA), and a vertical pipette 
puller (Narishige, Long Island, NY) was used to seal the glass around the carbon fiber.  
Carbon fibers were cut at the glass seal, which was then reinforced with epoxy (15 % m-
phenylenediamine in Epon 828 resin (Miller-Stephenson, Danbury, CT) heated to between 
80 and 90 oC).  Electrodes were kept at room temperature overnight, and then the epoxy 
was cured via sequential heating at 100 and 150 oC for 8 h and overnight, respectively.  
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Prior to use, electrodes were beveled at 45 degrees on a diamond dust-embedded polishing 
wheel (Sutter Instruments, Novato, CA) and soaked in isopropyl alcohol for at least 20 min 
(Bath et al., 2000). 
 Amperometric recordings were made using a GeneClamp 500B amplifier (Axon 
Instruments, Molecular Devices, Union City, CA).  Electrodes were held at 0.650 V vs. a 
Ag/AgCl reference electrode (BASi, West Lafayette, IN), a potential sufficient to oxidize 
catecholamines.  For measurements at neurons, the output current was collected at 100 
kHz and filtered at 10 kHz with a low-pass Bessel filter.  Post-collection, traces were further 
digitally filtered using a 3 kHz low-pass Bessel filter.  For measurements at chromaffin cells, 
the output current was collected at 20 kHz and filtered at 5 kHz with a low-pass Bessel filter.  
Post-collection, traces were further digitally filtered using a 400 Hz low-pass Bessel filter.  
Data collection and filtering were controlled via the pClamp software provided with the 
amplifier.  Amperometric spike analysis was performed using MiniAnalysis software 
(Synaptosoft, Decatur, GA).  For inclusion, spike amplitude was required to be 5 times 
greater than the root-mean-squared current noise. 
Single Cell Experiments 
 Glass coverslips containing plated cells were secured in a stainless steel coverslip 
holder and mounted on the stage of an inverted microscope (Eclipse TE300, Nikon 
Instruments, Melville, NY).  A temperature controller (Warner Instruments, Hamden, CT) 
connected to the stage maintained cells at 37 oC throughout the experiments.  In all 
experiments, the extracellular recording buffer contained (in mM): 145 NaCl, 3 KCl, 1.2 
MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 11 glucose, and 10 HEPES, pH adjusted to 7.4 with NaOH.  
Exocytosis/Ca2+ influx was triggered via pressure ejection of high K+ buffer (80 mM for 
neurons, 60 mM for chromaffin cells) from a stimulating pipette located 20 to 60 µm from the 
cell.  Stimulating pipettes with 6 to 10 µm tip diameters were fabricated using a horizontal 
pipette puller (Sutter Instruments, Novato, CA) and a microforge (Narishige, Long Island, 
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NY).  Pressure ejection was controlled via a multi-channel Picospritzer (General Valve 
Corporation, Parker Hannifin, Fairfield, NJ).  Positioning of both the electrode and 
stimulating pipette was controlled using piezoelectric micromanipulators (Burleigh 
Instruments, Exfo, Plano, TX).  For neuronal experiments, GFP-positive dopamine neurons 
were identified via epifluorescence using a Xe arc lamp and Nikon endow GFP bandpass 
filter set. 
Fluorescent Measurements of Intracellular Ca2+ 
 Intracellular Ca2+ dynamics were monitored using the ratiometric dye fura-FF 
(Invitrogen, Carlsbad, CA).  Plated cells were incubated for 20 min at 25 oC in extracellular 
recording buffer with 1 µg/mL esterified fura dye and 0.1 % (w/v) BSA, washed twice with 
buffer without dye, and then incubated for 20 min at 25 oC in buffer without dye for 
deesterification.  Ca2+ bound and unbound dye were excited at 340 and 380 nm, 
respectively, using a computer-controlled high speed wavelength switcher (Sutter 
Instruments, Novato, CA).  Emission was monitored at 510 nm using a CCD camera and 
acquisition software (Empix Imaging, Mississauga, ON, Canada). 
HPLC Determination of Dopamine Content 
 Tissue samples were dissected from a slice (300 - 500 μm in thickness) containing 
the region of interest.  The tissue was weighed and homogenized with a wand sonicator 
(Fisher Scientific, Hampton, NH) in 200 µL 0.1 N perchloric acid spiked with 1 µM 
hydroquinone (HQ).  Following centrifugation at 6,000 rpm for 10 min, the supernatant was 
removed and filtered with a 0.2 µm syringe filter unit (Millex-LG).  Injections (50 µL) were 
made onto a reverse phase column (C-18, 5 µm, 4.6 x 250 mm, Waters symmetry 300 or 
Waters Atlantis T3).  The mobile phase (prepared in HPLC grade water) contained 0.1 M 
citric acid, 0.1 mM EDTA, and 1 mM hexyl sodium sulfate, pH 3.5.  Methanol was added as 
the organic modifier at a concentration of 10 % to shorten analyte elution times.  
Catecholamines were detected with a thin-layer radial electrochemical flowcell (BASi, West 
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Lafayette, IN), with the working electrode at 700 mV vs. a Ag/AgCl reference electrode 
(BASi, West Lafayette, IN).  The HQ (1 μM) was used as an internal standard for analyte 
quantification and recovery.  All analyte response ratios were taken with respect to the 
internal standard to account for differential electrode responses.  The determination of peak 
areas for HPLC measurements was performed using custom written Igor programs.  These 
programs were a gift from the Jorgenson lab at UNC-CH.  Peak area determination was 
performed using statistical moments regression theory (Hsieh and Jorgenson, 1996).  The 
peak area of the analyte was taken as a ratio to that of an internal standard at a known 
concentration, adjusted for differential detector response.  The ratio was then used to 
calculate a mass of analyte in the extraction solution which was normalized by the mass of 
tissue taken. 
Histochemistry 
 Dopamine neurons were identified by visualization of TH or dopamine.  Detection of 
dopamine was performed using the sucrose-potassium phosphate-glyoxylic acid (SPG) 
histofluorescence method (De la Torre, 1980).  Plates were incubated in ice-cold SPG 
solution (1 % glyoxylic acid, 6.8 % sucrose, 3.2 % KH2PO4, pH 7.4) for 5 min, dried in a 
laminar flow hood, covered with mineral oil, and heated at 95 oC for 5 min.  Plates were 
cooled by replacing the mineral oil and visualized with fluorescein epifluorescence.  For TH 
immunohistochemistry, plates were fixed with 3.7 % formaldehyde in PBS for 30 min.  
Following a 2 h treatment with a pre-blocking solution (1 % BSA, 10 % goat serum, and 0.3 
% Triton X-100 in PBS), cells were incubated overnight at 4 oC in PBS with 5 % goat serum 
and 1:1000 rabbit anti-TH (Chemicon AB152).  Plates were incubated for 1 h in PBS with 5 
% goat serum and 5 µg/mL biotinylated goat anti-rabbit (Vector BA-1000), then for 30 min in 
R.T.U. Horseradish Peroxidase Avidin D (Vector A2704), and visualized with 
diaminobenzidine (DAB). 
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Chemicals 
 Unless noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO) and 
used as received.  All solutions were prepared using doubly-distilled, deionized water. 
Results 
Properties of Acutely Dissociated Midbrain Dopamine Neurons 
 A procedure for the study of Na+ and Ca2+ currents in isolated SN neurons (Puopolo 
et al., 2007) was modified to produce acutely dissociated midbrain dopamine neurons from 
both the SN and VTA.  TH staining revealed that 38 % of neurons (31/81) in these 
preparations were dopaminergic (Figure 2.1A).  Consistent with the staining, 35 % of live 
cells (30/86) harvested from TH-GFP mice demonstrated GFP fluorescence (Figure 2.1B).  
In contrast to the diverse morphologies and dense axodendritic networks observed in the 
postnatal midbrain in vivo (Domesick et al., 1983; Tepper et al., 1987), acutely dissociated 
midbrain dopamine neurons resembled the immature shapes of cells cultured from fetal 
tissue.  With no glial scaffold to support process outgrowth and only hours of recovery time, 
dopaminergic cells generally possessed only a few small neurites at experimentation (Figure 
2.1), and on occasion were spherical and devoid of processes. 
 As an exocytotic mechanism of extrasynaptic dopamine release would be Ca2+-
dependent, the dynamics of depolarization-induced [Ca2+]i changes at cell bodies of 
dissociated dopamine neurons were monitored with the fluorescent dye fura-FF.  GFP 
fluorescence has been shown to significantly interfere with the use of fura dyes (Bolsover et 
al., 2001), so measurements were made at cells isolated from WT mice.  TH staining was 
performed after experimentation to identify dopaminergic neurons.  Figure 2.2A shows 
representative [Ca2+]i responses from the cell body of a dopamine neuron to a 1 s pressure 
ejection of 80 mM K+ at both 25 oC and 37 oC.  As expected, cellular Ca2+ buffering capacity 
is enhanced at physiological temperature relative to room temperature recordings.  At both 
temperatures, no detectable increase in [Ca2+]i was observed upon removal of Ca2+ from the  
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Figure 2.1.  Identification of dissociated midbrain dopamine neurons.  (A)  TH labeling of a 
fixed cell visualized with the peroxidase/DAB method.  The characteristic dark brown 
precipitate is clearly visible at the cell body.  (B)  Brightfield (left panel) and fluorescent (right 
panel) image of a live cell isolated from a TH-GFP mouse.  All images taken at total 
magnification of 400X.  Scale bar = 20 µm.  
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Figure 2.2.  Intracellular Ca2+ transients at midbrain dopamine neurons.  (A)  Time course of 
[Ca2+]i changes measured at the cell body in response to a 1 s stimulation with 80 mM K+ 
(arrow).  Responses are shown at both room (RT) and physiological temperatures (37 oC).  
(B)  Comparison of [Ca2+]i dynamics at the cell body of TH positive (n = 18) and TH negative 
(n = 21) neurons.  No significant difference (p > 0.05, Student’s t-test) was observed in the 
area (in arbitrary units) or halfwidth (in s) of the Ca2+ transient between cell types at 37 oC.
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extracellular buffer and stim.  The intracellular Ca2+ transients measured at TH-positive cells 
(n = 18) were statistically identical (p > 0.05, Student's t-test) to those from TH-negative cells 
(n = 21) at 37 oC (Figure 2.2B).  The [Ca2+]i peak had an area of 2.0 ± 0.2 arbitrary units in 
TH-positive cells, with a halfwidth of 5.2 ± 0.3 s.  In TH-negative cells, the [Ca2+]i spike had 
an area of 2.1 ± 0.2 arbitrary units and a halfwidth of 4.7 ± 0.4 s. 
Vesicular Release at Cell Bodies of Dissociated Midbrain Neurons 
 Initial amperometric recordings at the cell bodies of acutely dissociated midbrain 
dopamine neurons revealed no current changes either spontaneously or in response to 
depolarizing stimulations with 80 mM K+.  To enhance dopamine synthesis, cells were 
incubated with 100 µM L-3,4-dihydroxy-phenylalanine (L-DOPA) for 30 min at 37 oC prior to 
experimentation (Pothos et al., 2000).  After incubation, amperometric traces obtained at the 
cell body of GFP-positive neurons revealed a number of discrete current spikes 
characteristic of the vesicular release of dopamine (Figure 2.3).  These spikes were 
dependent on the presence of extracellular Ca2+ and were only observed if the electrode 
was held at a potential sufficient to oxidize catecholamines.  The frequency of vesicular 
events was very low, and no spontaneous release was ever observed prior to stimulation.  
Relative to the fast coupling of depolarization and secretion at chromaffin cells and axon 
terminals, the latencies between stimulation and the first detectable events were unusually 
long and variable at dopamine neuron cell bodies, ranging from 5 to 20 s. 
 In the bottom panel of Figure 2.3, individual amperometric spikes are shown on an 
expanded time axis.  Unlike events recorded at chromaffin cells, the spikes measured at the 
cell body of acutely dissociated dopamine neurons were not uniform in shape.  A subset of 
spikes (like those labeled 1 and 3) displayed single, rapid rising and falling phases.  A 
second subset (like those labeled 2 and 4) exhibited significantly broader time courses and 
were occasionally marked by multiple rising and/or falling phases.  The distribution of 
amperometric spike halfwidth (t1/2) reinforces the visual classification of events into two  
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Figure 2.3.  Vesicular release of dopamine from the cell body of an acutely dissociated 
midbrain dopamine neuron.  Upper trace shows multiple exocytotic events detected with 
amperometry following 10 s pressure ejection of high K+.  Individual spikes are shown below 
on an expanded timescale.  
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subtypes.  Figure 2.4A shows a histogram of the t1/2 values, adjusted to normalize the 
distribution by taking the cube root (Finnegan et al., 1996; Pothos et al., 1998; Villanueva et 
al., 2006).  The plot shows two distinct populations (best fit line is sum of two Gaussians, R2 
= 0.95).  Quantal events were officially divided into two subtypes, narrow and wide, based 
on whether their adjusted halfwidth was below or above, respectively, the population 
intersection value of 0.8 ms1/3.  Of the recorded events, 65 % of spikes were classified as 
narrow, with an average t1/2 of 0.19 ± 0.01 ms, and 35 % of spikes were classified as wide, 
with an average t1/2 of 1.33 ± 0.09 ms.  On average, the wide subset of events resulted in 
the release of substantially more dopamine than narrow events (Figure 2.4B).  Narrow 
spikes had an average quantal size (Q) of 5.3 ± 0.6 zmol dopamine (3190 molecules per 
vesicle), while wide spikes had an average Q of 49 ± 4 zmol dopamine (29500 molecules 
per vesicle).   
Effects of Axodendritic Differentiation on Release at Cell Bodies 
 To ensure the vesicular release recorded at cell bodies of acutely dissociated 
midbrain dopamine neurons was not an artifact of the immature cellular morphologies, 
neurons were seeded on glial monolayers and given a 2 week recovery period prior to 
amperometric measurements.  After 2 weeks, neuronal shapes were consistent with in vivo 
observations, and cells extended vast axodendritic networks (Figure 2.5).  The additional 
recovery period had no effect on the proportion of isolated cells that were dopaminergic, as 
37 % of the cells (29/78) on plates from TH-GFP mice were GFP-positive (Figure 2.5B).  
Glyoxylic acid-induced dopamine histofluorescence was confirmed in 39 % of cells (34/87) 
as well (Figure 2.5A).  As before, amperometric traces obtained at the cell bodies of these 
neurons displayed a series of discrete current spikes in response to depolarizing stimulation 
with 80 mM K+.  Release again required preincubation with L-DOPA and was dependent on 
the presence of extracellular Ca2+.  Spikes were only observed with electrode holding 
potentials sufficient to oxidize catecholamines, confirming the released substance was  
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Figure 2.4.  Amperometric spike distributions reveal two vesicle pools.  (A)  Distribution of 
the cube root of t1/2.  Distribution was best fit by sum of two gaussians (dashed red line).  (B)  
Distribution of Q1/3.  Vesicular events were classified as narrow or wide using a cutoff value 
of 0.8 ms1/3 determined from the t1/2 distribution.   
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Figure 2.5  Identificaiton of dissociated midbrain dopamine neurons grown on glial 
monolayers.  (A)  Fixed cell exhibiting glyoxylic acid-induced dopamine histofluoresence.  
(B)  Fluorescent image of live cells isolated from a TH-GFP mouse.  Both images taken at 
total magnification of 400X.  Scale bar = 20 um.   
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dopamine.  The frequency of events was again very low, and spontaneous events were 
never recorded.  Latencies between stimulation and detected events were still long and 
variable, ranging from 3 to 20 s. 
 Visual inspection of the amperometric spikes revealed the same two subtypes: 
spikes with single, rapid rising and falling phases and broader spikes with occasional 
multiple rising and/or falling phases.  Figure 2.6A shows the adjusted halfwidth distribution, 
indicating two populations (best fit line is sum of two Gaussians, R2 = 0.91).  Events were 
divided into two subtypes, narrow and wide, based on whether their adjusted halfwidth was 
below or above, respectively, the population intersection value of 0.9 ms1/3.  Of the 
measured events, 76 % of spikes were classified as narrow, with an average t1/2 of 0.23 ± 
0.02 ms, and 24 % of spikes were classified as wide, with an average t1/2 of 1.2 ± 0.1 ms.  
The wide subset of events resulted, on average, in the release of more dopamine than 
narrow events (Figure 2.6B).  Narrow spikes had an average Q of 9 ± 1 zmol dopamine 
(5420 molecules per vesicle), while wide spikes had an average Q of 47 ± 6 zmol dopamine 
(28300 molecules per vesicle).  All in all, release measured at the cell bodies of acutely 
dissociated midbrain dopamine neurons was remarkably similar after allowing time for 
axodendritic differentiation.  Ca2+-dependence, spike frequency, and spike latency were 
unaffected and two populations of vesicular events were discovered in both preparations.  
Only minor differences were observed in the percentages of narrow and wide events and 
the spike characteristics of those events.  Figure 2.7 summarizes the t1/2 and Q values for 
spikes recorded from acutely dissociated dopamine neurons with and without a two week 
recovery on a glial monolayer.  The t1/2 and Q values for wide events from both preps are the 
same (p > 0.05, Student's t-test).  For narrow events, neurons grown on glial monolayers 
showed a small but statistically significant (p < 0.05) increase in t1/2 and Q. 
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Figure 2.6.  Amperometric spike distributions remain bimodal.  (A)  Distribution of the cube 
root of t1/2.  Distribution was best fit by sum of two gaussians (dashed red line).  (B)  
Distribution of Q1/3.  Vesicular events were classified as narrow or wide using a cutoff value 
of 0.9 ms1/3 determined from the t1/2 distribution. 
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Figure 2.7.  Differences in amperometric spike characteristics between neuron isolation 
procedures.  Average t1/2 and Q values were compared for acutely dissociated midbrain 
dopamine neurons and those grown on glial monolayers.  Acutely dissociated neurons 
grown on glial monolayers showed a statistically significant increase (* p < 0.05, Student's t-
test) in t1/2 and Q for spikes classified as narrow, while no significant change (p > 0.05) was 
observed for spikes classified as wide.  
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TH-GFP Mice as Suitable Models for Midbrain Studies 
 To assess whether the exocytotic mechanism is affected in the genetically altered 
TH-GFP mice, vesicular release at murine chromaffin cells was compared for WT and TH-
GFP animals.  As both dopamine neurons and chromaffin cells express TH, potential side 
effects of the TH-linked transgene should be similar in these cells.  Amperometry was used 
to record vesicular events at chromaffin cells from both mice following a single 1 s 
stimulation with 60 mM K+.  The results of these experiments are displayed in Figure 2.8.  
An average of 38 ± 9 amperometric spikes were detected per stimulation at WT cells (n = 
10).  These events occurred at a frequency of 8.2 ± 0.9 Hz and had an average t1/2 of 5.0 ± 
0.2 ms.  No significant differences (p > 0.05, Student's t-test) in these parameters were 
observed at TH-GFP cells (n = 22).  An average of 32 ± 3 spikes were detected per 
stimulation.  These events occurred at a frequency of 7.2 ± 0.6 Hz and had an average t1/2 of 
5.4 ± 0.1 ms.  Taken together, these results suggest that the size of the readily releasable 
pool, the efficiency of vesicular docking, and the kinetics of vesicular extrusion are 
unchanged in TH-GFP mice.  One difference was observed, however, between the WT and 
TH-GFP cells.  In WT cells, the average Q was 1.7 ± 0.1 amol catecholamine.  TH-GFP cells 
showed a significant reduction (p < 0.05) in quantal size to 1.38 ± 0.06 amol catecholamine. 
 As a further test of potentially altered dopamine release in TH-GFP mice, HPLC with 
electrochemical detection was used to determine total dopamine content in the cell body 
and terminal region of midbrain dopamine neurons for both WT and TH-GFP animals.  As 
can be seen in Table 2.1, dopamine content in the VTA was identical for WT and TH-GFP 
mice at 0.7 ± 0.1 and 0.7 ± 0.2 µg dopamine/g tissue, respectively.  In the caudate putamen, 
dopamine content was 9.6 ± 1.7 µg/g in WT mice and 7.3 ± 0.8 µg/g in TH-GFP mice.  While 
the difference was not statistically significant (p > 0.05), the 24 % decrease in dopamine 
content in the terminal region of TH-GFP mice relative to WT mice matches in magnitude 
the 21 % reduction in Q observed at chromaffin cells.   
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Figure 2.8.  Comparison of exocytosis between WT and TH-GFP mice.  Vesicular release 
was recorded at isolated murine chromaffin cells following a 1 s stimulation with 60 mM K+.  
Spikes observed at TH-GFP cells (n = 22) showed a statistically significant reduction (* p < 
0.05, Student's t-test) in Q relative to WT cells (n = 10).  No significant difference (p > 0.05) 
was noted in the number of spikes, spike frequency, and average t1/2 between cell types.
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Table 2.1.  Comparison of total dopamine content in WT and TH-GFP mice.  HPLC with 
electrochemical detection was used to evaluate the amount of dopamine per gram of tissue 
in the caudate putamen and VTA of adult mice.  No statistically significant differences (p > 
0.05, Student's t-test) were detected between WT and TH-GFP mice.  
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Discussion 
 The work described here demonstrates the successful development of a procedure 
for the isolation of mammalian midbrain dopaminergic neurons.  Utilizing this technique with 
TH-GFP mice, freshly dissociated dopamine neurons can be identified in vitro for 
amperometric recordings of dopamine release.  In response to depolarizing stimulations of 
high K+, amperometric traces from the cell bodies of these neurons displayed a number of 
current spikes that meet the criteria for exocytosis of dopamine.  First, spikes were only 
observed at TH-positive cells (identified by GFP fluorescence) and only when holding the 
electrode at a potential sufficient to oxidize catecholamines.  Together, these observations 
are strong evidence that the substance being detected is indeed dopamine.  Second, events 
were only detected in the presence of extracellular Ca2+.  While intracellular Ca2+ stores may 
play a role in the release process, the requirement of depolarization-induced influx of 
extracellular Ca2+ as a first step is a consistent marker of vesicular exocytosis across all cell 
types (Burgoyne and Morgan, 2003).  Third, the current spikes were rapid, discrete 
phenomena consistent with the delivery of individual packets of molecules to the electrode 
surface.  Individual release events demonstrated a rapid outward flux of dopamine (~3x106 
molecules/s), significantly higher than what has been observed experimentally for 
monoamine transporters (Galli et al., 1998).  In sum, the experiments in this work argue 
strongly that the extrasynaptic release of dopamine occurs through a Ca2+-mediated 
exocytosis, not reversal of DAT. 
 One of the more striking features of the extrasynaptic release was the prolonged 
latency from the onset of depolarization to the first detectable vesicular events (Figure 2.3).  
This observation establishes an important distinction between synaptic and extrasynaptic 
transmission in midbrain dopamine neurons.  At neuronal synapses, the close physical 
association of VGCCs and the exocytosis machinery (Ca2+ sensors, vesicles, SNARE 
proteins, etc…) helps establish a very tight correlation between depolarization and vesicular 
54 
 
fusion and release.  One potential explanation for the long latencies observed in these 
experiments could be a less dense population of VGCCs at the cell body.  It has previously 
been observed in neuroendocrine cells that delays between stimulation and secretion can 
be explained by prolonged Ca2+ diffusion (Chow et al., 1996).  This diffusional delay could 
depend not only on VGCC density, but also vesicle location.  Unlike nerve terminals, cell 
bodies lack presynaptic active zones characterized by a pool of vesicles docked at the cell 
membrane and primed for release.  VMAT2 staining of retinal dopamine neurons labeled 
vesicles that were randomly distributed throughout the cell body (Puopolo et al., 2001).  
These vesicles were spaced at a considerable distance from each other and the cell 
membrane.  Coincidentally, amperometric measurements at the cell bodies of these cells 
displayed similar release latencies of 0.5 – 30 s.  Therefore, the observed delay in vesicular 
events could likely stem from the time required to recruit and mobilize vesicles to the plasma 
membrane for fusion.  As the intracellular movement of vesicles is thought to occur via Ca2+-
dependent interactions with the cytoskeletal network (Burgoyne and Morgan, 2003), 
differences in these interactions at the cell body compared to the nerve terminals could also 
influence the observed delay in amperometric spikes following depolarization. 
 The vesicular events observed at the cell bodies of midbrain dopamine neurons were 
heterogeneous in nature.  Visually, spikes could easily be separated into two classes based 
on their time course.  While the narrow events always consisted of a single rising and falling 
phase, the wide events sometimes displayed multiple rising and/or falling phases.  
Distributions of the raw amperometric t1/2 and Q values were broad and skewed to the right, 
such that the means were greater than the modes.  Similar distributions have been 
previously observed in secretory cells (Finnegan et al., 1996; Pothos et al., 1998; Villanueva 
et al., 2006).  Plotting the cube roots resulted in normalized distributions.  The explanation 
being that vesicle radii are normally distributed, and since the amperometric spike 
characteristics depend on vesicular volume (r3) their cube root should also be normally 
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distributed (Bekkers et al., 1990).  Transformed distributions of the extrasynaptic release t1/2 
and Q values were normalized and the t1/2 distribution was described by two Gaussians, 
consistent with the visual classification of events (Figure 2.4 and Figure 2.6).  Individually, 
both subtypes of events showed amperometric spike characteristics on the same order of 
magnitude as events previously recorded from other dopamine neuron preparations (Jaffe et 
al., 1998; Pothos et al., 1998; Puopolo et al., 2001; Kim et al., 2008). 
 The fundamental question raised by these studies involves the biological origin of the 
two vesicular populations.  Two subpopulations of amperometric spikes have been observed 
previously in release from the cell body of both the leech Retzius cell and a dopamine 
neuron in the pond snail (Bruns and Jahn, 1995; Chen and Ewing, 1995).  In each case the 
two populations could be attributed to release from small synaptic vesicles (SSVs) and large 
dense-core vesicles (LDCVs).  VMAT has been localized to numerous intracellular 
compartments in the somatodendritic region of midbrain dopamine neurons: tubulovesicles 
resembling saccules of SER, SSVs, LDCVs, and multivesicular bodies (Nirenberg et al., 
1996b).  Similarly, three types of secretory organelles were observed at the cell body of 
retinal dopamine neurons, including SSVs and LDCVs (Puopolo et al., 2001).  Thus, it's 
plausible that the two observed vesicular populations arise from the exocytosis of two 
different secretory organelles.  A second possibility is that the two populations correspond to 
the exocytosis of one type of vesicle, but via two different fusion mechanisms.  
Amperometric spikes detected at axonal varicosities of midbrain dopamine neurons have 
shown a bimodal distribution of this type (Staal et al., 2004).  Events with single rising and 
falling phases or with multiple rising and falling phases of decreasing amplitude were 
attributed to dopamine release through a fusion pore that flickers either once or multiple 
times in succession.  As not all of the wide events from this study exhibited multiple rising 
and/or falling phases, such a mechanism could not, however, be the sole explanation for the 
two vesicular populations.   
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 As all of the amperometric measurements were made at cells from transgenic mice, 
it was necessary to confirm that the genetic manipulations had not resulted in significant 
deviations from the vesicular release that would have been observed in WT animals.  As 
direct comparisons between neuronal release were unfeasible, a common model cell for 
neuronal exocytosis was employed: the chromaffin cell.  Unlike midbrain dopamine neurons, 
homogenous populations of morphologically identifiable chromaffin cells can easily be 
obtained from WT animals.  Chromaffin cells are an especially valid model for our 
experiments, as they express TH.  Vesicular release measured at chromaffin cells was 
predominantly unchanged between WT and TH-GFP mice.  The size of the readily 
releasable pool, efficiency of vesicle docking with the plasma membrane, and kinetics of 
vesicular extrusion were similar in both animals.  One deficiency was observed, though, in 
the release from TH-GFP cells: a 21 % reduction in vesicular content.  As a second check of 
potential transgenic side effects, total brain dopamine content as determined by HPLC was 
compared between WT and TH-GFP mice.  Dopamine content was statistically equivalent in 
the cell body and synaptic terminal regions of both mice, although the raw content values for 
TH-GFP mice were reduced by 24 % at the terminals.  Taken with the release data from the 
MAMC cells, the HPLC analysis suggests that, at worse, the amperometric data obtained 
from the cell bodies of dopamine neurons is underreporting the average vesicular content by 
about 20 %.  Potential explanations for a lower vesicular content in TH-GFP mice include 
reduced catecholamine synthesis and impaired vesicular packaging.  As the reporter gene 
in the transgenic mouse is linked to TH expression, reduced synthesis seems the most likely 
candidate.  Insertion of the GFP gene downstream of the TH promoter could negatively 
impact TH transcription leading to lower protein levels and lower catecholamine synthesis.  
  
57 
 
References 
Bath BD, Michael DJ, Trafton BJ, Joseph JD, Runnels PL, Wightman RM (2000) Subsecond 
adsorption and desorption of dopamine at carbon-fiber microelectrodes. Anal Chem 
72:5994-6002. 
Beckstead MJ, Grandy DK, Wickman K, Williams JT (2004) Vesicular dopamine release 
elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 
42:939-946. 
Bekkers JM, Richerson GB, Stevens CF (1990) Origin of variability in quantal size in 
cultured hippocampal neurons and hippocampal slices. Proc Natl Acad Sci U S A 
87:5359-5362. 
Bergquist F, Nissbrandt H (2003) Influence of R-type (Cav2.3) and t-type (Cav3.1-3.3) 
antagonists on nigral somatodendritic dopamine release measured by microdialysis. 
Neuroscience 120:757-764. 
Bergquist F, Niazi HS, Nissbrandt H (2002) Evidence for different exocytosis pathways in 
dendritic and terminal dopamine release in vivo. Brain Res 950:245-253. 
Bergquist F, Jonason J, Pileblad E, Nissbrandt H (1998) Effects of local administration of L-, 
N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the 
striatum and the substantia nigra: a microdialysis study in rat. J Neurochem 70:1532-
1540. 
Bjorklund A, Lindvall O (1975) Dopamine in dendrites of substantia nigra neurons: 
suggestions for a role in dendritic terminals. Brain Res 83:531-537. 
Bolsover S, Ibrahim O, O'Luanaigh N, Williams H, Cockcroft S (2001) Use of fluorescent 
Ca2+ dyes with green fluorescent protein and its variants: problems and solutions. 
Biochem J 356:345-352. 
Bruns D, Jahn R (1995) Real-time measurement of transmitter release from single synaptic 
vesicles. Nature 377:62-65. 
Burgoyne RD, Morgan A (2003) Secretory granule exocytosis. Physiol Rev 83:581-632. 
Chen BT, Rice ME (2001) Novel Ca2+ dependence and time course of somatodendritic 
dopamine release: substantia nigra versus striatum. J Neurosci 21:7841-7847. 
Chen BT, Moran KA, Avshalumov MV, Rice ME (2006) Limited regulation of somatodendritic 
dopamine release by voltage-sensitive Ca channels contrasted with strong regulation 
of axonal dopamine release. J Neurochem 96:645-655. 
Chen G, Ewing AG (1995) Multiple classes of catecholamine vesicles observed during 
exocytosis from the Planorbis cell body. Brain Res 701:167-174. 
Chow RH, Klingauf J, Heinemann C, Zucker RS, Neher E (1996) Mechanisms determining 
the time course of secretion in neuroendocrine cells. Neuron 16:369-376. 
58 
 
Cragg S, Rice ME, Greenfield SA (1997) Heterogeneity of electrically evoked dopamine 
release and reuptake in substantia nigra, ventral tegmental area, and striatum. J 
Neurophysiol 77:863-873. 
De la Torre JC (1980) An improved approach to histofluorescence using the SPG method 
for tissue monoamines. J Neurosci Methods 3:1-5. 
Domesick VB, Stinus L, Paskevich PA (1983) The cytology of dopaminergic and 
nondopaminergic neurons in the substantia nigra and ventral tegmental area of the 
rat: a light- and electron-microscopic study. Neuroscience 8:743-765. 
Elverfors A, Jonason J, Jonason G, Nissbrandt H (1997) Effects of drugs interfering with 
sodium channels and calcium channels on the release of endogenous dopamine 
from superfused substantia nigra slices. Synapse 26:359-369. 
Falkenburger BH, Barstow KL, Mintz IM (2001) Dendrodendritic inhibition through reversal of 
dopamine transport. Science 293:2465-2470. 
Finnegan JM, Pihel K, Cahill PS, Huang L, Zerby SE, Ewing AG, Kennedy RT, Wightman 
RM (1996) Vesicular quantal size measured by amperometry at chromaffin, mast, 
pheochromocytoma, and pancreatic beta-cells. J Neurochem 66:1914-1923. 
Fortin GD, Desrosiers CC, Yamaguchi N, Trudeau LE (2006) Basal somatodendritic 
dopamine release requires snare proteins. J Neurochem 96:1740-1749. 
Galli A, Blakely RD, DeFelice LJ (1998) Patch-clamp and amperometric recordings from 
norepinephrine transporters: channel activity and voltage-dependent uptake. Proc 
Natl Acad Sci U S A 95:13260-13265. 
Geffen LB, Jessell TM, Cuello AC, Iversen LL (1976) Release of dopamine from dendrites in 
rat substantia nigra. Nature 260:258-260. 
Groves PM, Linder JC (1983) Dendro-dendritic synapses in substantia nigra: descriptions 
based on analysis of serial sections. Exp Brain Res 49:209-217. 
Hausser M, Stuart G, Racca C, Sakmann B (1995) Axonal initiation and active dendritic 
propagation of action potentials in substantia nigra neurons. Neuron 15:637-647. 
Hoffman AF, Gerhardt GA (1999) Differences in pharmacological properties of dopamine 
release between the substantia nigra and striatum: an in vivo electrochemical study. 
J Pharmacol Exp Ther 289:455-463. 
Hoffman AF, Lupica CR, Gerhardt GA (1998) Dopamine transporter activity in the substantia 
nigra and striatum assessed by high-speed chronoamperometric recordings in brain 
slices. J Pharmacol Exp Ther 287:487-496. 
Hounsgaard J, Nedergaard S, Greenfield SA (1992) Electrophysiological localization of 
distinct calcium potentials at selective somatodendritic sites in the substantia nigra. 
Neuroscience 50:513-518. 
59 
 
Hsieh S, Jorgenson JW (1996) Preparation and evaluation of slurry-packed liquid 
chromatography microcolumns with inner diameters from 12 to 33 microns. Anal 
Chem 68:1212-1217. 
Jaffe EH, Marty A, Schulte A, Chow RH (1998) Extrasynaptic vesicular transmitter release 
from the somata of substantia nigra neurons in rat midbrain slices. J Neurosci 
18:3548-3553. 
John CE, Jones SR (2006) Exocytotic release of dopamine in ventral tegmental area slices 
from C57BL/6 and dopamine transporter knockout mice. Neurochem Int 49:737-745. 
Kawagoe KT, Zimmerman JB, Wightman RM (1993) Principles of voltammetry and 
microelectrode surface states. J Neurosci Methods 48:225-240. 
Kessler MA, Yang M, Gollomp KL, Jin H, Iacovitti L (2003) The human tyrosine hydroxylase 
gene promoter. Brain Res Mol Brain Res 112:8-23. 
Kim Y, Park MK, Chung S (2008) Voltage-operated Ca2+ channels regulate dopamine 
release from somata of dopamine neurons in the substantia nigra pars compacta. 
Biochem Biophys Res Commun 373:665-669. 
Kita JM, Kile BM, Parker LE, Wightman RM (2009) In vivo measurement of somatodendritic 
release of dopamine in the ventral tegmental area. Synapse 63:951-960. 
Kolski-Andreaco A, Cai H, Currle DS, Chandy KG, Chow RH (2007) Mouse adrenal 
chromaffin cell isolation. J Vis Exp:129. 
Llinas R, Greenfield SA, Jahnsen H (1984) Electrophysiology of pars compacta cells in the 
in vitro substantia nigra--a possible mechanism for dendritic release. Brain Res 
294:127-132. 
Mercer L, del Fiacco M, Cuello AC (1979) The smooth endoplasmic reticulum as a possible 
storage site for dendritic dopamine in substantia nigra neurones. Experientia 35:101-
103. 
Nieoullon A, Cheramy A, Glowinski J (1977) Release of dopamine in vivo from cat 
substantia nigra. Nature 266:375-377. 
Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1996a) The dopamine 
transporter is localized to dendritic and axonal plasma membranes of nigrostriatal 
dopaminergic neurons. J Neurosci 16:436-447. 
Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM (1996b) Ultrastructural localization of 
the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential 
sites for somatodendritic storage and release of dopamine. J Neurosci 16:4135-
4145. 
Nirenberg MJ, Chan J, Liu Y, Edwards RH, Pickel VM (1997) Vesicular monoamine 
transporter-2: immunogold localization in striatal axons and terminals. Synapse 
26:194-198. 
60 
 
61 
 
Pothos EN, Davila V, Sulzer D (1998) Presynaptic recording of quanta from midbrain 
dopamine neurons and modulation of the quantal size. J Neurosci 18:4106-4118. 
Pothos EN, Larsen KE, Krantz DE, Liu Y, Haycock JW, Setlik W, Gershon MD, Edwards 
RH, Sulzer D (2000) Synaptic vesicle transporter expression regulates vesicle 
phenotype and quantal size. J Neurosci 20:7297-7306. 
Puopolo M, Raviola E, Bean BP (2007) Roles of subthreshold calcium current and sodium 
current in spontaneous firing of mouse midbrain dopamine neurons. J Neurosci 
27:645-656. 
Puopolo M, Hochstetler SE, Gustincich S, Wightman RM, Raviola E (2001) Extrasynaptic 
release of dopamine in a retinal neuron: activity dependence and transmitter 
modulation. Neuron 30:211-225. 
Rice ME, Cragg SJ, Greenfield SA (1997) Characteristics of electrically evoked 
somatodendritic dopamine release in substantia nigra and ventral tegmental area in 
vitro. J Neurophysiol 77:853-862. 
Rice ME, Richards CD, Nedergaard S, Hounsgaard J, Nicholson C, Greenfield SA (1994) 
Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral 
tegmental area in vitro. Exp Brain Res 100:395-406. 
Staal RG, Mosharov EV, Sulzer D (2004) Dopamine neurons release transmitter via a 
flickering fusion pore. Nat Neurosci 7:341-346. 
Tepper JM, Sawyer SF, Groves PM (1987) Electrophysiologically identified nigral 
dopaminergic neurons intracellularly labeled with HRP: light-microscopic analysis. J 
Neurosci 7:2794-2806. 
Villanueva M, Thornley K, Augustine GJ, Wightman RM (2006) Synapsin II negatively 
regulates catecholamine release. Brain Cell Biol 35:125-136. 
Wassef M, Berod A, Sotelo C (1981) Dopaminergic dendrites in the pars reticulata of the rat 
substantia nigra and their striatal input. Combined immunocytochemical localization 
of tyrosine hydroxylase and anterograde degeneration. Neuroscience 6:2125-2139. 
Wilson CJ, Groves PM, Fifkova E (1977) Monoaminergic synapses, including dendro-
dendritic synapses in the rat substantia nigra. Exp Brain Res 30:161-174. 
 
 
Chapter 3 
Energy Stores in Regulated Exocytosis 
 
Introduction 
 The hormone leptin operates as a negative feedback signal in the brain, helping to 
regulate an organism's body weight (specifically, the adipose tissue mass) by modulating 
the activity of neuronal circuits controlling food intake and energy expenditure (Friedman, 
2009).  Leptin is a 16 kD protein secreted into the bloodstream primarily by white adipose 
tissue.  The hormone binds to leptin receptors in the arcuate nucleus of the hypothalamus, 
inhibiting orexigenic neurons that express neuropeptide Y and Agouti gene-related peptide 
and activating anorexigenic neurons that express pro-opiomelanocortin (Broberger, 2005).  
Plasma concentrations of leptin have been shown to mimic increases and decreases in 
adipose tissue (Maffei et al., 1995), and infusions of leptin have reduced food intake and 
body weight in both normal and obese mice (Halaas et al., 1995).  A striking example of 
leptin's physiological importance is the ob/ob mouse, in which a nonsense mutation renders 
the protein nonfunctional (Ingalls et al., 1950).  These animals are grossly obese and  
exhibit overeating, hypometabolism, and decreased locomotor activity (Coleman, 1978). 
 Recently, novel roles for leptin regulation outside the hypothalamus have been 
documented.  Leptin-deficient ob/ob mice show a substantial decrease in stimulated 
dopamine release in the nucleus accumbens (NAc) and impaired vesicular somatodendritic 
dopamine stores in the ventral tegmental area (VTA) and the substantia nigra compacta 
(SNc) (Fulton et al., 2006; Roseberry et al., 2007).  A potential action of leptin on vesicular 
release from midbrain dopamine neurons is fitting given the well-documented roles they play 
in regulating movement and in mediating the rewarding properties of natural stimuli such as 
food (Roitman et al., 2004).  Leptin has also been shown to act outside the central nervous 
system, as it induces an acute, Ca2+-dependant increase in tyrosine hydroxylase (TH) 
activity and catecholamine secretion from chromaffin cells (Takekoshi et al., 1999; 
Takekoshi et al., 2001).  Taken together, these findings suggest that one of the pathways 
through which leptin regulates food intake and energy expenditure could be via a largely 
unexplored role in the exocytosis of chemical messengers, particularly in catecholaminergic 
cells. 
 Uncoupling protein 2 (UCP2) is a carrier protein located at the inner mitochondrial 
membrane with ubiquitous expression in mammalian tissues (Fleury et al., 1997).  UCP2 is 
one of five UCP homologues that, despite isoform-specific tissue distributions (Alan et al., 
2009), all function as dissipaters of the inner mitochondrial membrane potential.  This 
electrochemical potential is generated via the coupling of the electron transport chain to the 
active pumping of protons from the matrix into the intermembrane space, and serves as the 
primary driving force for the phosphorylation of ADP by ATP synthase.  By leaking protons 
back into the mitochondrial matrix, UCP2 dissipates the electrochemical gradient and 
uncouples oxidative phosphorylation (Andrews et al., 2005). 
 Through disruption of the mitochondrial membrane potential, and its subsequent 
effect on cellular ATP levels, UCP2 could influence vesicular exocytosis via several 
mechanisms.  The packaging of chemical messengers into vesicles is dependent on an 
ATP-driven pump that shuttles protons from the cytosol to the vesicle interior (Maycox et al., 
1988).  In addition, several other steps in exocytosis are ATP-dependent, including the 
recruitment and mobilization of vesicles to the plasma membrane and the priming of docked 
vesicles for Ca2+-triggered fusion (Burgoyne and Morgan, 2003; Keating, 2008).  Cellular 
ATP levels can also help shape the intracellular Ca2+ signal, which acts as the ultimate 
trigger for vesicular exocytosis, as ATP-dependent Ca2+ pumps on the endoplasmic 
63 
 
reticulum (ER) and plasma membranes help restore cytosolic Ca2+ to resting levels (Garcia 
et al., 2006).  Finally, UCP2 can also affect cellular Ca2+ handling directly through dissipation 
of the mitochondrial membrane potential.  This potential is the main driving force for 
clearance of cytosolic Ca2+ through the uniporter on the outer mitochondrial membrane 
(Gunter and Pfeiffer, 1990).  An additional, and rather surprising, role for UCP2 in exocytosis 
has recently been proposed.  UCP2 mRNA levels were significantly increased in two models 
of obesity: WT mice fed a high fat diet and leptin-deficient ob/ob mice (Parton et al., 2007).  
This finding suggests that some of the locomotor activity and transmitter release deficits in 
ob/ob mice could stem from a UCP2-induced decrease in cellular ATP levels. 
 To investigate the individual roles of leptin and UCP2 in vesicular release a multi-
dimensional approach was used to study exocytosis in mice lacking the two proteins.  
Vesicular release in ob/ob and UCP2 KO mice was monitored using fast scan cyclic 
voltammetry (FSCV) in brain slices and amperometry and fluorescent Ca2+ imaging at 
isolated chromaffin cells.  This combinatorial method has been used successfully in this lab 
to elucidate the mechanism responsible for the impaired dopamine release in a mouse 
model of Huntington's disease (Johnson et al., 2006; Johnson et al., 2007), and provides a 
complete description of transmitter release, from release and uptake from multiple 
exocytosis sites down to the individual vesicular event characteristics.  Brain slice 
measurements in ob/ob mice revealed significant decreases in both dopamine release and 
uptake relative to WT mice.  Measurements at individual chromaffin cells suggest the 
impaired release is due to Ca2+-independent decreases in both vesicle mobilization and 
packaging.  In slices from UCP2 KO mice, dopamine release and uptake were significantly 
increased compared to WT mice.  However, no changes were observed in the individual 
vesicular events or intracellular Ca2+ dynamics at chromaffin cells, hindering identification of 
the mechanism responsible for the changes observed in slices. 
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Disclaimer 
 The experiments on exocytosis in UCP2 KO and ob/ob mice were undertaken in 
collaboration with the lab of Dr. Brad Lowell at Beth Israel Deaconess Hospital at Harvard 
University.  The individual in this lab responsible for providing the genotypes of mice used in 
the study has recently been removed from his/her position as part of an investigation into 
academic misconduct.  The genotypes of all mice used in this study have since been 
independently confirmed, and the results presented here are considered valid.  However, 
many of the initial hypotheses driving this collaboration/study were based on data that is 
now in question.  Much care has been taken so that the results and discussions included in 
this chapter are presented independently of these previous theories. 
Materials and Methods 
Animals 
 Mice were handled in accordance with the guidelines set forth by the Institutional 
Animal Care and Use Committee (IACUC) at UNC-Chapel Hill.  UCP2 KO, ob/ob, and their 
littermate WT mice were generously provided by the lab of Dr. Brad Lowell at Harvard 
Unversity.  
Preparation of Adrenal Medullary Chromaffin Cells 
 Murine chromaffin cells were prepared as previously described (Kolski-Andreaco et 
al., 2007) with some modifications.  Mice were deeply anesthetized with ether, decapitated, 
and the adrenal glands rapidly removed into ice-cold, oxygenated Ca2+ and Mg2+-free 
Locke's buffer containing (in mM): 154 NaCl, 3.6 KCl, 5.6 NaHCO3, 5.6 glucose, and 10 
HEPES, pH adjusted to 7.2 with NaOH.  The medullae were isolated via gentle removal of 
cortical tissue and digested for 20 min at 37 oC in Dulbecco's Modified Eagle's 
Medium/Nutrient Mixture F-12 Ham (DMEM/F12) with 25 U/mL papain.  The digestion media 
was replaced with a fresh aliquot, followed by a second 20 min digestion period.  Digested 
tissue was washed and triturated with pipette tips of decreasing bore size in 500 µL 
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DMEM/F12 with 10 % fetal bovine serum and 2 % horse serum.  The resulting cell 
suspension was distributed evenly to 3 poly-L-lysine-coated (0.1 mg/mL) 25 mm round glass 
coverslips.  After 15 min attachment plates were fed with 2 mL DMEM/F12 containing 100 
U/mL penicillin, 0.1 mg/mL streptomycin, 50 U/mL nystatin, and 40 µg/mL gentamicin.  
Plates were maintained in a humidified, 5 % CO2 atmosphere at 37 oC for at least 24 h prior 
to experimentation. 
Preparation of Brain Slices 
 Mice were anesthetized with ether and decapitated.  The brain was rapidly removed 
and placed on ice.  Coronal brain slices (300 µm thick) containing the caudate putamen or 
substantia nigra pars reticulata (SNr) were prepared in ice cold artificial cerebral spinal fluid 
(aCSF) using a Lancer Vibratome (World Precision Instruments, Sarasota, Fl.).  The aCSF 
contained (in mM): 20 HEPES, 2.4 CaCl2, 1.2 MgCl2, 1.2 NaH2PO4, 2.45 KCl, 126 NaCl, 11 
glucose, and 25 NaHCO3.  The pH was adjusted to pH 7.4 and the aCSF was saturated with 
95 % O2/5 % CO2.  Slices were superfused in aCSF at 37 oC for 35-40 minutes prior to 
recording. 
Electrodes and Electrochemistry 
 Carbon-fiber microelectrodes were prepared using T650 carbon fibers (6 µm 
diameter, Amoco, Greenville, SC) as previously described (Kawagoe et al., 1993).  Fibers 
were aspirated into glass capillaries (A-M Systems, Sequim, WA), and a vertical pipette 
puller (Narishige, Long Island, NY) was used to seal the glass around the carbon fiber.  For 
cylinder electrodes, the exposed carbon fiber was trimmed to a length of 50 µm.  For disk 
electrodes, the carbon fibers were cut at the glass seal, which was then reinforced with 
epoxy (15 % m-phenylenediamine in Epon 828 resin (Miller-Stephenson, Danbury, CT) 
heated to between 80 and 90 oC).  Electrodes were kept at room temperature overnight, and 
then the epoxy was cured via sequential heating at 100 and 150 oC for 8 h and overnight, 
respectively.  Disks were generated by beveling electrodes at 45 degrees on a diamond 
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dust-embedded polishing wheel (Sutter Instruments, Novato, CA).  Prior to use, all 
electrodes were soaked in isopropyl alcohol for at least 20 min (Bath et al., 2000). 
 Amperometric recordings at single cells were made using a GeneClamp 500B 
amplifier (Axon Instruments, Molecular Devices, Union City, CA).  Disk electrodes were held 
at 0.650 V vs. a Ag/AgCl reference electrode (BASi, West Lafayette, IN), a potential 
sufficient to oxidize catecholamines.  The output current was analog filtered at 5 kHz with a 
low-pass Bessel filter and acquired at 20 kHz.  Post-collection, traces were further digitally 
filtered using a 400 Hz low-pass Bessel filter.  Data collection and filtering were controlled 
via the pClamp software provided with the amplifier. 
 Measurements of dopamine and serotonin (5-HT) release in brain slices were made 
using FSCV at cylinder electrodes.  Waveform application, current monitoring, and stimulus 
application were all controlled by locally written software (Tarheel CV, Labview) through a 
home built potentiostat (UEI, UNC electronics shop).  For dopamine detection, the potential 
at the electrode was scanned from -0.4 V to 1 V and back at 600 V/s, with the ramp 
repeated at 60 Hz.  For 5-HT, the electrode was scanned from 0.2 V to 1 V down to -0.1 V 
and back to 0.2 V at 1000 V/s, with the waveform repeated at 10 Hz (Jackson et al., 1995).  
After an experiment, electrodes were calibrated in a flow injection system with a 1 µM bolus 
of analyte. 
Single Cell Experiments 
 Glass coverslips containing plated cells were secured in a stainless steel coverslip 
holder and mounted on the stage of an inverted microscope (Eclipse TE300, Nikon 
Instruments, Melville, NY).  A temperature controller (Warner Instruments, Hamden, CT) 
connected to the stage maintained cells at 37 oC throughout the experiments.  The 
extracellular recording buffer contained (in mM): 145 NaCl, 3 KCl, 1.2 MgCl2, 2.4 CaCl2, 1.2 
NaH2PO4, 11 glucose, and 10 HEPES, pH adjusted to 7.4 with NaOH.  Exocytosis was 
triggered via a 0.5 s pressure ejection of 60 mM K+ buffer from a stimulating pipette located 
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30 µm from the cell.  Cells were stimmed every 30 s for 10 total stimulations.  Stimulating 
pipettes with 6 to 10 µm tip diameters were fabricated using a horizontal pipette puller 
(Sutter Instruments, Novato, CA) and a microforge (Narishige, Long Island, NY).  Pressure 
ejection was controlled via a multi-channel Picospritzer (General Valve Corporation, Parker 
Hannifin, Fairfield, NJ).  Positioning of both the electrode and stimulating pipette was 
controlled using piezoelectric micromanipulators (Burleigh Instruments, Exfo, Plano, TX). 
Slice Experiments 
Recordings were performed on a microscope (Nikon FN1, Gibraltar Stage) fitted with 
a slice perfusion chamber (Warner Instruments, Hamden CT).  Neurotransmitter release 
was evoked by local electrical stimulation delivered through a tungsten bipolar stimulating 
electrode placed on the surface of the slice (Frederick Haer Co., Bowdoinham, ME).  The 
stimulation consisted of a computer generated, biphasic (2 ms per phase), constant-current 
(350 µA) pulse.  A single stimulation pulse was used to evoke striatal dopamine release in 
the caudate putamen (Jones et al., 1995) and a 20 pulse 100 Hz stimulation train was used 
to evoke 5-HT release in the SNr (Bunin et al., 1998).  The current pulse was optically 
isolated from the preparation (NL 800, Neurolog, Medical Systems, Great Neck, NY).  
Stimulations were performed at regular 3-5 min intervals to maintain consistent release.  
Neurotransmitter release was detected at a microelectrode placed 75-100 µm into the slice 
at a distance of 100-200 µm from the stimulating electrode. 
Data Analysis 
 Amperometric spike analysis was performed using MiniAnalysis software 
(Synaptosoft, Decatur, GA).  For inclusion, spike amplitude was required to be 5 times 
greater than the root-mean-squared current noise.  Overlapping peaks were included in 
frequency and foot analysis, but excluded from individual spike analysis.  Visual examination 
of the peaks was used to determine presence of pre- and post-spike feet.  For frequency 
analysis, the first observed spike following stimulation marked the burst start time.  Burst 
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end time was denoted by the first interspike interval > 1s.  Individual amperometric spike 
characteristics such as quantal size (Q), t1/2, and amplitude were averaged for an individual 
cell.  The cumulative mean for an experimental group was then determined using the cell 
averages (Colliver et al., 2000). 
 Release values reported from the slice experiments are the maximal 
neurotransmitter concentrations obtained following stimulation.  Values were averaged 
across multiple locations in each slice, and then pooled for each genotype.  For 
determination of kinetic constants such as maximal uptake rate (Vmax), concentration traces 
were fit to a Michaelis-Menten-based regression model (Wightman et al., 1988).  Kinetic 
parameters were fixed, creating a simulated trace.  This trace is then convoluted by the 
electrode time constant and compared to the experimental data (Wu et al., 2001). 
 All data are presented as means ± standard errors of the mean.  Statistical 
comparisons were performed using a one-way ANOVA or a Student's t-test, as appropriate. 
Fluorescent Measurements of Intracellular Ca2+ 
 Intracellular Ca2+ dynamics were monitored using the ratiometric dye fura-FF 
(Invitrogen, Carlsbad, CA).  Plated cells were incubated for 20 min at 25 oC in extracellular 
recording buffer with 1 µg/mL esterified fura dye and 0.1 % (w/v) BSA, washed twice with 
buffer without dye, and then incubated for 20 min at 25 oC in buffer without dye for 
deesterification.  Ca2+ bound and unbound dye were excited at 340 and 380 nm, 
respectively, using a computer-controlled high speed wavelength switcher (Sutter 
Instruments, Novato, CA).  Emission was monitored at 510 nm using a CCD camera and 
acquisition software (Empix Imaging, Mississauga, ON, Canada). 
Results 
Stimulated Release in Brain Slices from ob/ob Animals 
 The effect of leptin deficiency on stimulated dopamine release was examined using 
brain slices containing the caudate putamen from both WT and ob/ob mice (Figure 3.1A).   
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Figure 3.1.  Leptin deficiency affects striatal dopamine release but not stimulated 5-HT 
release in the substantia nigra.  (A) Stimulated dopamine release in the caudate putamen of 
ob/ob mice is significantly reduced (n = 9, *** p < 0.001, one-way ANOVA).  Similarly, the 
Vmax of dopamine uptake is significantly diminished in ob/ob mice compared to WT animals 
(*** p < 0.001, n = 5 both genotypes).  (B) There is no significant difference in stimulated 5-
HT release between WT animals or ob/ob animals ( p > 0.05, n = 9).  
70 
 
Dopamine release was evoked with a single pulse electrical stimulation and detected with 
FSCV.  Leptin deficiency resulted in significantly reduced (p < 0.001, one-way ANOVA, n = 
9 for both genotypes) stimulated dopamine release, with the average maximal dopamine 
concentration measured at 1.74 ± 0.08 µM in WT slices and 1.23 ± 0.05 µM in ob/ob slices.  
In addition to decreased release of dopamine, clearance of the neurotransmitter was also 
significantly impaired (p < 0.001, n = 5 for both genotypes) in the leptin deficient animals, 
with the average Vmax observed at 5.5 ± 0.4 µM/s in WT slices and 3.3 ± 0.2 µM/s in ob/ob 
slices.  These alterations in transmitter release and uptake appear to be specific to 
dopamine neurons, as no significant difference (p > 0.05, n = 9 for both genotypes) was 
measured in electrically stimulated 5-HT release in the SNr of slices from WT and ob/ob 
mice (Figure 3.1B).  Average maximal 5-HT concentrations were an equivalent 155 ± 8 nM 
and 151 ± 5 nM in WT and ob/ob animals, respectively. 
Exocytosis at Chromaffin Cells from ob/ob Mice 
 Amperometric recordings of exocytosis were performed at isolated chromaffin cells 
from both WT (n = 18 cells) and ob/ob (n = 23 cells) mice.  Vesicular release was triggered 
with a 0.5 s application of 60 mM K+, spaced every 30 s, for a total of 10 stimulations.  
Figure 3.2 shows a representative amperometric trace following a single stimulation for both 
cell types.  The amperometric spike characteristics for both genotypes are summarized in 
Table 3.1.  On average, significantly fewer (p < 0.05, one-way ANOVA) vesicular events 
were detected at ob/ob cells (240 ± 16) compared to WT (310 ± 20).  This difference was 
due to the frequency of events during each stimulated exocytotic burst, not the length.  In 
WT cells, the average burst was 4.0 ± 0.3 s long with a spike frequency of 7.3 ± 0.4 Hz.  In 
cells from the leptin-deficient mice, the burst length was unchanged (p > 0.05) at 3.9 ± 0.2 s, 
but the frequency of spikes was significantly reduced (p < 0.001) to 5.4 ± 0.2 Hz.  The 
diminished spike frequency in ob/ob cells indicates an impaired vesicle mobilization process. 
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Figure 3.2.  Vesicular release at WT and ob/ob cells.  Representative amperometric traces 
(lower, solid line) and changes in [Ca2+]i (upper, dotted line) measured in response to a 0.5 s 
stimulation with 60 mM K+ at chromaffin cells from WT (A) and ob/ob (B) mice.  
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Table 3.1.  Amperometric spike characteristics of WT, ob/ob, and UCP2 KO mice.  Table 
shows the average number of spikes recorded during a trace (10 stimulations) and the 
average length of and frequency of spikes within an individual burst of exocytosis following a 
0.5 s stimulation with 60 mM K+.  Individual spike characteristics, including % of events with 
a foot feature, amplitude (Imax, in pA), quantal size (Q, in molecules of catecholamine), and 
halfwidth (t1/2, in ms), were averaged over the entire trace.  No significant differences were 
observed between WT and UCP2 KO cells (p > 0.05, one-way ANOVA).  Several measures 
of exocytosis were significantly reduced in ob/ob cells relative to WT (* = p < 0.05, ** = p < 
0.01, *** = p < 0.001). 
 
 
 
  
73 
 
 While the mobilization of vesicles was altered in ob/ob cells, the efficiency of vesicle 
docking and the kinetics of catecholamine extrusion following fusion were both unchanged.  
There was no significant difference (p > 0.05) between WT (6.5 ± 0.5 %) and ob/ob cells 
(5.7 ± 0.6 %) in the percentage of events exhibiting a pre- and/or post-spike foot, and the 
average t1/2 for events from WT (5.8 ± 0.3 ms) and ob/ob cells (6.3 ± 0.3 ms) was similar.  
However, the size of individual vesicular events was affected in the leptin-deficient mice.  
Spike amplitude was significantly reduced (p < 0.01) in ob/ob cells (40 ± 4 pA) compared to 
WT (62 ± 4 pA).  In addition, the average spike Q was only (5.9 ± 0.3) x 105 molecules in 
ob/ob cells, significantly smaller (p < 0.05) than the Q of (8.1 ± 0.6) x 105 molecules 
observed in WT cells.  The decreased content suggests that leptin-deficient mice have 
deficits in vesicular packaging, storage, and/or catecholamine synthesis. 
 As previous reports have implicated leptin acts via a Ca2+-mediated pathway 
(Takekoshi et al., 2001), the ratiometric dye fura-FF was used to monitor intracellular Ca2+ 
concentrations ([Ca2+]i) in WT (n = 28) and ob/ob (n = 21) cells following depolarization with 
60 mM K+.  Figure 3.2 shows a representative trace of [Ca2+]i for each cell type following a 
single stimulation.  The properties of the intracellular Ca2+ transient for both genotypes are 
summarized in Table 3.2.  No significant difference (p > 0.05, one-way ANOVA) was 
observed in the [Ca2+]i response between WT and ob/ob cells.  The area under the [Ca2+]i 
peak was 1.37 ± 0.09 arbitrary units in WT cells and 1.54 ± 0.17 in ob/ob cells.  The duration 
of the Ca2+ increase was also unchanged, with a t1/2 in WT cells of 3.0 ± 0.2 s and a t1/2 in 
ob/ob cells of 2.8 ± 0.2 s.  These results indicate that the differences in vesicular release in 
leptin-deficient mice can't be attributed to changes in depolarization-induced Ca2+ influx.  
Stimulated Release in Brain Slices from UCP2 KO Animals 
 Potential changes in the release and uptake of dopamine were evaluated in brain 
slices containing the caudate putamen from both WT and UCP2 KO mice (Figure 3.3A).  
Dopamine release was evoked with a single pulse electrical stimulation and monitored with  
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Table 3.2.  Intracellular Ca2+ dynamics in WT, ob/ob, and UCP2 KO mice.  Table shows the 
average area (in arbitrary units), halfwidth (t1/2, in s), and decay time (td, in s) of the increase 
in [Ca2+]i following a 0.5 s stimulation with 60 mM K+.  No significant difference is observed 
between WT and ob/ob or UCP2 KO mice for any of the measures (p > 0.05, one-way 
ANOVA).  
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Figure 3.3.  Lack of UCP2 affects striatal dopamine release but not stimulated 5-HT release 
in the substantia nigra.  (A) Stimulated dopamine release in the caudate putamen of UCP2 
KO mice is significantly enhanced relative to WT animals (** p < 0.01, one-way ANOVA, n = 
9 both genotypes).  Likewise, the Vmax of dopamine uptake is significantly increased in UCP2 
KO mice compared to WT animals (** p < 0.01, n = 5 both genotypes).  (B) There is no 
significant difference in stimulated 5-HT release between WT animals or UCP2 KO animals 
(p > 0.05, n ≥ 9, both genotypes).  
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FSCV.  Animals lacking UCP2 demonstrated significantly increased (p < 0.01, one-way 
ANOVA, n = 9 for both genotypes) stimulated dopamine release, with average maximal 
dopamine concentrations of 1.74 ± 0.08 µM in WT slices and 2.06 ± 0.07 µM in UCP2 KO 
slices. Similar to the ob/ob animals, this change in release was mirrored by a corresponding 
change in uptake.  The maximal uptake rate of dopamine was significantly enhanced (p < 
0.01, n = 5 for both genotypes) in UCP2 deficient mice, with an average Vmax of 5.5 ± 0.4 
µM/s in WT slices and 7.0 ± 0.2 µM/s in UCP2 KO mice.  These alterations in dopamine 
signaling are apparently the result of long-term or adaptive changes at the terminals, as 
attempts to mimic the UCP2 KO phenotype with acute treatment of a UCP2 inhibitor were 
unsuccessful.  A 35 min incubation with 20 µM genipin, which cross-links UCP2 and 
prevents proton shuttling (Zhang et al., 2006), did not significantly alter (p > 0.05, n = 5 for 
both genotypes) the maximal dopamine concentration or uptake rate in WT slices (Figure 
3.4).  This dosage and time frame had previously been shown to acutely modulate ATP 
levels in dopamine synaptosomes (Lowell lab, unpublished) and glucose sensing in slices of 
hypothalamus (Parton et al., 2007).  Interestingly, the effects of UCP2 KO appear specific to 
dopaminergic neurons.  No significant difference (p > 0.05, n = 9 for both genotypes) was 
observed in electrically stimulated 5-HT release in the SNr, with average maximal 5-HT 
concentrations of 155 ± 8 nM in WT slices and 164 ± 4 nM in UCP2 KO slices (Figure 3.3B). 
Exocytosis at Chromaffin Cells from UCP2 KO Mice 
 Amperometric recordings of exocytosis were also compared at isolated chromaffin 
cells from WT (n = 18 cells) and UCP2 KO (n = 20 cells) mice.  As before, vesicular release 
was triggered with a 0.5 s application of 60 mM K+, spaced every 30 s, for a total of 10 
stimulations.  Figure 3.5 shows a representative amperometric trace following a single 
stimulation for both cell types.  The amperometric spike characteristics for both genotypes 
are summarized in Table 3.1.  Despite the ATP-dependence of virtually all phases of the 
vesicle cycle, vesicular release observed at UCP2 KO cells was completely unaffected (p >  
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Figure 3.4.  Genipin modulation of dopamine release and uptake in mouse brain slices.  
The addition of 20 μM genipin to striatal brain slices for 35 minutes does not significantly 
alter (p > 0.05, n = 5 both genotypes) [DA]max or Vmax in WT mice when compared to UCP2 
KO mice.  In this experiment, the UCP2 KO mouse is the control animal because UCP2 KO 
mice are insensitive to genipin.  
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Figure 3.5.  Vesicular release at WT and UCP2 KO cells.  Representative amperometric 
traces (lower, solid line) and changes in [Ca2+]i (upper, dotted line) measured in response to 
a 0.5 s stimulation with 60 mM K+ at chromaffin cells from WT (A) and UCP2 KO (B) mice.  
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0.05 for all characteristics, one-way ANOVA) in reference to WT cells.  An average of 310 ± 
20 events were detected at WT cells, with individual bursts lasting 4.0 ± 0.3 s and having a 
spike frequency of 7.3 ± 0.4 Hz.  Similarly, an average of 280 ± 20 events were detected at 
UCP2 KO cells, with each burst lasting 4.0 ± 0.2 s and having a spike frequency of 6.4 ± 0.3 
Hz.  The percentage of WT cells exhibiting a pre- and/or post-spike foot was 6.5 ± 0.5 %, 
equivalent to the 6.4 ± 0.6 % noted for UCP2 KO cells.  The average amperometric spike for 
WT cells had an Imax of 62 ± 4 pA, t1/2 of 5.8 ± 0.3 ms, and Q of (8.1 ± 0.6) x 105 molecules.  
Likewise, the average spike for UCP2 KO cells had an Imax of 55 ± 5 pA, t1/2 of 6.5 ± 0.4 ms, 
and Q of (8.5 ± 0.8) x 105 molecules. 
 As cellular ATP levels and the mitochondrial membrane potential are involved in 
controlling the clearance of Ca2+ from the cytosol, the ratiometric dye fura-FF was used to 
monitor [Ca2+]i in WT (n = 28) and UCP2 KO (n = 23) cells following depolarization with 60 
mM K+.  Figure 3.5 shows a representative trace of [Ca2+]i for each cell type following a 
single stimulation.  The properties of the intracellular Ca2+ transient for both genotypes are 
summarized in Table 3.2.  Surprisingly, no significant differences (p > 0.05, one-way 
ANOVA) were observed in the [Ca2+]i response between WT and UCP2 KO cells.  The area 
under the [Ca2+]i peak was 1.37 ± 0.09 arbitrary units in WT cells and 1.30 ± 0.09 in UCP2 
KO cells.  The cytosolic Ca2+ influx in WT cells had a t1/2 of 3.0 ± 0.2 s and took 3.7 ± 0.2 s to 
return to resting levels from peak [Ca2+]i.  In UCP2 KO cells, the cytosolic Ca2+ influx had a 
t1/2 of 2.9 ± 0.1 s and took 3.4 ± 0.2 s to return to resting levels from peak [Ca2+]i. 
Discussion 
 FSCV recordings of stimulated neurotransmitter release in brain slices of leptin-
deficient animals revealed dopamine-specific alterations in transmission (Figure 3.1).  
Dopamine release in the caudate putamen was reduced by approximately 30 % in ob/ob 
mice, a finding consistent with previous reports showing decreased dopamine release in the 
NAc and impaired dopamine stores in the VTA and SNc (Fulton et al., 2006; Roseberry et 
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al., 2007). This reduction in release was coincident with a near 40 % decrease in the 
maximal uptake rate, suggesting a natural adaptive mechanism in which the brain attempts 
to maintain extracellular dopamine tone by modulating uptake in response to release.  For a 
more detailed examination of vesicular release in leptin-deficient animals, single cell studies 
were also performed.  Amperometric measurements of exocytosis at chromaffin cells from 
ob/ob mice showed a 26 % decrease in the frequency of vesicular events and a 27 % 
reduction in Q, or vesicular catecholamine content (Figure 3.2 and Table 3.1).  These results 
strongly suggest that the observed changes in dopamine release result from  impairments in 
vesicle mobilization upon depolarizing stimulation and either vesicular packaging, storage, 
or catecholamine synthesis, or some combination thereof.  Separate studies have shown 
that acute leptin application facilitates a Ca2+-dependent increase in catecholamine 
secretion and TH activity (Takekoshi et al., 1999; Takekoshi et al., 2001).  However, the 
diminished vesicular release observed here was independent of changes in [Ca2+]i dynamics 
(Figure 3.2 and Table 3.2), suggesting that the leptin-induced Ca2+ currents are not a 
substantial contributor to the endogenous exocytosis-triggering Ca2+ influx.  As a whole, 
these data support a model whereby leptin signaling outside the hypothalamus is important 
in its regulation of metabolism and energy expenditure.  In ob/ob animals the absence of 
basal leptin tone results in reduced catecholaminergic transmission.  One component of this 
reduction is a decrease in vesicular catecholamine stores, which current evidence suggests 
could be due to a depressed state of synthesis via TH (Takekoshi et al., 2001). 
 One final but crucial point to make in regards to leptin deficiency is the inherent 
complexity in analyzing the phenotype of the ob/ob mouse.  The genetic loss of a functional 
leptin protein leads to behaviors that make the animals grossly obese.  The obese state 
itself is associated with wide-ranging deficits in physiological function.  Thus, while the 
results reported here are consistent with a leptin effect, it's impossible to separate the 
hormone deficit from the obesity and assign a direct causal relationship.  Illustrating this 
81 
 
difficulty, work on a separate mouse model of obesity also observed impairments in tyrosine 
hydroxylase expression and K+-stimulated catecholamine secretion in chromaffin cells 
(Martins et al., 2004).  In addition, high fat diet-induced obesity has been shown to reduce 
dopamine transporter density in the caudate putamen (South and Huang, 2008), consistent 
with the decrease in Vmax observed in this study.  Future experiments in WT mice fed an 
obesity-inducing, high fat diet could help illuminate the true origin of these alterations in 
catecholamine exocytosis. 
 By dissipating the proton gradient across the inner mitochondrial membrane, UCP2 
effectively limits the maximal rate of cellular ATP production.  UCP2 KO animals would then 
be expected to exist in a hyperenergetic state.  Increased cellular ATP levels would exert 
competing effects on vesicular release through several ATP-dependent processes.  
Packaging of transmitters through vesicular transporters, mobilization of vesicles to plasma 
membrane, and priming of docked vesicles would theoretically be facilitated (Burgoyne and 
Morgan, 2003; Keating, 2008).  However, clearance of cytosolic Ca2+ by pumps on the 
plasma and ER membranes would also be facilitated, limiting the elevations in [Ca2+]i that 
trigger exocytosis (Garcia et al., 2006).  In brain slices of UCP2 KO mice, FSCV recordings 
in the caudate putamen suggest that, at least for dopamine release, the facilitation of steps 
in the vesicle cycle overrides the increase in Ca2+ clearance (Figure 3.3A).  Dopamine 
release is enhanced by approximately 20 % in UCP2 KO animals, and accompanied by a 
similar 27 % increase in maximal uptake rate.  The time course necessary for increased 
ATP production to impact exocytosis is apparently greater than 35 min, as acute blockade of 
UCP2 with genipin did not alter dopamine release (Figure 3.4).  By contrast, 5-HT release in 
the SNr was completely unaffected by UCP2 removal (Figure 3.3B); somewhat surprising 
given the multitude of potential ATP effects.  However, this null result was repeated in 
studies of exocytosis at single chromaffin cells.  Amperometric measurements showed no 
changes in frequency of spikes or average vesicular content (Figure 3.5 and Table 3.1), 
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indicating no increase in vesicular packaging, mobilization, or priming.  The size and 
duration of the depolarization-induced intracellular Ca2+ transient were equal in both cell 
types (Figure 3.5 and Table 3.2), indicating no alterations in cytosolic Ca2+ clearance 
through ATP-driven Ca2+ pumps or uptake via the mitochondrial uniporter. 
 The varied effects observed in the vesicular release of chemical messengers in 
UCP2 KO mice prevent a straightforward description of the protein's role in exocytosis.  One 
partial explanation for these contradictory results is that the uncoupling mechanism of UCP2 
isn't constitutively active.  A recently emerging hypothesis proposes that UCP2 does not 
contribute to a basal proton conductance, but is activated by reactive oxygen species 
generated by the leak of electrons from the electron transport chain (Cannon et al., 2006; 
Echtay, 2007).  The activity-dependent uncoupling of oxidative phosphorylation would then 
protect the cell from damage.  Such a mechanism would help explain the absence of 
significant changes in individual vesicular events and Ca2+ handling at chromaffin cells, in 5-
HT release in brain slices containing the SNr, and in dopamine release in the caudate 
putamen following acute inhibition of UCP2 with genipin.  However, the enhanced dopamine 
release and uptake in UCP2 KO animals doesn't fit with this explanation.  A protective role 
for UCP2 in response to reactive oxygen species would predict either no effect on dopamine 
release in UCP2 KO mice or a decrease in release owing to greater dopaminergic cell 
degeneration.  A second possible reason for the diverse responses could be cell-type 
specific differences in the expression of UCP2 or in the endogenous activity of the protein.  
The release measurements would indicate that, relative to 5-HT neurons and chromaffin 
cells, dopamine neurons express either a greater amount of UCP2 or a variant with higher 
basal proton conductance.  Although, the failure of genipin to acutely alter dopamine release 
would argue that even with higher expression/activity UCP2 does not effectively couple 
vesicular release to short term changes in oxidative phosphorylation.  Future measurements 
of exocytosis from WT and UCP2 KO cells/slices under conditions of oxidative stress and 
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extension of the genipin treatment to SNr slices and chromaffin cells could help elucidate 
the function of UCP2 in regulating vesicular release. 
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Chapter 4 
 
Exocytosis in a Mouse Model of Fragile X Syndrome 
 
 
Introduction 
 Fragile X syndrome (FXS) is the most commonly inherited form of mental retardation, 
often presenting as an autism spectrum disorder (Garber et al., 2008).  FXS is an X 
chromosome-linked disorder with an unusual inheritance pattern, in which intellectually 
normal male carriers pass the relevant alleles through their unaffected carrier daughters and 
on to their affected sons (Sherman et al., 1985).  The gene responsible for FXS is Fragile X 
Mental Retardation 1 gene (Fmr1), which encodes an mRNA-binding protein termed fragile 
X mental retardation protein (FMRP) (Verkerk et al., 1991; Ashley et al., 1993).  FMRP 
selectively binds about 4 % of the mRNA in the mammalian brain, and is hypothesized to 
play a role in synaptic plasticity through negative regulation of local protein synthesis at the 
synapse (Bassell and Warren, 2008).  In FXS, expansion of a CGG repeat in the 5'-
untranslated region of Fmr1 leads to hypermethylation-induced silencing of the gene and the 
absence of FMRP (Sutcliffe et al., 1992; Coffee et al., 1999). 
 A common phenotype of human FXS patients and a mouse model of the disease, in 
which the Fmr1 gene is knocked out (1994), is the prevalence of long, thin dendritic spines 
of immature morphology (Comery et al., 1997; Irwin et al., 2000).  Naturally, most 
investigations of the role of FMRP in FXS have thus focused on a postsynaptic mechanism.  
These studies suggest that the cognitive deficits in FXS arise from excess protein synthesis 
in the basal state and a loss of stimulus-induced translation upon activation of metabotropic 
glutamate receptors (Muddashetty et al., 2007).  Dysregulation of mRNA translation at the 
synapse would have significant consequences on dendritic spine development and long-
term synaptic plasticity, processes crucial to learning and memory.  While most work to date 
has focused on the postsynaptic role of FMRP, evidence for a presynaptic mechanism has 
also surfaced.  Cortical neurons in Fmr1 KO mice show diminished levels of several 
presynaptic proteins associated with the exocytotic machinery, including Rab and 
synaptotagmin isoforms and Munc-13 (Liao et al., 2008).  The putative down regulation of 
Rab isoforms in FXS is particularly compelling as Rab3A has been shown to be essential for 
the expression of LTP in the hippocampus (Castillo et al., 1997).  Further evidence for 
presynaptic mechanisms in FXS comes from observed deficiencies in the release of 
neuropeptides from large dense core vesicles (LDCVs) in Fmr1 KO mice (Dr. Jonathan 
Sweedler, personal communication).  Additionally, impairments in object recognition have 
been noted in Fmr1 KO mice (Ventura et al., 2004).  These impairments were coincident 
with lower basal levels of dopamine in the caudate putamen and altered amphetamine-
induced dopamine release in the prefrontal cortex and caudate putamen. 
 This chapter explores a potential presynaptic role of FMRP in regulating exocytosis 
by studying vesicular release in Fmr1 KO mice in two complementary preparations: fast 
scan cyclic voltammetry (FSCV) monitoring of transmitter release in brain slices and 
amperometric recordings at isolated chromaffin cells.  Measurements at single cells allow for 
characteristics of individual exocytotic events to be evaluated while measurements in the 
intact tissue slices can probe the summated release from multiple exocytosis sites as well as 
the diffusion, uptake, and receptor interactions of neurotransmitters following release.  
Together, these two techniques have previously been utilized in this lab to attribute the 
diminished dopamine release in a mouse model of Huntington's disease to impaired vesicle 
packaging (Johnson et al., 2006; Johnson et al., 2007).  Presently, both techniques were 
unable to detect any alterations in the presynaptic release of chemical messengers in Fmr1 
KO mice, supporting a role for FMRP that is predominantly postsynaptic. 
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Materials and Methods 
Animals 
 Mice were handled in accordance with the guidelines set forth by the Institutional 
Animal Care and Use Committee (IACUC) at UNC-Chapel Hill.  Fmr1 KO mice and their 
littermate WT mice were provided by the lab of Jonathan Sweedler at the University of 
Illinois at Urbana Champaign. 
Preparation of Adrenal Medullary Chromaffin Cells 
 Murine chromaffin cells were prepared as previously described (Kolski-Andreaco et 
al., 2007) with some modifications.  Mice were deeply anesthetized with ether, decapitated, 
and the adrenal glands rapidly removed into ice-cold, oxygenated Ca2+ and Mg2+-free 
Locke's buffer containing (in mM): 154 NaCl, 3.6 KCl, 5.6 NaHCO3, 5.6 glucose, and 10 
HEPES, pH adjusted to 7.2 with NaOH.  The medullae were isolated via gentle removal of 
cortical tissue and digested for 20 min at 37 oC in Dulbecco's Modified Eagle's 
Medium/Nutrient Mixture F-12 Ham (DMEM/F12) with 25 U/mL papain.  The digestion media 
was replaced with a fresh aliquot, followed by a second 20 min digestion period.  Digested 
tissue was washed and triturated with pipette tips of decreasing bore size in 500 µL 
DMEM/F12 with 10 % fetal bovine serum and 2 % horse serum.  The resulting cell 
suspension was distributed evenly to 3 poly-L-lysine-coated (0.1 mg/mL) 25 mm round glass 
coverslips.  After 15 min attachment plates were fed with 2 mL DMEM/F12 containing 100 
U/mL penicillin, 0.1 mg/mL streptomycin, 50 U/mL nystatin, and 40 µg/mL gentamicin.  
Plates were maintained in a humidified, 5 % CO2 atmosphere at 37 oC for at least 24 h prior 
to experimentation. 
Preparation of Brain Slices 
 Mice were anesthetized with ether and decapitated.  The brain was rapidly removed 
and placed on ice.  Coronal brain slices (300 µm thick) containing the caudate putamen, 
substantia nigra pars reticulata (SNr), or ventral bed nucleus of the stria terminalis (vBNST) 
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were prepared in ice cold artificial cerebral spinal fluid (aCSF) using a Lancer Vibratome 
(World Precision Instruments, Sarasota, Fl.).  The aCSF contained (in mM): 20 HEPES, 2.4 
CaCl2, 1.2 MgCl2, 1.2 NaH2PO4, 2.45 KCl, 126 NaCl, 11 glucose, and 25 NaHCO3.  The pH 
was adjusted to pH 7.4 and the aCSF was saturated with 95 % O2/5 % CO2.  Slices were 
superfused in aCSF at 37 oC for 35-40 minutes prior to recording. 
Electrodes and Electrochemistry 
 Carbon-fiber microelectrodes were prepared using T650 carbon fibers (6 µm 
diameter, Amoco, Greenville, SC) as previously described (Kawagoe et al., 1993).  Fibers 
were aspirated into glass capillaries (A-M Systems, Sequim, WA), and a vertical pipette 
puller (Narishige, Long Island, NY) was used to seal the glass around the carbon fiber.  For 
cylinder electrodes, the exposed carbon fiber was trimmed to a length of 50 µm.  For disk 
electrodes, the carbon fibers were cut at the glass seal, which was then reinforced with 
epoxy (15 % m-phenylenediamine in Epon 828 resin (Miller-Stephenson, Danbury, CT) 
heated to between 80 and 90 oC).  Electrodes were kept at room temperature overnight, and 
then the epoxy was cured via sequential heating at 100 and 150 oC for 8 h and overnight, 
respectively.  Disks were generated by beveling electrodes at 45 degrees on a diamond 
dust-embedded polishing wheel (Sutter Instruments, Novato, CA).  Prior to use, all 
electrodes were soaked in isopropyl alcohol for at least 20 min (Bath et al., 2000). 
 Amperometric recordings at single cells were made using a GeneClamp 500B 
amplifier (Axon Instruments, Molecular Devices, Union City, CA).  Disk electrodes were held 
at 0.650 V vs. a Ag/AgCl reference electrode (BASi, West Lafayette, IN), a potential 
sufficient to oxidize catecholamines.  The output current was analog filtered at 5 kHz with a 
low-pass Bessel filter and acquired at 20 kHz.  Post-collection, traces were further digitally 
filtered using a 400 Hz low-pass Bessel filter.  Data collection and filtering were controlled 
via the pClamp software provided with the amplifier. 
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 Measurements of dopamine, norepinephrine (NE) and serotonin (5-HT) release in 
brain slices were made using FSCV at cylinder electrodes.  Waveform application, current 
monitoring, and stimulus application were all controlled by locally written software (Tarheel 
CV, Labview) through a home built potentiostat (UEI, UNC electronics shop).  For dopamine 
and NE detection, the potential at the electrode was scanned from -0.4 V to 1 V and back at 
600 V/s, with the ramp repeated at 60 Hz.  For 5-HT, the electrode was scanned from 0.2 V 
to 1 V down to -0.1 V and back to 0.2 V at 1000 V/s, with the waveform repeated at 10 Hz 
(Jackson et al., 1995).  After an experiment, electrodes were calibrated in a flow injection 
system with a 1 µM bolus of analyte. 
Single Cell Experiments 
 Glass coverslips containing plated cells were secured in a stainless steel coverslip 
holder and mounted on the stage of an inverted microscope (Eclipse TE300, Nikon 
Instruments, Melville, NY).  A temperature controller (Warner Instruments, Hamden, CT) 
connected to the stage maintained cells at 37 oC throughout the experiments.  The 
extracellular recording buffer contained (in mM): 145 NaCl, 3 KCl, 1.2 MgCl2, 2.4 CaCl2, 1.2 
NaH2PO4, 11 glucose, and 10 HEPES, pH adjusted to 7.4 with NaOH.  Exocytosis was 
triggered via a 0.5 s pressure ejection of 60 mM K+ buffer from a stimulating pipette located 
30 µm from the cell.  Cells were stimmed every 30 s for 10 total stimulations.  Stimulating 
pipettes with 6 to 10 µm tip diameters were fabricated using a horizontal pipette puller 
(Sutter Instruments, Novato, CA) and a microforge (Narishige, Long Island, NY).  Pressure 
ejection was controlled via a multi-channel Picospritzer (General Valve Corporation, Parker 
Hannifin, Fairfield, NJ).  Positioning of both the electrode and stimulating pipette was 
controlled using piezoelectric micromanipulators (Burleigh Instruments, Exfo, Plano, TX). 
Slice Experiments 
Recordings were performed on a microscope (Nikon FN1, Gibraltar Stage) fitted with 
a slice perfusion chamber (Warner Instruments, Hamden CT).  Neurotransmitter release 
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was evoked by local electrical stimulation delivered through a tungsten bipolar stimulating 
electrode placed on the surface of the slice (Frederick Haer Co., Bowdoinham, ME).  The 
stimulation consisted of a computer generated, biphasic (2 ms per phase), constant-current 
(350 µA) pulse.  A single stimulation pulse was used to evoke striatal dopamine release in 
the caudate putamen (Jones et al., 1995), a 20 pulse 100 Hz stimulation train was used to 
evoke 5-HT release in the SNr (Bunin et al., 1998), and a 60 pulse 60 Hz stimulation was 
used to evoke NE release in the vBNST (Miles et al., 2002).  The current pulse was optically 
isolated from the preparation (NL 800, Neurolog, Medical Systems, Great Neck, NY).  
Stimulations were performed at regular 3-5 min intervals to maintain consistent release.  
Neurotransmitter release was detected at a microelectrode placed 75-100 µm into the slice 
at a distance of 100-200 µm from the stimulating electrode. 
Data Analysis 
 Amperometric spike analysis was performed using MiniAnalysis software 
(Synaptosoft, Decatur, GA).  For inclusion, spike amplitude was required to be 5 times 
greater than the root-mean-squared current noise.  Overlapping peaks were included in 
frequency and foot analysis, but excluded from individual spike analysis.  Visual examination 
of the peaks was used to determine presence of pre- and post-spike feet.  For frequency 
analysis, the first observed spike following stimulation marked the burst start time.  Burst 
end time was denoted by the first interspike interval > 1s.  Individual amperometric spike 
characteristics such as quantal size (Q), t1/2, and amplitude were averaged for an individual 
cell.  The cumulative mean for an experimental group was then determined using the cell 
averages (Colliver et al., 2000).  Release values reported from the slice experiments are the 
maximal neurotransmitter concentrations obtained following stimulation.  Values were 
averaged across multiple locations in each slice, and then pooled for each genotype.  All 
data are presented as means ± standard errors of the mean.  Statistical comparisons were 
performed using a Student's t-test. 
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Results 
Presynaptic Release of Biogenic Amines in Brain Slices 
 Possible presynaptic alterations in FXS were evaluated using brain slices containing 
the caudate putamen, vBNST, or SNr from both WT and Fmr1 KO mice (n = 6 animals for 
both genotypes) (Figure 4.1).  No discernible deficits in the presynaptic release mechanism 
were observed as electrically stimulated neurotransmitter release monitored by FSCV was 
unchanged in Fmr1 KO mice when compared to WT mice (p > 0.05 for all three regions, 
Student's t-test).  The maximum dopamine concentration measured in the caudate following 
stimulation was 1.50 ± 0.08 µM in WT slices and 1.61 ± 0.09 µM in Fmr1 KO slices.  NE 
release in the vBNST was equivalent in slices from WT and Fmr1 KO mice at 0.95 ± 0.14 
µM and 1.02 ± 0.14 µM, respectively.  Additionally, no differences were detected in the SNr, 
where electrically stimulated 5-HT release reached a maximal concentration of 133 ± 9 nM 
in WT slices and 127 ± 6 nM in Fmr1 KO slices. 
Vesicular Release at Chromaffin Cells 
 To further investigate the role of FMRP in modulating presynaptic secretory proteins, 
the vesicular release machinery was examined in isolated chromaffin cells from WT (n = 53 
cells) and Fmr1 KO (n = 43 cells) mice.  Amperometry was used to measure the exocytosis 
stimulated by 10 successive 0.5 s applications of 60 mM K+, spaced 30 s apart.  Figure 4.2 
shows a representative amperometric trace following a single stimulation for both cell types.  
The amperometric spike characteristics for both genotypes are summarized in Table 4.1.  
The mouse model of FXS showed no effects on the exocytotic protein machinery as 
vesicular release observed at Fmr1 KO cells was unchanged (p > 0.05 for all characteristics, 
Student's t-test) compared to WT cells.  An average of 310 ± 20 events were detected at WT 
cells, with individual bursts lasting 3.4 ± 0.2 s and having a spike frequency of 8.4 ± 0.3 Hz.  
Similarly, an average of 320 ± 20 events were detected at Fmr1 KO cells, with each burst 
lasting 3.5 ± 0.2 s and having a spike frequency of 9.1 ± 0.4 Hz.  The percentage of WT and  
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Figure 4.1.  Stimulated neurotransmitter release in three regions of the adult mouse brain.  
Brain slices containing the caudate putamen, vBNST, or SNr were taken from WT mice and 
Fmr1 KO mice.  Dopamine release evoked by a single pulse electrical stimulation was 
unchanged in Fmr1 KO mice compared to WT mice (p > 0.05, n = 6 both genotypes).  The 
same can be said for 5-HT release evoked by a 20 pulse 100 Hz stimulation in the SNr and 
NE release evoked by a 60 pulse 60 Hz stimulation in the vBNST (p > 0.05, n = 6 both 
genotypes).  
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Figure 4.2.  Vesicular release at WT and Fmr1 KO cells.  Representative amperometric 
traces measured in response to a 0.5 s stimulation with 60 mM K+ at chromaffin cells from 
WT (A) and Fmr1 KO (B) mice.   
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Table 4.1.  Amperometric spike characteristics of WT and Fmr1 KO mice.  Table shows the 
average number of spikes recorded during a trace (10 stimulations) and the average length 
of and frequency of spikes within an individual burst of exocytosis following a 0.5 s 
stimulation with 60 mM K+.  Individual spike characteristics, including % of events with a foot 
feature, amplitude (Imax, in pA), quantal size (Q, in molecules of catecholamine), and 
halfwidth (t1/2, in ms), were averaged over the entire trace.  No significant differences were 
observed between WT and Fmr1 KO cells (p > 0.05, one-way ANOVA). 
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Fmr1 cells exhibiting a pre- and/or post-spike foot was an identical 11.1 ± 0.4 %.  The 
average amperometric spike for WT cells had an Imax of 76 ± 4 pA, t1/2 of 5.3 ± 0.2 ms, and Q 
of (8.0 ± 0.4) x 105 molecules.  Likewise, the average spike for Fmr1 KO cells had an Imax of 
78 ± 4 pA, t1/2 of 5.5 ± 0.2 ms, and Q of (8.9 ± 0.6) x 105 molecules. 
Discussion 
 Of the many mRNA cargoes of FMRP, several presynaptic proteins involved in the 
secretory pathway have been identified (Brown et al., 2001; Miyashiro et al., 2003).  In the 
brains of Fmr1 KO mice, the lack of FMRP is associated with the down regulation of 
numerous presynaptic proteins linked to vesicle exocytosis (Liao et al., 2008).  Most notable 
among the mRNA and protein targets is Rab3A, a small GTPase implicated in the GTP-
dependent docking and fusion of vesicles with the plasma membrane (Geppert et al., 1997; 
Leenders et al., 2001).  Dysregulation of Rab3A expression, and that of other presynaptic 
mRNA cargoes of FMRP, is proposed to contribute to the observed mental deficits in FXS 
through alterations in the vesicular release of neurotransmitters.  This theorized link has 
recently been observed.  Cortical synaptoneurosomes from Fmr1 KO mice exhibit a 90 % 
reduction in stimulation-dependent release of neuropeptides from LDCVs (Dr. Jonathan 
Sweedler, personal communication).  This deficit in exocytosis was coincident with a 50 % 
decrease in Rab3A expression. 
 To further examine the role of FMRP in regulating the presynaptic release of 
chemical messengers, electrochemical monitoring of neurotransmitter release with FSCV 
and amperometry has been performed in Fmr1 KO animals.  Electrically stimulated 
dopamine release in the caudate putamen, NE release in the vBNST, and 5-HT release in 
the SNr are all unchanged in brain slices from Fmr1 KO mice relative to WT mice (Figure 
4.1).  Similarly, no significant differences were measured in the frequency of vesicular 
events or individual amperometric spike characteristics between WT and Fmr1 KO 
chromaffin cells (Figure 4.2 and Table 4.1).  Taken together, these results suggest that 
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presynaptic regulation of biogenic amine release is largely intact in Fmr1 KO mice.  In light 
of the evidence for vesicular release deficiencies discussed above, these results imply that 
the presynaptic regulation of exocytosis by FMRP may be specific to cortical brain regions or 
to the release of neuropeptides.  Future experiments assessing the presynaptic release 
mechanism in different brain locations or of other neurotransmitters could help elucidate the 
function of FMRP in the expression of FXS symptoms. 
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Chapter 5 
 
Fast Scan Cyclic Voltammetry of Trace Amines 
 
 
Introduction 
 The trace amines are a family of endogenous amines closely related in structure and 
metabolism to the classical monoamine neurotransmitters (Philips et al., 1974; Axelrod and 
Saavedra, 1977).  As the name suggests, these compounds are present at trace amounts 
(0.1 – 100 ng/g tissue) in the mammalian brain, several hundred-fold lower than the 
classical monoamines (Berry, 2004).  Trace amines are distributed heterogeneously in the 
brain, although this distribution closely mimics the cell body and projection regions of the 
dopamine, norepinephrine (NE), and serotonin systems (Philips, 1984).  Synthesis and 
turnover rates for the trace amines are equivalent or greater than those for dopamine and 
NE (Durden and Philips, 1980; Durden et al., 1988), with oxidative deamination by the 
monoamine oxidase enzymes primarily responsible for the high turnover rates (Philips and 
Boulton, 1979).  Though initially considered simple metabolic byproducts of the classical 
monoamine transmitters, renewed interest in the physiological role of these compounds was 
triggered by discovery of a family of mammalian trace amine receptors (Borowsky et al., 
2001).  As summarized in recent reviews, current opinion holds that trace amines function 
mainly as modulators of monoamine neurotransmission, affecting both presynaptic release 
and uptake and postsynaptic sensitivity. (Berry, 2004; Burchett and Hicks, 2006). 
 Although the label extends to derivatives of L-phenylalanine and L-tryptophan as 
well, this work will focus only on those trace amines derived from the precursor amino acid 
L-tyrosine: tyramine, octopamine, and synephrine.  These molecules are structurally similar 
to dopamine, NE, and epinephrine (E), respectively, but are phenolamines rather than 
catecholamines (Figure 5.1).  Over the years, several methods have been employed for the 
detection and quantification of trace amines including radioenzymatic assays (Axelrod and 
Saavedra, 1977), immunohistochemistry (Kitahama et al., 2005), mass spectrometry (Philips 
et al., 1974), and high performance liquid chromatography (D'Andrea et al., 2003).  
However, none of these methods permit measurement of concentration changes on the 
subsecond time scale of vesicular release of monoamine transmitters in the brain.  Fast 
scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes is one technique that would 
provide the necessary temporal resolution for real-time measurements while still maintaining 
the sensitivity required to monitor such low concentrations (Robinson et al., 2008).  To date 
though, little is known about the electrochemistry of phenolamines at carbon-fiber 
microelectrodes.  The electrochemistry of tyramine has been investigated at gold, platinum, 
and graphite electrodes (Tenreiro et al., 2007; de Castro et al., 2008; Luczak, 2008), but at 
scan rates significantly lower than those used for FSCV recordings of neurotransmission.  
Like other phenols, these studies show that oxidation of tyramine produces phenoxy radicals 
that react with other tyramine molecules to yield a para-linked dimer.  Subsequent oxidation 
leads to polymerization, which could form a passivating, insulating film on the electrode 
surface.  The electrochemistry of octopamine and synephrine is likely very similar, and the 
potential fouling of the electrode through film formation will need to be addressed for the 
electrochemical detection of phenolamines to prove viable. 
 This chapter reports the development of FSCV techniques for the real-time 
monitoring of tyramine, octopamine, and synephrine concentration changes.  The 
electrochemistry of the trace amines is described using two FSCV waveforms.  While the 
generation of polymerized films was diminished with higher holding potentials, no significant 
evidence for fouling was observed with either waveform.  Both waveforms qualitatively 
distinguish trace amines from their catecholamine counterparts, but show a limited time  
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Figure 5.1.  Chemical structures of the catecholamines and trace amines.  Left hand column 
shows the classical catecholamine transmitters derived from the precursor amino acid l-
tyrosine.  Right hand column shows the structurally related trace amines.  These 
compounds are also derived from l-tyrosine, but as phenolamines possess only one ring 
hydroxyl group.  
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course for simultaneous quantitative measurements.  These techniques could serve as 
valuable tools for future studies of trace amine modulation of the classical monoamine 
neurotransmitters. 
Materials and Methods 
Electrodes and Electrochemistry 
 Carbon-fiber microelectrodes were prepared using P55 carbon fibers (10 µm 
diameter, Amoco, Greenville, SC) as previously described (Kawagoe et al., 1993).  Fibers 
were aspirated into glass capillaries (A-M Systems, Sequim, WA), and a vertical pipette 
puller (Narishige, Long Island, NY) was used to seal the glass around the carbon fiber.  
Carbon fibers were cut at the glass seal, which was then reinforced with epoxy (15 % m-
phenylenediamine in Epon 828 resin (Miller-Stephenson, Danbury, CT) heated to between 
80 and 90 oC).  Electrodes were kept at room temperature overnight, and then the epoxy 
was cured via sequential heating at 100 and 150 oC for 8 h and overnight, respectively.  
Prior to use, electrodes were beveled at 45 degrees on a diamond dust-embedded polishing 
wheel (Sutter Instruments, Novato, CA) and soaked in isopropyl alcohol for at least 20 min 
(Bath et al., 2000).  FSCV measurements were made using an EI-400 biopotentiostat (ESA, 
Chelmsford, MA).  Waveform application, data acquisition, and post-collection digital filtering 
at 2 kHz were controlled by locally written software (Tarheel CV, Labview).  A Ag/AgCl 
reference electrode (BASi, West Lafayette, IN) was used for all experiments. 
Flow Injection Experiments 
 Carbon-fiber disk microelectrodes were situated in an electrochemical cell at the 
output of a flow injection system (Kristensen et al., 1986; Zachek et al., 2008).  A six-port 
high performance liquid chromatography injection valve (Upchurch Scientific, Oak Harbor, 
WA) was mounted on a two-position pneumatic actuator (Rheodyne, Rohnert Park, CA).  
The actuator was used in conjunction with a 12 V solenoid valve kit (Rheodyne) at 50 psi to 
precisely control the introduction of analytes to the electrode surface.  Solvent flow (2 
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mL/min) was driven with a variable-resistance infusion pump (Harvard Apparatus, Holliston, 
MA) through the valve and into the electrochemical cell. 
Chemicals 
 All chemicals were purchased from Sigma Aldrich (St. Louis, MO) and used as 
received.  Aqueous solutions were prepared in doubly-distilled, deionized water.  The 
running buffer for flow injection experiments contained (in mM): 140 NaCl, 4 KCl, 1 MgCl2, 2 
CaCl2, 10 glucose, and 20 Tris-HCl, pH adjusted to 7.4 with NaOH.  Stock solutions of 
catecholamines and trace amines were prepared in 0.1 N HClO4 and diluted in running 
buffer on the day of each experiment.  All solutions were deoxygenated prior to use with at 
least 20 min of N2 bubbling. 
Results 
Characterization of Trace Amine Electrochemistry 
 For catecholamine detection in brain slices, the potential at the carbon-fiber 
microelectrode is generally scanned from -0.4 V to 1.0 V and back at 600 V/s, with the ramp 
repeated at 60 Hz (see Chapters 3 and 4).  As the oxidation potentials of the trace amines 
were predicted to be higher than those of the catecholamines (de Castro et al., 2008; 
Luczak, 2008), the switching potential was increased to 1.3 V (referred to hereafter as the 
extended waveform).  Application of the extended waveform to a disk carbon-fiber 
microelectrode during a 1 s flow injection of 10 µM tyramine, octopamine, or synephrine 
resulted in the background-subtracted cyclic voltammograms (CVs) and current versus time 
traces shown in Figure 5.2.  The CVs for all three trace amines were largely similar.  A main 
oxidation peak was observed at 0.98 ± 0.02 V for tyramine, 1.03 ± 0.02 V for octopamine, 
and 1.02 ± 0.02 V for synephrine (n = 3 electrodes for all compounds).  Initially, the main 
oxidation peak was the primary feature of the CV, along with a small reduction peak at -0.2 
V and a small oxidative current near the switching potential (Figure 5.2A-C).  However, a 
second oxidation peak at 0.6 V slowly grew in over the time course of the injection and was  
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Figure 5.2.  Electrochemical characterization of tyramine, octopamine, and synephrine with 
the extended waveform.  Top panel (A, B, C) shows the first background-subtracted cyclic 
voltammogram (CV) obtained after exposure to 10 µM tyramine, octopamine, or synephrine.  
All three compounds exhibit a main oxidation peak around 1.0 V.  Middle panel (D, E, F) 
shows the 20th CV of the injection, approximately 0.33 s after initial exposure to the trace 
amine.  All three compounds now exhibit a pronounced secondary oxidation peak around 
0.6 V.  The bottom panel (G, H, I) shows the current (I) measured at the electrode as a 
function of time (t) at the potential of both the main (filled circles) and secondary (open 
triangles) oxidation peaks.  The bar indicates when the electrode was exposed to each 
compound.   
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clearly visible after only 0.33 s of exposure (Figure 5.2D-F).  The growth of this oxidation 
peak coincided with an increase in the size of the reduction peak at -0.2 V.  Additionally, the 
oxidative current near the switching potential increased with time, but only for tyramine.  The 
current versus time traces show that the secondary oxidation peak continued to increase in 
current throughout the 1 s injection and returned to baseline much slower than the main 
peak after the trace amine had been washed out of the flow cell (Figure 5.2G-I).  For 
tyramine, this secondary peak reached 76 ± 2 % of the amplitude of the main oxidation peak 
by the end of the injection.  For octopamine it reached 120 ± 4 % of the amplitude and for 
synephrine 105 ± 3 %.   
 FSCV detection with the extended waveform displayed minimal sensitivity 
differences for the three trace amines.  On average, peak currents of 1.56 ± 0.07 nA, 1.48 ± 
0.02 nA, and 1.22 ± 0.07 nA were observed for the main oxidation peak of 10 µM tyramine, 
octopamine, and synephrine, respectively.  The square pulse of analyte resulted in a square 
current response at the main oxidation peak (Figure 5.2G-I), suggesting no short-term 
fouling of the electrode surface.  There was also no evidence for long-term fouling of the 
electrode.  No decrease was observed in the measured current at the main oxidation 
potential during six successive flow injections of the three trace amines.  Further, the 
electrode response to a 10 µM injection of NE was unaltered (p > 0.05, Student's t-test) 
following exposure to trace amine.  After six successive tyramine injections the current 
measured in response to NE oxidation was 103 ± 4 % of pre-exposure levels.  After 
octopamine exposure the response was 99 ± 5 % of pre-exposure levels and for synephrine 
103 ± 3 %. 
Discrimination from Catecholamines with the Extended Waveform 
 With use of the extended waveform, the CVs for dopamine, NE, and E are 
indistinguishable.  The catecholamines all exhibit an oxidation peak at 0.6 V and a reduction 
peak at -0.2 V.  Unfortunately, these potentials are identical to those of the secondary peak 
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and reduction peak that arise during oxidation of the trace amines.  As such, the extended 
waveform had a limited time window for distinguishing catecholamine and phenolamine 
species.  Flow cell injection of mixtures containing 10 µM NE and 10 µM tyramine, 
octopamine, or synephrine are summarized in Figure 5.3.  The first CVs collected upon 
exposure to these mixtures showed an oxidation peak at 0.6 V that can be attributed solely 
to the presence of NE (Fig 5.3A-C).  The magnitude of the current at this potential was 
significantly increased (p < 0.05, Student's t-test, n = 3 electrodes) within 3 to 5 CVs from 
the initial scan for all three trace amines, owing to the appearance of the secondary 
oxidation peak.  These data suggest that simultaneous measures of catecholamine and 
trace amine concentration can only be made accurately for very brief exposures (less than 
100 ms) using the extended waveform. 
The Effect of Holding Potential on the Secondary Oxidation Peak 
 The lag between trace amine washout and the current at the secondary oxidation 
potential returning to baseline indicate that this peak stems from a species adsorbed to the 
electrode surface.  Presumably, like the trace amines themselves, these secondary products 
contain protonated amines at pH 7.4.  In an attempt to reduce adsorption of these species, 
the holding potential of the FSCV waveform was increased from -0.4 V to 0.1 V (referred to 
hereafter as the short waveform) (Bath et al., 2000).  Application of the short waveform to a 
disk carbon-fiber microelectrode during 1 s flow injections of 10 µM tyramine, octopamine, or 
synephrine resulted in the CVs and current versus time traces shown in Figure 5.4.  Minus 
the reductive wave, the initial CVs for all three trace amines were nearly identical to those 
obtained with the extended waveform (Figure 5.4A-C).  A main oxidation peak was observed 
at 0.97 ± 0.02 V for tyramine, 0.99 ± 0.03 V for octopamine, and 0.98 ± 0.03 V for 
synephrine (n = 3 electrodes for all compounds).  The small oxidative current near the 
switching potential was also still present, and again showed an increase in size during the 
injection that was specific to tyramine oxidation.  Though its size was greatly diminished, the  
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Figure 5.3. Discrimination of catecholamines and trace amines with the extended waveform.  
Top panel (A, B, C) shows the first background-subtracted cyclic voltammogram (CV) 
obtained after exposure to a mixture of 10 µM norepinephrine (NE) and 10 µM tyramine, 
octopamine, or synephrine.  Two oxidation peaks are clearly visible: one for the trace amine 
around 1.0 V and one for NE around 0.6 V.  Middle panel (D, E, F) shows the 20th CV of the 
injection, approximately 0.33 s after initial exposure to the mixture.  The secondary oxidation 
peak for the trace amines overlaps with the NE oxidation peak, leading to an increase in 
signal as it grows in.  The bottom panel (G, H, I) shows the current (I) measured at the 
electrode as a function of time (t) at the potential of both the main (filled circles) and 
secondary (open triangles) oxidation peaks.  The bar indicates when the electrode was 
exposed to the mixture.   
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Figure 5.4.  Electrochemical characterization of tyramine, octopamine, and synephrine with 
the short waveform.  Top panel (A, B, C) shows the first background-subtracted cyclic 
voltammogram (CV) obtained after exposure to 10 µM tyramine, octopamine, or synephrine.  
All three compounds exhibit a main oxidation peak around 1.0 V.  Middle panel (D, E, F) 
shows the 20th CV of the injection, approximately 0.33 s after initial exposure to the trace 
amine.  While still present, the secondary oxidation peak around 0.6 V is significantly 
reduced compared to the extended waveform.  The bottom panel (G, H, I) shows the current 
(I) measured at the electrode as a function of time (t) at the potential of both the main (filled 
circles) and secondary (open triangles) oxidation peaks.  The bar indicates when the 
electrode was exposed to each compound.  
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secondary oxidation peak persisted with application of the short waveform and was readily 
identifiable within 0.33 s of exposure to trace amine (Figure 5.4D-F).  The shape of the 
current response at the secondary oxidation potential was unchanged, exhibiting a slow, 
continual increase in current throughout the 1 s injection and a prolonged return to baseline 
(Figure 5.4G-I).  For tyramine, the secondary peak reached 33 ± 2 % of the amplitude of the 
main oxidation peak by the end of the injection.  For octopamine it reached 51 ± 4 % of the 
amplitude and for synephrine 38 ± 3 %.   
 Increasing the holding potential diminished the electrode sensitivity for the three 
trace amines.  On average, peak currents of 1.00 ± 0.02 nA, 1.01 ± 0.03 nA, and 1.06 ± 0.02 
nA were observed for the main oxidation peak of 10 µM tyramine, octopamine, and 
synephrine, respectively.  The square pulse of analyte resulted in a square current response 
at the main oxidation peak for octopamine and synephrine (Figure 5.4H,I), suggesting no 
short-term fouling of the electrode surface.  For tyramine injection, a gradual decrease in 
peak current was observed (Figure 5.4G), indicating a small but immediate loss of sensitivity 
during exposure.  This change in sensitivity was temporary, as both the background and 
peak currents fully recovered by the next injection.  Similarly, no decrease was observed in 
the measured current at the main oxidation potential during six successive flow injections of 
octopamine and synephrine.  As with the extended waveform, the electrode response to a 
10 µM injection of NE was unaltered (p > 0.05, Student's t-test) following exposure to trace 
amine.  After six successive tyramine injections the current measured in response to NE 
oxidation was 94 ± 5 % of pre-exposure levels.  After octopamine exposure the response 
was 97 ± 2 % of pre-exposure levels and for synephrine 97 ± 3 %. 
Discrimination from Catecholamines with the Short Waveform 
 With the continued presence of the secondary oxidation peak, the short waveform is 
subject to comparable time limitations as the extended waveform when it comes to 
distinguishing catecholamines from phenolamines.  Flow cell injection of mixtures containing 
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10 µM NE and 10 µM tyramine, octopamine, or synephrine are summarized in Figure 5.5.  
As before, the first CVs collected upon exposure to these mixtures show an oxidation peak 
at 0.6 V that can be attributed solely to the presence of NE (Fig 5.5A-C).  Owing to the 
reduced size of the secondary oxidation peak, the magnitude of the current at this potential 
increases slower than was observed with the extended waveform, with the current response 
at 0.6 V for tyramine even staying flat throughout the injection (Figure 5.5D-I).  The peak 
current during octopamine and synephrine injection was still significantly increased (p < 
0.05, Student's t-test, n = 3 electrodes) within 5 CVs of the initial scan, suggesting 
quantitative measures of catecholamine and trace amine concentration would remain limited 
to very brief exposures (less than 100 ms). 
Discussion 
 The electrochemistry of the trace amines tyramine, octopamine, and synephrine at 
disk carbon-fiber microelectrodes has been described using two FSCV waveforms.  With 
both the extended and the short waveforms, all three trace amines exhibit a primary 
oxidation wave around 1.0 V.  In contrast, the primary oxidation wave for catecholamines 
with these waveforms occurs at 0.6 V, demonstrating a higher energy barrier for electron 
removal from the phenol moiety.  While the oxidation potentials of the catecholamines and 
trace amines are sufficiently resolved from each other by FSCV, selective detection of 
individual trace amines is not feasible due to their nearly identical CVs (Figure 5.2A-C and 
Figure 5.4A-C).  Thus, like the catecholamines, positive analyte identification of an unknown 
trace amine cannot be performed solely by electrochemistry.  Other analytical or 
pharmacological approaches would be necessary for confirmation. 
 In addition to displaying analogous CV shapes, the trace amines also demonstrated 
similar sensitivities for detection at the electrode surface.  With the extended waveform, 
peak currents at the primary oxidation potential were equal for 10 µM tyramine and 
octopamine injections, and those for synephrine injections were only slightly lower (Figure  
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Figure 5.5.  Discrimination of catecholamines and trace amines with the short waveform.  
Top panel (A, B, C) shows the first background-subtracted cyclic voltammogram (CV) 
obtained after exposure to a mixture of 10 µM norepinephrine (NE) and 10 µM tyramine, 
octopamine, or synephrine.  Two oxidation peaks are clearly visible: one for the trace amine 
around 1.0 V and one for NE around 0.6 V.  Middle panel (D, E, F) shows the 20th CV of the 
injection, approximately 0.33 s after initial exposure to the mixture.  The increase in the NE 
signal at 0.6 V is less pronounced than with the extended waveform, owing to a decrease in 
formation of the trace amine secondary oxidation product.  The bottom panel (G, H, I) shows 
the current (I) measured at the electrode as a function of time (t) at the potential of both the 
main (filled circles) and secondary (open triangles) oxidation peaks.  The bar indicates when 
the electrode was exposed to the mixture.  
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5.2G-I).  By shifting the holding potential from a negative to a positive value, the short 
waveform resulted in diminished sensitivities for all three compounds (Figure 5.4G-I).  This 
decrease could result from less adsorption of the trace amines, with their positively charged 
amine groups, to the electrode surface during the time between voltage scans (Bath et al., 
2000).  The adsorption deficits are evidently greater for primary amines, as synephrine 
sensitivity was equal to that of tyramine and octopamine when using the short waveform. 
 It is well documented that tyramine, like other phenols, polymerizes following 
oxidation, generating a film on electrode surfaces (Pham et al., 1982; Tenreiro et al., 2007; 
de Castro et al., 2008).  The electrodeposition of polytyramine films by cyclic voltammetry 
has even been used to immobilize enzymes for the fabrication of enzyme-modified 
electrodes (Manihar et al., 2001).  As the polymerization reaction is driven by formation of 
phenoxy radicals, it is predicted that octopamine and synephrine would behave similarly.  
The formation of these films is generally observed as electrode passivation and the 
disappearance of tyramine oxidative currents over successive scans.  In one instance, 
however, the deposited film was electroactive and accompanied by the appearance of a 
broad oxidative current between 0.2 and 0.7 V and a corresponding reduction peak (de 
Castro et al., 2008).  This finding is in line with the electrochemistry observed during the 
present experiments.  With the extended waveform, trace amine oxidation results in the 
formation of a secondary product from side reactions of the initial oxidized species.  
Generation of the secondary product is measured as a slow, continual increase in oxidative 
current at 0.6 V throughout the injection and coincides with the growth of a reduction peak at 
-0.2 V (Figure 5.2D-I).  This trend is repeated with the short waveform, although the 
potential window precludes observation of the reduction peak (Figure 5.4D-I).  Considering 
the identical oxidation potentials, the secondary products could be catechol molecules 
generated from side reactions of the phenoxy radicals.  However, both the previous 
literature reports and the persistence of the secondary peak oxidation current after the end 
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of the injection strongly support that these oxidative and reductive waves correspond to an 
electroactive film at the electrode surface resulting from polymerization of the trace amines. 
 The rates of polymerization differed between the three trace amines, but were 
consistent under both waveforms.  The current at the secondary oxidation peak grew in 
fastest for octopamine, followed by synephrine, then tyramine (Figure 5.2G-I and Figure 
5.4G-I).  The extent of polymerization was significantly diminished upon shift of the holding 
potential from -0.4 to 0.1 V, as evident from the sharp decrease in current response at the 
secondary peak.  This result is consistent with the proposed oxidation and polymerization 
schemes for tyramine (Pham et al., 1984; Tenreiro et al., 2007), and suggests that 
adsorption of the monomeric and polymeric species to the electrode surface via electrostatic 
interactions with the protonated free amino groups may provide a significant driving force for 
film formation at physiological pH.  At the end of trace amine injection, the current at the 
secondary oxidation peak begins a prolonged return to baseline.  Though the time course is 
slow (30 – 60 s), the current returning to pre-exposure levels suggests that, at least under 
these FSCV conditions, either the polymerization mechanism or attachment of the film to the 
electrode surface is reversible and dependent on continued oxidation of the trace amine.  
This would help explain why no evidence for long-term fouling of the electrode was 
observed during successive trace amine injections or for NE sensitivity following trace amine 
exposure.  Additionally, no evidence for short-term fouling of the electrode during actual 
trace amine injection and film formation was noted in all but one case.  This is not surprising, 
as the permeability of thin polytyramine films has been demonstrated (Situmorang et al., 
1998; Zhou et al., 2009).  For tyramine injections monitored with the short waveform, where 
a gradual decrease in current of the primary oxidation peak was observed, an additional 
feature is noted on the CV: an increase in the oxidative current near the switching potential 
(Figure 5.4D).  This current response could represent the generation of additional side 
products or alternate polymer structures that do affect electrode sensitivity.  However, this 
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same feature can be seen during tyramine injections monitored with the extended waveform 
(Figure 5.2D), where no change in current of the primary oxidation peak was observed 
throughout exposure.   
 As the trace amines are thought to act predominantly as modulators of monoamine 
neurotransmission (Berry, 2004; Burchett and Hicks, 2006), the ideal FSCV waveform would 
be able to simultaneously detect both classes of compound.  The short and extended 
waveforms described in this chapter would allow for the qualitative distinction between 
experimental measurements in the presence of catecholamines or trace amines alone and 
those in the presence of both catecholamines and trace amines (Figure 5.3 and 5.5).  Both 
waveforms would also allow real-time monitoring of concentration changes for either 
catecholamines or trace amines.  However, quantitative measurements of catecholamine 
concentration changes when both species are present are temporally limited to a very brief 
window (100 ms) due to the overlapping trace amine secondary oxidation peak at 0.6 V.  
While this timescale would be sufficient for the observation of individual vesicular events at 
single cells, it is most likely too brief for in vivo or brain slice recordings.  Of course, this limit 
is derived from mixtures of equal concentration.  In the mammalian brain, endogenous 
concentrations of trace amines are over a hundred-fold lower than the catecholamines 
(Berry, 2004).  The oxidative current from the electroactive trace amine films could prove 
negligible in these conditions, permitting accurate measurements over greater timescales. 
 One approach for improving the utility of these FSCV techniques could be through 
lowering the repetition rate.  During collection of the data presented in this chapter, a paper 
was published on the electrochemistry of tyramine and octopamine at cylindrical carbon-
fiber microelectrodes (Cooper and Venton, 2009).  Using identical waveforms, only with a 
repetition rate of 10 Hz instead of 60 Hz, the authors obtained virtually the same results 
described here.  Polymerization of tyramine and octopamine at the electrode surface 
coincided with the growth of an oxidation current at 0.5 V and a reduction current at -0.2 V.  
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This film was associated with only a minimal loss of tyramine sensitivity after successive 
injections (12%).  However, at 10 Hz, raising the holding potential from -0.4 to 0.1 V 
completely eliminated the secondary oxidation peak rather than just diminishing the 
amplitude.  Though the authors did not extend their studies to trace amine and 
catecholamine discrimination, by preventing generation of the polymer film they developed a 
technique that would allow for simultaneous and accurate measures of concentration 
changes for both species.  In sum, the findings from both this chapter and the recent 
publication establish FSCV at carbon-fiber microelectrodes as a viable technique for 
monitoring real-time changes in trace amine concentration and as a tool that should prove 
useful in future experiments exploring the role trace amines play in neurotransmission. 
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Chapter 6 
 
The Plasticity of Vesicular Content 
 
 
Introduction 
 The original recordings of postsynaptic responses at the neuromuscular junction 
indicated that neurotransmitter release was built upon a fundamental unit, or quantum, of 
synaptic transmission (Fatt and Katz, 1952; Del Castillo and Katz, 1954).  The quantal 
hypothesis identified single presynaptic vesicles filled with neurotransmitter as these 
fundamental units (Katz, 1971), and vesicular quantal size (Q) has classically been modeled 
as invariant.  However, considerable evidence has accumulated that indicates the amount of 
transmitter released per vesicle is not uniform (Edwards, 2007).  While Q can be regulated 
at steps following vesicle fusion (Harata et al., 2006), this chapter will focus on pre-fusion 
mechanisms that impact the vesicular packing and storage of transmitter. 
 Chemical messengers are packaged into vesicles via active transport by transporter 
proteins located on the vesicle membrane.  For catecholamines, this packaging is controlled 
by two differentially expressed isoforms of the vesicular monoamine transporter (VMAT): 
VMAT1 in chromaffin cells and VMAT2 in neuronal cells (Erickson et al., 1992; Liu et al., 
1992).  Like all vesicular transporters, the extent to which VMAT loads catecholamines into 
vesicles is dependent on both an electrochemical proton gradient and the cytoplasmic 
concentration of substrate (Chaudhry et al., 2008).  Thus, the biosynthesis of transmitters is 
directly tied to Q.  For catecholamines, the rate-limiting step in synthesis is the conversion of 
tyrosine into L-3,4-dihydroxy-phenylalanine (L-DOPA) by tyrosine hydroxylase (TH).  
Accordingly, bypassing this rate-limiting step in synthesis through the incubation of cells with 
L-DOPA has been shown to increase Q in isolated midbrain dopamine neurons (Pothos et 
al., 1998), rat phaeochromocytoma (PC12) cells (Pothos et al., 1996; Colliver et al., 2000a), 
and bovine chromaffin cells (Pothos et al., 2002).  This effect has not yet been 
demonstrated in rodent chromaffin cells. 
 In addition to the extent of catecholamine packaging by VMAT, Q is also dependent 
on the ability of vesicles to store the loaded transmitters.  One class of compounds that has 
been shown to affect vesicular storage is the amphetamines.  In the brain, amphetamine 
treatment results in the redistribution of vesicular catecholamine to the cytosol, followed by 
an increase in extracellular catecholamine concentration via reverse transport (Jones et al., 
1998).  This redistribution of vesicular catecholamine has been shown to decrease Q in both 
isolated PC12 and bovine chromaffin cells following amphetamine incubation (Sulzer et al., 
1995; Mundorf et al., 1999).  Though considered to function primarily as neuromodulators of 
monoamine transmission at their low physiological concentrations (tens of nM), doses of 
trace amine at levels significantly higher than endogenous concentrations have 
demonstrated amphetamine-like properties (Berry, 2004; Burchett and Hicks, 2006).  Given 
their amphetamine-like actions on vesicular catecholamine stores, and their activity as 
substrates for VMAT (Knoth et al., 1984; Romanenko et al., 1998), a potential function for 
trace amines as false transmitters has been suggested.  In this scenario, packaging of trace 
amines by VMAT would lead to the displacement of catecholamine and the vesicular release 
of trace amines instead.  However, the replacement of catecholamine exocytosis with that of 
trace amines has not been directly observed.  
 This chapter describes experiments designed to explore the plasticity of vesicular 
content at murine chromaffin cells.  Amperometric measurements of exocytosis showed no 
change in Q following preincubation with L-DOPA, norepinephrine (NE), or epinephrine (E).  
High performance liquid chromatography (HPLC) suggests that despite bypassing the rate-
limiting step in catecholamine synthesis, these treatments do not increase cytosolic 
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concentrations of catecholamine.  Fast scan cyclic voltammetry (FSCV) recordings of 
release after trace amine exposure revealed large deficits in both the size and number of 
vesicular events.  However, no evidence for the exocytosis of these putative false 
transmitters was detected.  HPLC measurements of total cellular catecholamine content 
indicate that in addition to the redistribution of vesicular stores to the cytoplasm, trace amine 
treatment also stimulates catecholamine synthesis. 
Materials and Methods 
Animals 
 Mice were handled in accordance with the guidelines set forth by the Institutional 
Animal Care and Use Committee (IACUC) at UNC-Chapel Hill.  C57BL/6J mice were 
obtained from The Jackson Library (Bar Harbor, ME). 
Preparation of Adrenal Medullary Chromaffin Cells 
 Murine chromaffin cells were prepared as previously described (Kolski-Andreaco et 
al., 2007) with some modifications.  A female mouse, 4-8 weeks old, was deeply 
anesthetized with ether, decapitated, and the adrenal glands rapidly removed into ice-cold, 
oxygenated Ca2+ and Mg2+-free Locke's buffer containing (in mM): 154 NaCl, 3.6 KCl, 5.6 
NaHCO3, 5.6 glucose, and 10 HEPES, pH adjusted to 7.2 with NaOH.  The medullae were 
isolated via gentle removal of cortical tissue and digested for 20 min at 37 oC in DMEM/F12 
with 25 U/mL papain.  The digestion media was replaced with a fresh aliquot, followed by a 
second 20 min digestion period.  Digested tissue was washed and triturated with pipette tips 
of decreasing bore size in 500 µL DMEM/F12 with 10 % fetal bovine serum and 2 % horse 
serum.  The resulting cell suspension was distributed evenly to 3 poly-L-lysine-coated (0.1 
mg/mL) 25 mm round glass coverslips.  After 15 min attachment plates were fed with 2 mL 
DMEM/F12 containing 100 U/mL penicillin, 0.1 mg/mL streptomycin, 50 U/mL nystatin, and 
40 µg/mL gentamicin.  Plates were maintained in a humidified, 5 % CO2 atmosphere at 37 
oC.  Experiments were carried out the following day. 
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Electrodes and Electrochemistry 
 Disk carbon-fiber microelectrodes were prepared using T650 (6 µm diameter, 
Amoco, Greenville, SC) or P55 carbon fibers (10 µm diameter, Amoco) as previously 
described (Kawagoe et al., 1993).  Fibers were aspirated into glass capillaries (A-M 
Systems, Sequim, WA), and a vertical pipette puller (Narishige, Long Island, NY) was used 
to seal the glass around the carbon fiber.  Carbon fibers were cut at the glass seal, which 
was then reinforced with epoxy (15 % m-phenylenediamine in Epon 828 resin (Miller-
Stephenson, Danbury, CT) heated to between 80 and 90 oC).  Electrodes were kept at room 
temperature overnight, and then the epoxy was cured via sequential heating at 100 and 150 
oC for 8 h and overnight, respectively.  Prior to use, electrodes were beveled at 45 degrees 
on a diamond dust-embedded polishing wheel (Sutter Instruments, Novato, CA) and soaked 
in isopropyl alcohol for at least 20 min (Bath et al., 2000). 
 Amperometric and FSCV recordings at single cells were made using a GeneClamp 
500B amplifier (Axon Instruments, Molecular Devices, Union City, CA).  For amperometry, 
electrodes were held at 0.650 V vs. a Ag/AgCl reference electrode (BASi, West Lafayette, 
IN), a potential sufficient to oxidize catecholamines.  The output current was analog filtered 
at 5 kHz with a low-pass Bessel filter and acquired at 20 kHz.  Post-collection, traces were 
further digitally filtered using a 400 Hz low-pass Bessel filter.  Data collection and filtering 
were controlled via the pClamp software provided with the amplifier.  For FSCV detection of 
catecholamines, the potential at the electrode was scanned from either -0.4 V or 0.1 V to 1.3 
V and back at 600 V/s, with the ramp repeated at 60 Hz.  Waveform application and current 
monitoring were controlled by locally written software (Tarheel CV, Labview). 
Single Cell Experiments 
 Glass coverslips containing plated cells were secured in a stainless steel coverslip 
holder and mounted on the stage of an inverted microscope (Eclipse TE300, Nikon 
Instruments, Melville, NY).  A temperature controller (Warner Instruments, Hamden, CT) 
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connected to the stage maintained cells at 37 oC throughout the experiments.  The 
extracellular recording buffer for amperometry contained (in mM): 145 NaCl, 3 KCl, 1.2 
MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 11 glucose, and 10 HEPES, pH adjusted to 7.4 with NaOH.  
For FSCV, the extracellular recording buffer contained (in mM): 140 NaCl, 4 KCl, 1 MgCl2, 2 
CaCl2, 10 glucose, and 20 Tris-HCl, pH adjusted to 7.4 with NaOH.  Exocytosis was 
triggered via pressure ejection of 60 mM K+ buffer from a stimulating pipette located 30 µm 
from the cell.  Stimulating pipettes with 6 to 10 µm tip diameters were fabricated using a 
horizontal pipette puller (Sutter Instruments, Novato, CA) and a microforge (Narishige, Long 
Island, NY).  Pressure ejection was controlled via a multi-channel Picospritzer (General 
Valve Corporation, Parker Hannifin, Fairfield, NJ).  Positioning of both the electrode and 
stimulating pipette was controlled using piezoelectric micromanipulators (Burleigh 
Instruments, Exfo, Plano, TX). 
Data Analysis 
 FSCV current versus time traces were extracted from the peak catecholamine 
oxidation potential.  Current was converted to concentration by post calibration in a flow 
injection system with a 10 µM bolus of NE and E.  Analysis of amperometric and FSCV 
traces was performed using MiniAnalysis software (Synaptosoft, Decatur, GA).  For 
inclusion, spike amplitude was required to be 5 times greater than the root-mean-squared 
current noise.  For frequency analysis, the first observed spike following stimulation marked 
the burst start time.  Burst end time was denoted by the first interspike interval > 1s.  
Individual spike characteristics such as quantal size (Q), amplitude, and t1/2 were averaged 
for an individual cell.  The cumulative mean for an experimental group was then determined 
using the cell averages (Colliver et al., 2000b).  All data are presented as means ± standard 
errors of the mean.  Statistical comparisons were performed using a Student's t-test. 
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HPLC Determination Cellular Catecholamine Content 
 Total content from all cells on one 25 mm coverslip was extracted via sonication in 
ice-cold 0.1 N perchloric acid spiked with 1 µM hydroquinone (HQ).  The extract was 
centrifuged at 6,000 rpm for 10 min, and the supernatant was removed and filtered with a 
0.2 µm syringe filter unit (Millex-LG).  The Lowry assay (Bio-Rad, Hercules, CA) was used to 
normalize extractions from different cell plates.  Injections (50 µL) were made onto a reverse 
phase column (C-18, 5 µm, 4.6 x 250 mm, Waters symmetry 300 or Waters Atlantis T3).  
For detection of catecholamines only, the mobile phase (prepared in HPLC grade water) 
contained 0.1 M citric acid, 0.1 mM EDTA, and 1 mM hexyl sodium sulfate, pH 3.5.  
Methanol was added as the organic modifier at a concentration of 10 % to shorten analyte 
elution times.  Catecholamines were detected with a thin-layer radial electrochemical 
flowcell (BASi, West Lafayette, IN), with the working electrode at 700 mV vs. a Ag/AgCl 
reference electrode (BASi, West Lafayette, IN).  For detection of catecholamines and trace 
amines, the mobile phased contained 7:3 0.02 M citric acid:0.02 M NaH2PO4, pH 3 (Pellati 
and Benvenuti, 2007).  The working electrode was held at 1.2 V.  The HQ (1 μM) was used 
as an internal standard for analyte quantification and recovery.  All analyte response ratios 
were taken with respect to the internal standard to account for differential electrode 
responses.  The determination of peak areas for HPLC measurements was performed 
using custom written Igor programs.  These programs were a gift from the Jorgenson lab at 
UNC-CH.  Peak area determination was performed using statistical moments regression 
theory (Hsieh and Jorgenson, 1996). 
Chemicals 
 All chemicals were purchased from Sigma Aldrich (St. Louis, MO) and used as 
received.  Aqueous solutions were prepared in doubly-distilled, deionized water.  Stock 
solutions of catecholamines and trace amines were prepared in 0.1 N HClO4 and diluted in 
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buffer on the day of each experiment.  All solutions were deoxygenated prior to use with at 
least 20 min of N2 bubbling. 
Results 
Vesicular Loading and Quantal Size at Chromaffin Cells 
 To examine the flexibility of vesicular Q, amperometric recordings of exocytosis were 
made at isolated murine chromaffin cells after treatments intended to increase cytosolic 
concentrations of NE and E.  Vesicular release was triggered with a single 3 s application of 
60 mM K+ from cells following a 1 h preincubation of plates at 37 oC with extracellular 
recording buffer or buffer containing 100 µM L-DOPA, NE, or E.  The average changes in 
amperometric spike characteristics are shown in Figure 6.1.  Treatment with L-DOPA 
produced no significant change (p > 0.05, Student's t-test) in any of the measures of 
exocytosis.  Events recorded at cells loaded with L-DOPA (n = 18) occurred at a frequency 
102 ± 12 % of that at untreated cells (n = 18).  Average Q was 97 ± 13 % and average t1/2 
was 100 ± 5 % of the unloaded levels.  Likewise, incubation with NE did not significantly 
alter (p > 0.05) vesicular release.  In cells loaded with NE (n = 15), the frequency of 
amperometric events was 92 ± 9 % of that in unloaded cells (n = 12), and the average Q 
and t1/2 for individual spikes were 100 ± 15 % and 97 ± 7 % of untreated levels, respectively.  
Finally, cells loaded with E (n = 14) also showed no significant changes (p > 0.05), with 
vesicular events having a frequency at 74 ± 12 %, average Q at 93 ± 16 %, and average t1/2 
at 107 ± 9 % of values from unloaded cells (n =10). 
  As L-DOPA, NE, and E loading had no affect on vesicular Q, HPLC with 
electrochemical detection was used to test if cytosolic concentrations of catecholamine were 
increasing.  Total intracellular NE and E content was determined from plated cells exposed 
to 50 µM or 100 µM L-DOPA for 1 h at 37 oC.  Consistent with the amperometric results, no 
changes were observed in catecholamine concentration after L-DOPA loading (Figure 6.2).  
Relative to untreated cells (n = 2 plates), NE and E levels were both at 101 % in cells  
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Figure 6.1.  Exocytosis following L-DOPA, NE, and E loading.  Vesicular release was 
measured by amperometry at murine chromaffin cells following a 3 s stimulation with 60 mM 
K+.  Release was measured at untreated cells and cells incubated for 1 h at 37 oC in 100 µM 
L-DOPA (n = 18), NE (n = 15), or E (n = 14).  The frequency of events and average spike 
quantal size and halfwidth after loading are shown as fractions of the unloaded values.  After 
loading, no significant differences (p > 0.05, Student’s t-test) were observed in any 
measures of exocytosis for all compounds.  
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Figure 6.2.  Cellular catecholamine content following L-DOPA loading.  HPLC with 
electrochemical detection was used to determine total NE and E content in untreated murine 
chromaffin cells and cells incubated for 1 h at 37 oC with 50 µM or 100 µM L-DOPA.  
Contents measured after loading are shown as a fraction of the unloaded values.  Data 
points are the averages from two 25 mm coverslips, one each from two separate 
preparations.  
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treated with 50 µM L-DOPA (n = 2 plates).  In cells loaded with 100 µM L-DOPA (n = 2 
plates), NE and E concentrations were at 98 % and 105 % of their values from unloaded 
cells, respectively. 
Trace Amines and Vesicular Content at Chromaffin Cells 
 As high concentrations of trace amine are proposed to displace vesicular 
catecholamines, FSCV was used to monitor exocytosis at individual chromaffin cells before 
and after a 20 min exposure at 37 oC to 1 mM tyramine, 1 mM octopamine, or 100 µM 
synephrine.  Vesicular release was initiated via a 0.5 s pressure ejection of 60 mM K+.  
Representative color plots and concentration versus time traces from cells incubated with 
the three trace amines are shown in Figures 6.3 through 6.5.  In all three cases, trace amine 
treatment produced a noticeable decrease in the number and/or size of detectable peaks.  
As a control, incubations were performed with normal extracellular recording buffer.  At 
these cells (n = 2), the number of peaks observed following treatment was reduced to 72 % 
of initial values, but peak size was unaffected at 104 %.  For cells exposed to tyramine (n = 
4), only 34 ± 12 % as many spikes were detected after incubation, with average amplitudes 
56 ± 16 % of pre-exposure values.  Similar decreases were seen for treatment with 
octopamine, where peak number and size were reduced to 39 ± 4 % and 61 ± 11 % of 
original levels, respectively.  Unlike tyramine and octopamine, synephrine incubation (n = 4 
cells) did not affect a greater reduction in observed spikes (63 ± 27 %) than control 
conditions, but did show a marked decrease in spike amplitude (41 ± 15 %).  Despite the 
obvious effects of trace amine treatment on the catecholamine content of vesicles, no 
evidence was observed for their replacement of catecholamines and subsequent vesicular 
release.  Examination of the cyclic voltammograms (CVs) recorded during the concentration 
spikes following incubation revealed no measurable currents at the characteristic trace 
amine oxidation potential of 1.0 V. 
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Figure 6.3.  Exocytosis following tyramine treatment.  FSCV was used to measure the K+-
stimulated vesicular release from a chromaffin cell prior to (A) and after (B) a 20 min 
incubation with 1 mM tyramine.  Color plots, concentration versus time traces, and 
representative cyclic voltammograms (from peaks marked with an asterisk) are shown for 
both conditions. Concentrations extracted from peak catecholamine oxidation current.  
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Figure 6.4.  Exocytosis following octopamine treatment.  FSCV was used to measure the 
K+-stimulated vesicular release from a chromaffin cell prior to (A) and after (B) a 20 min 
incubation with 1 mM octopamine.  Color plots, concentration versus time traces, and 
representative cyclic voltammograms (from peaks marked with an asterisk) are shown for 
both conditions. Concentrations extracted from peak catecholamine oxidation current.  
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Figure 6.5.  Exocytosis following synephrine treatment.  FSCV was used to measure the K+-
stimulated vesicular release from a chromaffin cell prior to (A) and after (B) a 20 min 
incubation with 100 µM synephrine.  Color plots, concentration versus time traces, and 
representative cyclic voltammograms (from peaks marked with an asterisk) are shown for 
both conditions.   Concentrations extracted from peak catecholamine oxidation current.  
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 To further investigate the fate of both the newly introduced trace amine and the 
displaced vesicular catecholamine, HPLC with electrochemical detection was used to probe 
any changes in non-vesicular stores.  Total intracellular catecholamine and trace amine 
contents were determined from plated cells exposed to 1 mM tyramine or octopamine for 30 
min at 37 oC.  Surprisingly, both treatments resulted in a large enhancement of cellular 
catecholamine concentration (Figure 6.6).  In cells incubated with tyramine (n = 2 plates), 
NE and E levels were 197 % and 161 %, respectively, of their values in untreated cells (n = 
2 plates).  Octopamine exposure (n = 2 plates) produced a comparable increase, with 
concentrations of NE raised to 173 % of original levels and E to 154 %.  In both cases, the 
growth in catecholamine stores was accompanied by only modest accumulation of trace 
amine.  Following tyramine incubation, tyramine levels were less than 6 % of the total 
catecholamine concentration.  Octopamine was also present, but at less than 1 %.  After 
octopamine treatment, cellular octopamine concentration was 1 % of the combined NE and 
E values.  No other trace amines were detected. 
Discussion 
 Incubation of isolated midbrain dopaminergic neurons, PC12 cells, and bovine 
chromaffin cells with L-DOPA has been shown to result in significant increases in Q (Pothos 
et al., 1996; Pothos et al., 1998; Colliver et al., 2000a; Pothos et al., 2002).  Through 
application of exogenous L-DOPA, the rate-limiting step in catecholamine synthesis is 
bypassed and the driving force for vesicular packaging by VMAT is increased due to the 
resulting enhancement of cytosolic catecholamine concentration.  This property of L-DOPA 
was even exploited in Chapter 2 to raise cellular dopamine levels at acutely dissociated 
midbrain neurons and facilitate the observation of exocytosis.  Therefore, it was rather 
surprising that L-DOPA treatment of mouse chromaffin cells produced no significant change 
in Q as measured by amperometry (Figure 6.1).  HPLC measurements of total cellular 
catecholamine content were also unaffected by L-DOPA treatment (Figure 6.2), confirming  
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Figure 6.6.  Cellular catecholamine content following trace amine treatment.  HPLC with 
electrochemical detection was used to determine total NE and E content in untreated murine 
chromaffin cells and cells incubated for 30 min at 37 oC with 1 mM tyramine or octopamine.  
Contents measured post-incubation are shown as a fraction of the unloaded values.  Data 
points are the averages from two 25 mm coverslips, one each from two separate 
preparations.  
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that neither the vesicular or cytosolic pools of catecholamine had been augmented.  Moving 
further down the biosynthetic pathway, incubations with the endogenously-released 
catecholamines NE and E also proved ineffective at increasing Q (Figure 6.1).  As a whole, 
the results from these loading experiments indicate that in murine chromaffin cells the 
vesicular pool of catecholamine is filled to a maximal capacity. 
 A previous report has shown L-DOPA-induced increases in Q at bovine chromaffin 
cells (Pothos et al., 2002), suggesting the results obtained here could be due to species-
specific regulation of catecholamine synthesis and packaging.  However, the vesicular 
events measured after L-DOPA treatment in this earlier study are slightly smaller than 
events observed in this laboratory at untreated bovine and mouse chromaffin cells.  Thus, 
it's proposed that the previous work was actually measuring rescue of an artificially-induced 
deficit and that chromaffin cell vesicles, unlike those from catecholamine-releasing neurons 
or PC12 cells, are largely insensitive to L-DOPA loading in the native state.  Recent 
experiments using intracellular patch electrochemistry to directly measure cytosolic 
catecholamine concentrations in chromaffin cells support this hypothesis (Mosharov et al., 
2003).  While resting cytosolic catecholamine concentrations were increased to roughly two-
fold during a 1 h exposure to 100 µM L-DOPA, they returned to control levels within 10 min 
of L-DOPA withdrawal.  This time course is comparable to the length of the washing and 
electrode placement steps used in the present study after the incubation step.  Given the 
current results that both vesicular and cytosolic levels of catecholamine are at control levels 
after roughly 10 min of withdrawal, the L-DOPA-induced rise in cytosolic catecholamine 
must either fail to produce a corresponding increase in Q or produce a temporary increase 
in vesicular catecholamine levels that dissipates in unison with those in the cytosol.  
Research showing that loaded dopamine in PC12 cells is preferentially located to the clear 
halo portion of the vesicle (Sombers et al., 2005), largely absent in chromaffin cell vesicles, 
indicates the former as a distinct possibility.  
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 Although chromaffin cell vesicles proved resistant to manipulations intended to 
increase Q, treatments expected to disrupt vesicular stores produced mostly anticipated 
results.  At high concentrations, the trace amines are thought to mimic the actions of 
amphetamine and redistribute catecholamines from the vesicular compartment to the cytosol 
(Berry, 2004; Burchett and Hicks, 2006).  Accordingly, exposure of chromaffin cells to 1 mM 
tyramine, 1 mM octopamine, or 100 µM synephrine noticeably reduced the number and 
amplitude of vesicular events measured by FSCV during K+-stimulated exocytosis (Figure 
6.3 and Table 6.1).  Unlike amperometry, the area under the spikes observed by FSCV is 
not directly related to the total number of molecules detected.  However, as the extracellular 
volume between the cell and the electrode is mostly confined, the peak concentration 
(amplitude) reached following a vesicular release event can be used as a suitable indicator 
of Q.  Thus, similar to amphetamine treatment (Sulzer et al., 1995; Mundorf et al., 1999), 
incubation with high concentrations of trace amine decreases Q at chromaffin cells. 
 Prior to trace amine exposure, every single CV recorded during vesicular release 
events displayed the characteristic shape of catecholamine oxidation and reduction (Figure 
6.3).  Following exposure, the oxidative current at 1.0 V indicative of trace amine presence 
was not distinguishable in any of the CVs (Figure 6.3).  The ability of FSCV to 
simultaneously measure trace amine-induced disruption of vesicular catecholamine stores 
despite no vesicular release of the trace amines themselves provides strong evidence that 
these molecules don't accumulate sufficiently to function as false transmitters.  Although the 
trace amines are transported by VMAT with an affinity and velocity comparable to the 
catecholamines (Romanenko et al., 1998; Partilla et al., 2006), the lack of a second ring 
hydroxyl (Figure 5.1) renders them more lipophilic.  This increased lipophilicity has been 
demonstrated to result in the permeation of tyramine in its unprotonated form across the 
chromaffin vesicle membrane (Johnson et al., 1982; Knoth et al., 1984).  The current results 
would then suggest that high concentrations of trace amine promote depletion of vesicular 
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stores through competitive inhibition of catecholamine transport at VMAT.  In the presence 
of extracellular trace amine, the transport and permeation processes most likely reach a 
steady state.  Upon removal of extracellular trace amine, the rate of active transport is 
rapidly diminished and permeation of trace amine from the vesicle interior prohibits the 
observation of these compounds in vesicles undergoing exocytosis. 
 HPLC measurements of total cellular catecholamine content were used to gain 
greater insight into the redistribution of vesicular stores triggered by trace amine treatment.  
Following incubations of plated cells with tyramine and octopamine, only very low levels of 
the trace amines were detected.  This result is consistent with both the lipid permeability 
discussed above and the greater metabolic turnover of trace amines relative to 
catecholamines (Durden et al., 1988).  Importantly, the presence of measurable octopamine 
levels following tyramine exposure confirms that the trace amines are gaining access to the 
vesicle interior, as the enzyme that catalyzes this conversion, dopamine β-hydroxylase, is 
located on the inside of the vesicular membrane.  As for the fate of the displaced 
catecholamines, HPLC showed substantial increases in total cellular catecholamine content 
(Figure 6.4).  This finding is rather counterintuitive.  Cytosolic regulation of catecholamine 
concentration is tightly controlled through rapid metabolism via monoamine oxidase (MAO) 
(Mosharov et al., 2003).  That total cellular content is greatly enhanced indicates trace 
amine treatment is not only preventing the metabolism of catecholamine, but actively 
stimulating synthesis.  Tyramine has demonstrated a higher affinity than NE and E for MAO 
in chromaffin cells (Youdim et al., 1986), so the lack of catecholamine degradation could be 
attributed to competitive inhibition by the trace amines.  The increased synthesis is a novel 
finding, however, and less easily explained.  Amphetamine has been shown to stimulate 
dopamine synthesis by TH (Kuczenski, 1975; Larsen et al., 2002).  As high trace amine 
concentrations mimic several of amphetamine's effects on vesicular catecholamine stores, it 
is possible they might also share the ability to activate TH.  Alternatively, liver microsomes 
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have been shown to catalyze the synthesis of catecholamines from the direct hydroxylation 
of the corresponding trace amines (Axelrod, 1963; Hiroi et al., 1998).  If the cytochrome 
P450 isoforms responsible for this reaction are expressed in chromaffin cells, this pathway 
could also be an explanation for the measured increase in cellular catecholamine content.  
Future investigations will certainly be necessary to shed more light on this exciting new role 
for trace amine modulation of catecholamine transmission.   
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Appendix 1 
 
Exploring the Origin of Post-Spike Feet 
 
 
Introduction 
 The final steps in vesicular exocytosis are the Ca2+-triggered fusion of secretory 
vesicles with the cell plasma membrane and the extrusion of the packaged chemical 
messengers into the extracellular space.  Mediating this fusion are SNARE proteins on the 
vesicle and plasma membranes, whose interactions provide the necessary driving force for 
destabilization and subsequent mixing of the two phospholipid bilayers (Hanson et al., 1997; 
Weber et al., 1998).  The initial mixing of the two membranes generates a fusion pore, a thin 
channel connecting the vesicle interior and the cell exterior.  Expansion of the fusion pore 
leads to a rapid flux of transmitter into the extracellular space, resulting in the sharp current 
spikes generally observed during amperometric studies of exocytosis (Figures 1.5 and 1.6).  
Occasionally, amperometric events will also exhibit pre-spike features termed feet, resulting 
from a slower efflux or leak of transmitter through the fusion pore prior to expansion (Chow 
et al., 1992).  In addition, work in this lab has noted the previously undocumented 
occurrence of post-spike features that closely resemble pre-spike feet (Figure A1.1) 
(Haynes, unpublished results).  These post-spike feet are hypothesized to result from the 
fast endocytosis of vesicles.  In a simple vesicle fusion event, the entire transmitter content 
is released and the vesicle membrane completely incorporates into the plasma membrane.  
Vesicles then recycle via the slow endocytosis pathway through formation of clathrin-coated 
pits (Smith et al., 2008).  In contrast, fast endocytosis recycles vesicles via reclosure of the 
expanded fusion pore, resulting in intact vesicles that may or may not undock from the 
  
 
Figure A1.1.  Examples of pre- and post-spike feet.  Individual vesicular events recorded 
with amperometry at bovine chromaffin cells are shown to demonstrate the appearance of 
pre-spike feet (left trace) and post-spike feet (right trace).  Pre-spike feet are observed as a 
result of the slow flux of chemical messengers through a narrow fusion pore intermediate 
prior to expansion.  Post-spike feet are hypothesized to result from a similar intermediate 
formed during the fast endocytosis pathway.  
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plasma membrane (Harata et al., 2006).  The natural assumption is that resealing the 
vesicle membrane would produce a second fusion pore intermediate through which the 
slower efflux or leak of transmitter could be detected by amperometry. 
 This appendix describes a single pharmacological attempt at understanding the 
origin of the observed post-spike feet.  Amperometric recordings of exocytosis were made at 
isolated bovine chromaffin cells exposed to wortmannin, a furanosteroid produced by the 
fungus Penicillium funiculosum.  Wortmannin is a potent inhibitor of phosphatidylinositol 3-
kinase (PI3K) (Arcaro and Wymann, 1993), and has been demonstrated to selectively inhibit 
the slow endocytosis of reserve pool (RP) vesicles (Richards et al., 2004).  This inhibition is 
tentatively attributed to disruption of clathrin-coat-dependent mechanisms, which are 
regulated by PI molecules (Cremona and De Camilli, 2001).  Treatment of chromaffin cells 
with wortmannin produced no measurable change in RP exocytosis.  The occurrence of 
post-spike feet was also unchanged, suggesting these features indeed result from the fast 
endocytosis pathway. 
Materials and Methods 
Preparation of Bovine Adrenal Medullary Chromaffin Cells 
 Bovine chromaffin cells were prepared from adrenal glands obtained at a local 
abattoir as previously described (Wilson and Viveros, 1981; Leszczyszyn et al., 1990). 
Chromaffin cells were isolated from the adrenal medulla via digestion with collagenase 
(Worthington Biochemical Corporation, Lakewood, NJ), followed by density gradient 
centrifugation in Renografin (Bracco Diagnostics, Princeton, NJ).  The resulting cell 
suspension was plated at a density of 300,000 cells/25 mm round glass coverslip.  Plates 
were maintained in a humidified, 5 % CO2 atmosphere at 37 oC, and used for experiments 
between 3 and 7 days post-plating. 
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Electrodes and Electrochemistry 
 Disk carbon-fiber microelectrodes were prepared using T650 carbon fibers (6 µm 
diameter, Amoco, Greenville, SC) as previously described (Kawagoe et al., 1993).  Fibers 
were aspirated into glass capillaries (A-M Systems, Sequim, WA), and a vertical pipette 
puller (Narishige, Long Island, NY) was used to seal the glass around the carbon fiber.  The 
carbon fibers were cut at the glass seal, which was then reinforced with epoxy (15 % m-
phenylenediamine in Epon 828 resin (Miller-Stephenson, Danbury, CT) heated to between 
80 and 90 oC).  Electrodes were kept at room temperature overnight, and then the epoxy 
was cured via sequential heating at 100 and 150 oC for 8 h and overnight, respectively.  
Prior to use, electrodes were beveled at 45 degrees on a diamond dust-embedded polishing 
wheel (Sutter Instruments, Novato, CA) and soaked in isopropyl alcohol for at least 20 min 
(Bath et al., 2000). 
 Amperometric recordings at single cells were made using an Axopatch 200B 
amplifier (Axon Instruments, Molecular Devices, Union City, CA).  Electrodes were held at 
0.650 V vs. a Ag/AgCl reference electrode (BASi, West Lafayette, IN), a potential sufficient 
to oxidize catecholamines.  The output current was analog filtered at 5 kHz with a low-pass 
Bessel filter and acquired at 20 kHz.  Post-collection, traces were further digitally filtered 
using a 250 Hz low-pass Bessel filter.  Data collection and filtering were controlled by locally 
written software (Tarheel CV, Labview). 
Single Cell Experiments 
 Glass coverslips containing plated cells were secured in a stainless steel coverslip 
holder and mounted on the stage of an inverted microscope (Eclipse TE300, Nikon 
Instruments, Melville, NY).  A temperature controller (Warner Instruments, Hamden, CT) 
connected to the stage maintained cells at 37 oC throughout the experiments.  The 
extracellular recording buffer contained (in mM): 145 NaCl, 3 KCl, 1.2 MgCl2, 2.4 CaCl2, 1.2 
NaH2PO4, 11 glucose, and 10 HEPES, pH adjusted to 7.4 with NaOH.  Exocytosis was 
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triggered via a single 5 s pressure ejection of 5 mM Ba2+ buffer from a stimulating pipette 
located 30 µm from the cell.  Stimulating pipettes with 6 to 10 µm tip diameters were 
fabricated using a horizontal pipette puller (Sutter Instruments, Novato, CA) and a 
microforge (Narishige, Long Island, NY).  Pressure ejection was controlled via a multi-
channel Picospritzer (General Valve Corporation, Parker Hannifin, Fairfield, NJ).  Positioning 
of both the electrode and stimulating pipette was controlled using piezoelectric 
micromanipulators (Burleigh Instruments, Exfo, Plano, TX). 
Data Analysis 
 Amperometric spike analysis was performed using MiniAnalysis software 
(Synaptosoft, Decatur, GA).  For inclusion, spike amplitude was required to be 5 times 
greater than the root-mean-squared current noise.  Overlapping peaks were included in 
frequency and foot analysis, but excluded from individual spike analysis.  Visual examination 
of the peaks was used to determine presence of post-spike feet.  Individual amperometric 
spike characteristics such as quantal size (Q) and t1/2 were averaged for an individual cell.  
The cumulative mean for an experimental group was then determined using the cell 
averages (Colliver et al., 2000).  All data are presented as means ± standard errors of the 
mean.  Statistical comparisons were performed using a Student's t-test. 
Results 
 To investigate potential wortmannin-induced changes in post-spike foot behavior, 
amperometry was used to measure vesicular release at isolated bovine chromaffin cells.  As 
wortmannin acts selectively on RP endocytosis (Richards et al., 2004), stimulated 
exocytosis of the RP was isolated from that of the readily releasable pool (RRP) using a 5 s 
application of 5 mM Ba2+ (Seward et al., 1996; Duncan et al., 2003).  Figure A1.2 shows 
representative amperometric traces obtained at control cells (n =19) and cells incubated with 
1 µM wortmannin for 15 min prior to recording (n =25).  Wortmannin treatment produced no 
significant changes (p > 0.05, Student's t-test) in any of the baseline measures of RP  
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Figure A1.2.  Vesicular release after wortmannin treatment.  Representative amperometric 
traces measured in response to a 5 s stimulation with 5 mM Ba2+ at bovine chromaffin cells 
following a 15 min incubation in normal recording buffer (A) or 1 µM wortmannin (B).
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Figure A1.3.  Amperometric spike characteristics following wortmannin treatment.  Bar 
graphs show the average frequency of vesicular events and individual spike characteristics, 
including halfwidth (t1/2, in ms), quantal size (Q, in amol of catecholamine), and % of events 
with a post-spike foot.  No significant differences (p > 0.05, Student’s t-test) were observed 
between control cells (n = 19) and cells treated with 1 µM wortmannin (n = 25) in any 
measures of exocytosis.  
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exocytosis (Figure A1.3).  In control cells, individual vesicular events occurred at a 
frequency of 1.6 ± 0.2 Hz, and the average amperometric spike had a t1/2 of 29 ± 2 ms and 
Q of 2.5 ± 0.3 amol of catecholamine.  Similarly, events at wortmannin treated cells occurred 
at a frequency of 2.3 ± 0.3 Hz with an average t1/2 of 26 ± 2 ms and Q of 3.5 ± 0.5 amol of 
catecholamine.  Most importantly, wortmannin incubation didn't alter the prevalence of post-
spike feet, with 2.1 ± 0.2 % and 2.9 ± 0.7 % of exocytotic spikes exhibiting these features in 
control and treated cells, respectively (Figure A1.3). 
Discussion 
 The fungal metabolite wortmannin, an inhibitor of PI3K, has been shown to 
selectively halt the slow endocytosis of RP vesicles (Richards et al., 2004).  Amperometric 
measurements at isolated chromaffin cells were conducted to determine if wortmannin 
treatment resulted in changes in the exocytosis of RP vesicles, specifically the occurrence of 
post-spike feet believed to represent fusion pore behavior solely during fast endocytosis 
pathways.  To isolate RP exocytosis from that involving both the RRP and RP, release was 
stimulated using Ba2+ as a secretagogue (Seward et al., 1996; Duncan et al., 2003).  As has 
been reported previously (Heldman et al., 1989; von Ruden et al., 1993), Ba2+-induced 
vesicular release is slower and longer lasting relative to K+-stimulated release (compare 
Figure A1.2 to Figure 4.2).  A 15 min incubation with 1 µM wortmannin did not significantly 
alter the prevalence of post-spike feet (Figure A1.3), supporting the hypothesis that these 
features arise when vesicles are recycled via a fast endocytosis pathway.  Inhibition of the 
slow endocytosis pathway produced no side effects on vesicular exocytosis, as wortmannin-
treated cells showed no changes in the frequency, Q, or t1/2 of Ba2+-stimulated events 
(Figure A1.3).  While the continued presence of post-spike feet following wortmannin 
incubation supports a fast endocytosis origin, it was initially surprising that no measures of 
exocytosis were affected.  By shutting down the slow pathway, it was assumed that more 
vesicles would undergo fast recycling and the frequency of events and/or the prevalence of 
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post-spike feet would increase.  That no changes were measured suggests that vesicle 
recycling via the slow endocytosis pathway is not a major component of Ba2+-induced RP 
exocytosis.  Future experiments with multiple stimulations could address the extent and time 
course to which slow endocytosis contributes to the release of RP vesicles.  
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Appendix 2 
 
Pressure Ejection, Extracellular Calcium, and Exocytosis 
 
 
Introduction 
 The ultimate trigger for synaptic vesicle exocytosis is the influx of Ca2+ ions through 
voltage-gated calcium channels (VGCCs) (Llinas et al., 1992; Borst and Sakmann, 1996).  
These channels open in response to depolarization of the plasma membrane as an action 
potential invades the synapse.  Neurotransmitter release is dependent on the appropriate 
timing of the Ca2+ influx relative to the action potential and proportional to the resulting 
increase in [Ca2+]i.  This Ca2+-based mechanism of stimulus-secretion coupling is conserved 
in most excitable cells, including chromaffin cells (Douglas and Rubin, 1961; Holz et al., 
1982).  The development of fluorescent Ca2+ indicators (Grynkiewicz et al., 1985) provided 
researchers the necessary tools to monitor this coupling in real time (Finnegan and 
Wightman, 1995).  In these experiments, Ca2+ influx is generally triggered via pressure 
ejection of depolarizing agents.  Ideally, these agents are dissolved in the extracellular 
recording buffer to ensure the secretagogue effect is distinct from any other changes in the 
local cell environment.  For experiments where such controls aren't possible, it is necessary 
to understand the extracellular Ca2+ ion concentration dynamics that result from mixing of 
the stimulus volume with the stationary recording buffer. 
 To examine the interplay between extracellular Ca2+ levels, pressure ejection-
mediated alterations in the cellular environment, and exocytosis-triggering Ca2+ influx, the 
fluorescent dye fura-2 was used to record changes in [Ca2+]i at bovine chromaffin cells 
following pressure ejection of a high [K+] secretagogue.  To isolate the role of Ca2+ ion 
dynamics, the only variable in these experiments was the presence or absence of Ca2+ in 
the recording buffer and the stim.  The presence of Ca2+ in the stim solution was sufficient to 
support K+-induced Ca2+ influx, suggesting a significant contribution of the stim to the local 
extracellular ion concentrations sensed by cells during pressure ejection.  However, the 
significantly diminished amplitude of this Ca2+ transient combined with the normal Ca2+ 
responses observed with Ca2+-free stims indicate that dilution of secretagogue ions by the 
extracellular buffer occurs on a timescale relevant to VGCC activation and exocytosis. 
Materials and Methods 
Preparation of Bovine Adrenal Medullary Chromaffin Cells 
 Bovine chromaffin cells were prepared from adrenal glands obtained at a local 
abattoir as previously described (Wilson and Viveros, 1981; Leszczyszyn et al., 1990). 
Chromaffin cells were isolated from the adrenal medulla via digestion with collagenase 
(Worthington Biochemical Corporation, Lakewood, NJ), followed by density gradient 
centrifugation in Renografin (Bracco Diagnostics, Princeton, NJ).  The resulting cell 
suspension was plated at a density of 300,000 cells/25 mm round glass coverslip.  Plates 
were maintained in a humidified, 5 % CO2 atmosphere at 37 oC, and used for experiments 
between 3 and 7 days post-plating. 
Fluorescent Measurements of Intracellular Ca2+ 
 Intracellular Ca2+ dynamics were monitored using the ratiometric dye fura-2 
(Invitrogen, Carlsbad, CA).  Plated cells were incubated for 20 min at 25 oC in extracellular 
recording buffer with 1 µg/mL esterified fura dye and 0.1 % (w/v) BSA, washed twice with 
buffer without dye, and then incubated for 20 min at 25 oC in buffer without dye for 
deesterification.  Ca2+ bound and unbound dye were excited at 340 and 380 nm, 
respectively, using a computer-controlled high speed wavelength switcher (Sutter 
Instruments, Novato, CA).  Emission was monitored at 510 nm using a CCD camera and 
acquisition software (Empix Imaging, Mississauga, ON, Canada). 
156 
 
Single Cell Experiments 
 Glass coverslips containing plated cells were secured in a stainless steel coverslip 
holder and mounted on the stage of an inverted microscope (Eclipse TE300, Nikon 
Instruments, Melville, NY).  A temperature controller (Warner Instruments, Hamden, CT) 
connected to the stage maintained cells at 37 oC throughout the experiments.  The 
extracellular recording buffer contained (in mM): 145 NaCl, 3 KCl, 1.2 MgCl2, 2.4 CaCl2, 1.2 
NaH2PO4, 11 glucose, and 10 HEPES, pH adjusted to 7.4 with NaOH.  Ca2+ influx was 
triggered via a single 3 s pressure ejection of 60 mM K+ buffer from a stimulating pipette 
located 30 µm from the cell.  Stimulating pipettes with 6 to 10 µm tip diameters were 
fabricated using a horizontal pipette puller (Sutter Instruments, Novato, CA) and a 
microforge (Narishige, Long Island, NY).  Pressure ejection was controlled via a multi-
channel Picospritzer (General Valve Corporation, Parker Hannifin, Fairfield, NJ).  Positioning 
of both the electrode and stimulating pipette was controlled using piezoelectric 
micromanipulators (Burleigh Instruments, Exfo, Plano, TX). 
Results 
 The ratiometric dye fura-2 was used to measure changes in [Ca2+]i at isolated bovine 
chromaffin cells following depolarization of the plasma membrane with a 3 s pressure 
ejection of 60 mM K+.  Three experimental conditions were tested.  Serving as the control, 
Ca2+ influx was recorded in cells (n =19) where both the extracellular buffer and the stim 
solution contained physiological Ca2+ levels (2.4 mM).  Additionally, responses were 
monitored when Ca2+ was completely removed from the extracellular buffer (n = 14 cells), 
the stim solution (n = 5 cells), or both (n = 5 cells).  As expected, depolarization of cells in 
the absence of both stim and buffer Ca2+ resulted in no increase in [Ca2+]i as measured by 
Fura-2 (data not shown).  Representative rises in [Ca2+]i for the other three conditions are 
shown in Figure A2.1.  Several key properties of the intracellular Ca2+ transients are 
summarized in Figure A2.2.  Under control conditions, the K+-triggered influx raised [Ca2+]i  
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Figure A2.1.  Effect of extracellular Ca2+ on intracellular Ca2+ responses.  Fura-2 was used 
to monitor increases in [Ca2+]i at bovine chromaffin cells after 3 s pressure ejection of 60 mM 
K+.  Representative traces from three different extracellular Ca2+ conditions are shown: Ca2+ 
in both the buffer and stim solution, in the stim solution only, or in the buffer only.  
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Figure A2.2. Intracellular Ca2+ dynamics depend on buffer Ca2+.  Graphs show the average 
amplitude (in µM), area (in arbitrary units), and halfwidth (t1/2, in s) of the increase in [Ca2+]i 
at isolated bovine chromaffin cells following a 3 s stimulation with 60 mM K+.  Experiments 
were performed with Ca2+ present in both the buffer and stim solutions (n = 19 cells), stim 
only (n = 14 cells), or buffer only (n = 5 cells).  No significant difference (p > 0.5 for all 
measures, one-way ANOVA) was observed upon removal of Ca2+ from the stim solution.  
Removal of Ca2+ from the extracellular buffer resulted in a significant decrease (p < 0.01) in 
the amplitude of the  [Ca2+]i signal, but  did not affect (p > 0.05) the overall size or time 
course.  
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by an average of 1.50 ± 0.10 µM.  Removal of Ca2+ from the extracellular buffer significantly 
depressed (p < 0.01, one-way ANOVA) this amplitude to 0.92 ± 0.12 µM, while no significant 
difference (p > 0.05) was observed upon removal of Ca2+ from the stim solution (1.42 ± 0.19 
µM).  However, the total area and t1/2 of the intracellular Ca2+ responses were unchanged (p 
> 0.05) relative to control values at cells were extracellular Ca2+ was present only in the 
buffer or stim solution. 
Discussion 
 The influx of extracellular Ca2+ ions through VGCCs on the plasma membrane is 
necessary for generation of the rapid increases in [Ca2+]i that trigger exocytosis.  
Demonstrating this, depolarization of chromaffin cells with 60 mM K+ produced no rise in 
[Ca2+]i, as measured by fura-2, when Ca2+ was removed from both the extracellular 
recording buffer and the stim solution.  Removal of Ca2+ from only one of these solutions 
produced more subtle effects (Figures A2.1 and A2.2).  The intracellular Ca2+ transients 
observed when Ca2+ was present only in the extracellular buffer were statistically 
indistinguishable from those in control conditions, suggesting that the small stim volume 
minimally impacts the local cell environment.  However, with the exception of a decrease in 
amplitude, the responses at cells where Ca2+ was present only in the stim solution were also 
unchanged from control conditions.  These results would indicate that the effective 
extracellular [Ca2+] at a cell during pressure ejection is largely due to the [Ca2+] in the stim 
solution, not the recording buffer.  Both data can be explained by a model of pressure 
ejection in which the effects of rapid mixing of the two solutions are equal or greater to 
volume displacement.  Thus, the Ca2+-containing stim is rapidly diluted by the Ca2+-free 
buffer, resulting in a lower effective extracellular [Ca2+] at the cell, a smaller driving force for 
Ca2+ influx, and smaller rise in [Ca2+]i.  Similarly, the absence of Ca2+ from the stim is 
overwhelmed by the larger volume of Ca2+-containing buffer, resulting in no change in the 
effective extracellular [Ca2+] sensed by the cell.  This initial mixing must occur on a timescale 
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comparable to the depolarization-induced opening of VGCCs, in the ms regime.  Future 
experiments in which the [Ca2+] in the recording buffer and stim, duration of pressure 
ejection, and distance of the stimulating pipette from the cell are varied would provide 
valuable insight into the kinetics of extracellular ion equilibration occurring at the local cell 
environment.  Additionally, simultaneous detection of [Ca2+]i with fluorescent dyes and 
exocytosis with amperometry could be used to demonstrate how changes in the intracellular 
Ca2+ transient impact vesicular release. 
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